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Neural induction is the process that occurs during embryogenesis whereby 
ectoderm is converted into neural tissue. However, the cellular and molecular 
mechanisms that govern this process are still not completely understood. For 
instance, in Xenopus, calcium signalling is known to play a pivotal role in neural 
induction but whether a similar mechanism occurs in mammals is unknown. As 
part of a wider study on genes regulating neural stem cell (NSC) development, 
we have discovered a novel role for Neuronatin (Nnat), a regulator of 
intracellular Ca2+ concentration. In my thesis, I describe the use of a mouse 
embryonic stem cell (ESC)-derived neural differentiation model to dissect the 
function of Nnat in neural development.  
 
Using gain- and loss-of function experiments I show that ESCs in which Nnat 
expression had been knocked-down have a dramatically decreased ability to 
generate NSCs, and subsequently neurons, while ESCs that over-expressed Nnat 
generate an excess of NSCs and neurons. I reveal that Nnat interacts directly 
with the sarcoendoplasmic reticulum Ca2+-ATPase 2 (Apt2a2/SERCA2), and 
that Apt2a/SERCA inhibitors cause an increase in cytosolic calcium levels 
rescuing the ability of Nnat knockdown cells to generate neural cell-types. From 
these experiments I conclude that Apt2a/SERCA inhibition mimics the function 
of Nnat and, via the increase of cytosolic calcium, causes neural induction in 
Nnat knocked-down ESCs. I go on to show that this increase in cytosolic Ca2+, 
caused by inhibiting Apt2a/SERCA, activates Erk signalling and that inhibition 
of Erk signalling dramatically reduces the ability of ESCs to generate NSC. 
 
Together these results suggest that Nnat functions by increasing cytosolic Ca2+ 
levels, which in turn causes activation of Erk signalling leading to neural 
induction. In line with this, the expression of BMP4, which is an inhibitor of 
neural induction, was found to be up-regulated by Nnat knocked-down. Overall 
my thesis research indicates that Nnat plays a pivotal role in enabling ESCs to 
differentiate along a neural lineage.  
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1.0 Introduction  
Neural induction is the earliest step of vertebrate neural development (Munoz-
Sanjuan and Brivanlou, 2002). During embryogenesis, neural induction is the 
process by which part of ectoderm is specified as neuroectoderm that ultimately 
gives rise to the central nervous system (Stern, 2006). The remaining ectoderm 
gives rise to epidermis and becomes skin (Wilson and Hemmati-Brivanlou, 
1995). The process of neural induction is complex and, as will be discussed in 
greater details below, involves the interaction of both instructive and inhibitory 
cues; however, the precise molecular mechanisms that govern this process have 
yet to be fully understood (Gaulden and Reiter, 2008). Within this introduction, 
I will discuss what is known about neural induction in vertebrates, focusing on 
similarities and differences between mammals and amphibians.  
    
1.1 Neural induction occurs during gastrulation  
During mammalian embryonic development, a fertilized egg goes through 
several cycles of cell division to form a solid ball-like structure called a 
morula (Tam and Loebel, 2007). The morula further develops into the 
blastocyst which consists of the inner cell mass (ICM) and the trophoblast, 
which is the outer layer of the blastocyst and will develop into the placenta 
(Adamson et al., 2002). The ICM differentiates into primitive ectoderm that 
goes on to generate the three primary germ layers (ectoderm, mesoderm and 
endoderm); a process called gastrulation (Tam and Loebel, 2007). 
Ultimately, the ectoderm (the external layer) forms skin, and nervous system, 
the mesoderm (the middle layer) forms the cardiovascular system, skeletal 
muscles, and hematopoietic cells, while the endoderm (the internal layer) 
forms the lungs, liver, and pancreas.  
 
The process by which the ectoderm is specified along a neural pathway 
(neuroectoderm) is called neural induction and requires signals from the 
underlying mesoderm (Fig. 1.1A; Hemmati-Brivanlou and Melton, 1997b; 
Munoz-Sanjuan and Brivanlou, 2002; Stern, 2005). The neuroectoderm 
develops into the neural plate whose boarders become elevated forming 
neural folds, leaving a deep neural groove at the midline (Fig. 1.1B-C). Next 
the neural folds move towards each other and fuse at the midline (Fig. 1.1D) 
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transforming the neural groove into a tubular structure called neural tube 
(Clarke et al., 1991; Downs and Davies, 1993; Gammill and Bronner-Fraser, 
2003). The caudal region of this neural tube develops into the spinal cord 
while the rostral region gives rise to the brain (Downs and Davies, 1993; 
Greene and Copp, 2009). 
 
 
Fig. 1.1. The formation of neural tube in vertebrates.  
(A) During gastrulation, primitive ectoderm gives rise to three primary germ layers known 
as ectoderm, mesoderm, and endoderm. The medial ectoderm overlying the notochord 
(derived from mesoderm) receives signals from the mesoderm and takes on a neural fate. 
This process is called neural induction. The peripheral ectoderm becomes the prospective 
epidermis. (B, C) After neural induction, the cells at the border of the neural plate become 
elevated neural folds, leaving a deep neural groove at the midline. (D) Both sides of neural 
folds move towards each other and fuse at the midline, forming the neural tube and surface 
ectoderm. The neural tube and surface ectoderm further give rise to central nervous system 




Amphibian embryos have been widely used to study embryonic 
development (Harland and Grainger, 2011), mainly because they are large, 
 21 
making it relatively easy to perform surgical procedures. In addition, gene-
expression in these embryos can be manipulated easily, through injections of 
mRNA or antisense RNA into embryos to evaluate their role in 
embryogenesis (Hulstrand et al., 2010). During Xenopus embryogenesis, 
after fertilization the egg goes through several rounds of cell division to 
form a hollow ball of cells called a blastula. At this stage the embryo 
consists of three portions, the animal cap, marginal zone, and the vegetal 
mass (Fig. 1.2; Heasman, 2006). The animal cap is located around the 
animal pole and the vegetal mass, consisting of yolky cells, is located 
opposite the animal cap. As its name suggests, the marginal zone is located 
between the animal cap and vegetal mass (Daniels et al., 2004). During 
gastrulation, the animal cap, marginal zone, and vegetal mass differentiate 
into embryonic ectoderm, mesoderm, and endoderm respectively (Gaulden 
and Reiter, 2008; Schneider and Mercola, 2001; Wylie et al., 1987). Further, 
the dorsal and ventral embryonic ectoderm gives rise to the neural plate and 
epidermis respectively (De Robertis and Kuroda, 2004; Suzuki et al., 1997). 
Like the mammalian neural plate, described above, the amphibian neural 





Fig. 1.2. Schematic amphibian embryo at the blastula stage. 
After several cell divisions the amphibian embryo forms a blastula with a fluid-filled 
blastocoel. The blastula consists of three portions, the animal cap, marginal zone, and the 
vegetal mass. The marginal zone is located between the animal cap and vegetal mass. The 
animal cap is located around the animal pole and the vegetal mass contains yolky cells and 
is located opposite the animal cap.  
(Adapted from http://www.proprofs.com/flashcards/upload/a4183539.jpg) 
 
Because of their size and ease of manipulating gene-expression, amphibian 
embryos have often been used as a neural developmental model to study the 
mechanisms of neural induction (Munoz-Sanjuan and Brivanlou, 2002; 
Wilson and Edlund, 2001). 
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1.2 Neural induction through BMP inhibition  
How neural induction is controlled is a long-standing question in vertebrate 
development. Over the past decades, many studies carried out in amphibian 
embryos have tried to answer this question (Munoz-Sanjuan and Brivanlou, 
2002; Wilson and Edlund, 2001). In the 1920s, Spemann and Mangold 
conducted transplantation studies in amphibian embryos and these studies 
provided the first insight into the regulation of neural induction (Spemann 
and Mangold, 2001). They found a group of mesodermal cells located at the 
dorsal lip (dorsal margin of the blastopore) of the amphibian embryo that 
could induce the development of an ectopic neural axis when transplanted 
into another amphibian embryo. They called this group of cells the 
‘organiser’ (Fig. 1.3A; Kuroda et al., 2004; Spemann and Mangold, 2001; 
Wilson and Edlund, 2001). When the organiser region was removed from 
the blastula, the Xenopus embryo no longer generated a brain (Kuroda et al., 
2004). This result suggested that the organiser plays a pivotal role in neural 
induction of Xenopus embryos. An equivalent organiser region, called 
Hensen's node, was identified in chick embryos at the cranial end of the 
primitive streak, which consists of mesenchymal cells along the prospective 
midline (Selleck and Stern, 1991). The transplantation of Hensen's node into 
a host chick embryo induced the generation of ectopic neural tissue (Fig. 
1.3B; Storey et al., 1992; Streit et al., 2000). Similarly in mouse embryos, 
‘the node’ is located at the anterior end of the primitive streak and has the 
ability to induce the formation of a second neural axis when transplanted 
into host mouse embryos (Fig. 1.1C; Beddington, 1994; Kinder et al., 2001). 
These results lead to an assumption that the organiser (or equivalents in 
chick and mouse) is the origin of the inductive signals that induce the 




Fig. 1.3. Transplantation of the organiser induces a second neural axis in a host embryo. 
(A) In Xenopus embryos, the organiser is the region at the dorsal lip of the blastopore and 
when this region was grafted to the ventral marginal zone of a host embryo during 
gastrulation, it induced the generation of a second head structure. (B) Hensen’s node is the 
organiser equivalent in birds and is located at the cranial end of the primitive streak. When 
the Hensen’s node of a quail embryo was transplanted to a chick embryo, a second neural 
axis developed in the host embryo. (C) ‘The node’ is the organiser equivalent in mouse and 
is located at the anterior end of the primitive streak. When tissue cut from this organiser 
region was transplanted to a host mouse embryo, ectopic Sox2-expressing neural tissue 
(black arrowheads) was induced from the host embryo.  
Abbreviations: A, anterior; D, dorsal; hf, head folds; nt, neural tube; P, posterior; som, 
somites; Sox2, SRY (sex determining region Y)-box 2.   
(Adapted from 
http://www.mun.ca/biology/desmid/brian/BIOL3530/DEVO_05/ch05f03.jpg, 
http://www.mun.ca/biology/desmid/brian/BIOL3530/DB_04/fig4_20.jpg, and Kinder et al., 
2001) 
 
To verify the assumption that the organiser was the source of neural 
inductive signals, researchers tried to identity these signals. In 1992, Smith 
and Harland found that a BMP (Bone morphogenetic protein) antagonist, 
Noggin, was expressed in the organiser region (Fig. 1.4), and the injection of 
Noggin mRNA into Xenopus embryos enlarged the head structures and 
induced a second neural axis (Molenaar et al., 1996; Smith and Harland, 
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1992). This observation was consistent with the idea that Noggin acts as a 
neural inducer. In addition to Noggin, in situ hybridization studies revealed 
that two other BMP antagonists, Chordin and Follistatin, were also 
expressed in the organiser region (Hemmati-Brivanlou et al., 1994; Sasai et 
al., 1994). The injection of Chordin or Follistatin mRNA into Xenopus 
embryos induced the generation of a second neural axis and expanded the 
neural tissue (Iemura et al., 1998; Pera et al., 2003; Piccolo et al., 1996; 
Sasai et al., 1994). These results suggest that BMP antagonists, Noggin, 
Chordin, and Follistatin, are secreted from the organiser region and convert 
the surrounding ectodermal cells into neural cells during gastrulation.  
 
 
Fig. 1.4. The organiser of Xenopus embryo expresses BMP antagonists. 
During gastrulation, the three germ layers are formed; ectoderm (green and purple), 
mesoderm (red), and endoderm (blue). Spemann’s organiser (black) is a group of 
mesodermal cells located at the dorsal lip of blastopore. It has been demonstrated that BMP 
antagonists Chordin, Noggin, and Follistatin are expressed in the organiser region, and these 
secreted BMP antagonists can induce neural specificity of the dorsal ectoderm (purple, close 
to the organiser) and let the ventral ectoderm (green, away from the organiser) give rise to 
epidermis.  
Abbreviations: BMP, Bone morphogenetic protein. 
(Adapted from Gaulden and Reiter, 2008) 
 
The neural markers NCAM (Neural cell adhesion molecule), Nrp1 
(Neuropilin-1), Sox2 (SRY (sex determining region Y)-box 2), and Sox3 
(SRY-box 3) are expressed in the neural plate of Xenopus embryos, but not 
in the non-neural ectoderm, so these genes are considered to be the markers 
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of neural induction (Kintner and Melton, 1987; Knecht et al., 1995; Stern, 
2005). If BMP antagonists are required for neural induction in Xenopus, then 
inhibiting their function should suppress the expression of these neural 
markers. However, knocking down the expression of Noggin by injection of 
antisense oligos into Xenopus embryos did not inhibit the generation of 
Sox2-expressing neural plate (Khokha et al., 2005). This was most probably 
due to the compensatory role played by the other antagonists present; 
Chordin, and Follistatin. Indeed, when antisense oligos for Noggin, Chordin, 
and Follistatin were injected together into Xenopus embryos, the expression 
of the neural plate markers Sox2 and Sox3 was abolished and the domain of 
Cytokeratin-expressing epidermal tissue was expanded (Khokha et al., 2005). 
These results suggest that BMP antagonists are needed for neural induction 
in Xenopus embryos.    
 
As well as the BMP antagonists discussed above, BMP signalling can also 
be suppressed by Smad6 and Smad7, the inhibitory effectors of the BMP 
signalling pathway (for details see section 1.4.1; Hata et al., 1998; Imamura 
et al., 1997; Nakao et al., 1997). The injection of Smad6 mRNA into 
Xenopus embryos induced the formation of a second neural axis (Linker and 
Stern, 2004). Similarly the over-expression of Smad7 in Xenopus embryos 
expanded the domain of Sox2-expressing neural plate cells and induced the 
generation of ectopic neural tissue (Wawersik et al., 2005). Therefore, like 
BMP antagonists, the inhibition of intracellular pathway of BMP signalling 
also induces neural induction in Xenopus embryos.  
 
In mouse embryos, if the inhibition of BMP signalling is needed for neural 
induction, like Xenopus embryos, then in the absence of BMP antagonists 
should cause abnormal neural plate development, yet Noggin or Follistatin 
null mice show normal gastrulation and neural induction (Bachiller et al., 
2000; Matzuk et al., 1995). This suggests that another BMP antagonist 
Chordin, whose expression overlaps with that of Noggin and Follistatin at 
‘the node’ (an equivalent organiser in mouse), can compensate for the lack 
of this antagonist (Bachiller et al., 2000; Feijen et al., 1994). This was 
confirmed by experiments where Noggin and Chordin have both been 
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knocked out since these double-homozygous mutants show defects in neural 
plate generation (Bachiller et al., 2000). Thus BMP antagonists play an 
important role in neural induction in mouse embryos. Further to this, in 
BMPR1a (BMP receptor 1a) null mouse embryos, not only are the domains 
of Six3 and Sox1-expressing neuroectoderm expanded, but the generation of 
neuroectoderm occurs prematurely compared with wild type embryos (Di-
Gregorio et al., 2007). This finding suggested that, like Xenopus embryo, the 
inhibition of BMP signalling induces neural induction in mouse embryos. 
 
1.3 Default model of neural induction in Xenopus embryos 
Based on the data obtained from experiments in Xenopus embryos, the 
‘default model’ of neural induction was hypothesised by Hemmati-
Brivanlou and Melton, which proposed that ectodermal cells will adopt a 
‘default’ neural fate in the absence of BMP signalling (Fig. 1.5; Hemmati-
Brivanlou and Melton, 1997a). However, the embryonic ectoderm expresses 
BMP4 that directs the embryonic ectoderm to take up an epithelium fate, 
preventing a neural fate; its natural tendency according to the default model 
(Hemmati-Brivanlou and Melton, 1997b; Wilson et al., 1997). During 
gastrulation, the organiser secrets the BMP antagonists Noggin, Chordin, 
and Follistatin, to inhibit the action of BMP and enable the surrounding 
ectodermal cells to take up their ‘default’ neural fate (Wilson et al., 1997; 
Zimmerman et al., 1996). This finding suggests that after BMP antagonists 
counteract the instructive effects of BMP signalling, the embryonic 
ectoderm cells receive no further instructive signal and are committed to a 




Fig. 1.5. Default model of neural induction in Xenopus embryos. 
(A) In Xenopus embryos, the organiser region is located at the dorsal mesoderm (red). 
During gastrulation, the dorsal ectoderm (blue) in the animal cap gives rise to 
neuroectoderm and the ventral ectoderm (yellow) gives rise to epidermis. (B) The 
ectodermal cells have a default fate to become neural cells (blue). Although ectodermal cells 
generate BMP4 that leads the ectoderm to differentiate into epidermis (yellow), the 
ectodermal cells will adopt their default fate autonomously when the endogenous BMP 
signalling is antagonised by Chordin, Noggin, or Follistatin (red) that emanate from the 
organiser.  
Abbreviations: BMP, Bone morphogenetic protein; D, dorsal; V, ventral. 
(Adapted from Stern, 2005) 
 
Experiments on Xenopus animal cap cells also supported this default model 
(Grunz and Tacke, 1989; Munoz-Sanjuan and Brivanlou, 2002). The animal 
cap of the blastula consists of the embryonic ectoderm that will differentiate 
into neuroectoderm (neural plate) or non-neural ectoderm (epidermis) during 
gastrulation (Lamb and Harland, 1995; Munoz-Sanjuan and Brivanlou, 
2002). Isolated intact animal cap explants cultured in the absence of growth 
factors give rise to epidermal tissue, due to the expression of BMP by these 
animal cap cells, which leads explants to acquire an epidermal fate 
(Hemmati-Brivanlou and Melton, 1997b; Sasai et al., 1995; Wilson and 
Hemmati-Brivanlou, 1995). When animal cap explants were cultured with 
the BMP antagonist Noggin, cells within the explants began to express the 
neural plate markers NCAM or Nrp1. Such expression was not observed in 
Noggin untreated explants (Knecht et al., 1995; Lamb and Harland, 1995). 
This finding implies that the exposure of animal caps to the BMP antagonist 
Noggin suppressed the effect of endogenous BMP4, resulting in the 
generation of neural tissue by default. Similarly, expression of the neural 
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plate marker NCAM was observed to be up-regulated in animal caps isolated 
from Xenopus embryos into which Chordin or Follistatin mRNA has been 
injected at 2 to 8-cell stage (Hemmati-Brivanlou et al., 1994; Pera et al., 
2003; Sasai et al., 1995). Again, these results fit with the default model 
which states that ectodermal cells in animal caps give rise to neural tissue 
autonomously when the action of BMP is suppressed by its antagonists 
Noggin, Chordin, or Follistatin.  
 
Further to this, the generation of NCAM, Sox2, and Sox3-expressing neural 
tissue was induced in animal cap explants that were isolated from Smad6 or 
Smad7 (intracellular inhibitors of BMP signalling, for details see section 
1.4.1) injected Xenopus embryos (Casellas and Brivanlou, 1998; Delaune et 
al., 2005; Linker and Stern, 2004; Wawersik et al., 2005). This suggested 
that the inhibition of the downstream effectors of BMP signalling also 
enabled neural development to occur. Similarly, when a dominant-negative 
BMP receptor RNA (acted antagonistically to the wild-type BMP receptor) 
was injected into Xenopus embryos at the 2-cell stage, to suppress BMP 
signalling, and the animal cap explants were subsequently removed at the 
late blastula stage, the expression of the neural plate marker NCAM was up-
regulated in the intact explants (Wilson et al., 1997). In contrast, in control 
non-injection embryos, the expression of the epidermal marker Epidermal 
keratin was up-regulated in the animal cap explants and the neural plate 
marker NCAM was not expressed. Thus, the inhibition of BMP signalling 
causes neuralisation of intact animal caps.  
 
Similarly, if animals cap cells were dissociated and grown as dispersed cells 
in the absence of any growth factors or inhibitors, neural tissue was 
generated from these dispersed cells and the expression of the neural cell 
marker NCAM was up-regulated (Grunz and Tacke, 1989; Munoz-Sanjuan 
and Brivanlou, 2002; Wilson et al., 1997). This is due to the fact that 
dispersed cells are unable to signal to each other via BMP signalling to 
prevent neural induction. In line with this, if the dispersed cells are allowed 
to reassociate, then the expression of neural markers is inhibited with the 
concomitant up-regulation of epidermal markers (Kuroda et al., 2005; 
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Munoz-Sanjuan and Brivanlou, 2002). Thus, overall, the results obtained 
from experiments using animal cap explants suggested that in the absence of 
BMP signalling, embryonic ectoderm generates neural tissue by default.    
 
1.4 BMP signalling represses neural induction 
In contrast to what happens upon inhibition of BMP signalling, when 
dispersed animal cap cells were cultured with BMP4 to activate BMP 
signalling, epidermis was induced, as detected by the expression of the 
epidermal markers Epi1 and Epidermal keratin, and the expression of the 
neural plate marker NCAM was abolished (Wilson and Hemmati-Brivanlou, 
1995; Wilson et al., 1997). Similarly the injection of BMP2, BMP4, or 
BMP7 mRNA into Xenopus embryos was shown to activate Msx1 (target 
gene of BMP signalling), which in turn induced expression of the epidermal 
marker Epidermal keratin and inhibition of neural induction (Fainsod et al., 
1997; Suzuki et al., 1997). These findings suggest that activation of BMP 
signalling induces the generation of epidermis and suppresses neural 
induction in Xenopus embryos. 
 
Similarly, in chick embryos, the activation of BMP signalling also inhibits 
neural induction (Wilson et al., 2000). When prospective epidermal and 
prospective neural plate explants were isolated from the embryonic ectoderm 
of chick embryos and cultured for 40 hours, the expression of BMP4 was 
down-regulated in prospective neural plate explants but up-regulated in 
prospective epidermal explants. At the same time, the prospective epidermal 
explants expressed Msx1 and Msx2 proteins (target genes of BMP signalling, 
for details see section 1.4.1) but not the neural plate markers Sox2 and Sox3; 
in contrast, the prospective neural plate explants expressed neural markers 
Sox2 and Sox3 proteins but not Msx1 and Msx2 (Wilson et al., 2000). These 
results suggested that BMP signalling was active in prospective epidermal 
explants of chick embryos and inactive in the prospective neural plate 
explants. If the prospective neural plate explants were cultured with BMP4, 
then the generation of Sox2 and Sox3-expressing neural tissue was 
significantly reduced and epidermal differentiation was increased compared 
with BMP4 untreated explants (Wilson et al., 2000). Experiments in whole 
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chick embryos also showed that BMP signalling inhibited neural induction 
in vivo. Before gastrulation, BMP4 is expressed throughout the epiblast (has 
the ability to differentiate into the three germ layers) of chick embryos, but 
during the period of neural induction, BMP4 is only expressed in the non-
neural tissue of chick embryos (Streit et al., 1998). Thus, BMP4 is not 
expressed in the neuroectoderm of chick embryos. However, when BMP4 
was electroporated into the prospective neural plate of chick embryos in vivo, 
expression of the neural plate markers Sox2 and Sox3 was inhibited (Linker 
and Stern, 2004). Thus, BMP signalling can repress neural induction in 
chick embryos.  
 
1.4.1 BMP signalling through Smad proteins 
As well as their role in neural development, as described above, BMPs 
play other diverse roles in development, including in bone and cartilage 
formation (Wang et al., 1990), epidermal induction (Munoz-Sanjuan and 
Brivanlou, 2002), limbs development (Yi et al., 2000), hematopoietic 
differentiation (Chadwick et al., 2003), and heart formation (Shi et al., 
2000). BMPs are members of the TGF (Transforming growth factor ) 
superfamily and the binding of BMP to type II and type I BMP receptors 
(BMPR) results in their phosphorylation (Heldin et al., 1997; Miyazono et 
al., 2005; Shi and Massague, 2003). The active type I BMPR 
phosphorylates Smad1, Smad5, and Smad8 (Fig. 1.6; Kretzschmar et al., 
1997; Shi and Massague, 2003) and once phosphorylated these proteins 
form a complex with Smad4 and this complex enters the nucleus to 
activate target genes, such as Msx1, Msx2, and Vent2 (Hardwick et al., 
2008; Marazzi et al., 1997; Phippard et al., 1996; Postigo, 2003; Tucker et 
al., 1998). As described above (see section 1.4), Msx1 and Msx2 play an 
important role in epidermal induction and the over-expression of Msx1 
induces the expression of the epidermal marker Epidermal keratin and 
inhibits neural induction in Xenopus embryos (Suzuki et al., 1997), while 
knocking down Msx1 and Msx2 induced ectopic Sox2-expressing neural 
tissue and suppressed the generation of epidermis in Xenopus embryos 
(Khadka et al., 2006). Similarly, it has been demonstrated that the 
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promoter region of Vent2 contains a Smad1 binding site, and the injection 
of Xenopus embryos with BMP4 mRNA up-regulated the expression of 
Vent2 (Karaulanov et al., 2004). Further, the over-expression of Vent2 in 
Xenopus embryos resulted in suppression of expression of the neural plate 
marker Sox3 (Rogers et al., 2008). Thus, BMP signalling activates Smad1 
and in turn up-regulates the expression of Msx1, Msx2, and Vent2 to 
repress neural induction.   
 
BMP signalling can be suppressed by a number of inhibitors including 
Noggin, Chordin, Follistatin, Smad6, and Smad7. Noggin and Chordin act 
by binding to BMP ligands thus preventing BMP binding to its receptors 
(Munoz-Sanjuan and Brivanlou, 2002; Piccolo et al., 1996; Zimmerman et 
al., 1996), while Follistatin forms a trimeric complex with BMP ligands, 
and BMPR to inhibit the phosphorylation of Smad1 and block BMP 
signalling (Fig. 1.7, Fainsod et al., 1997; Glister et al., 2004; Iemura et al., 
1998). Thus, the treatment of Noggin, Chordin, or Follistatin could reduce 
the expression of BMP target genes, Msx1, Msx2, and Vent2 (Iemura et al., 
1998; Ishimura et al., 2000; Pera et al., 2003; Streit and Stern, 1999a).  
Smad7 interacts with BMPR to inhibit the phosphorylation of Smad1 
(Nakao et al., 1997) and Smad6 competes with Smad4 for binding to 
Smad1/5/8, so Smad7 and Smad6 prevent BMP signalling from activation 







Fig. 1.6. The BMP signalling pathway.  
The binding of BMP to its receptors (BMPR1 and BMPR2) phosphorylates Smad1/5/8. 
The phosphorylated Smad1/5/8 forms a complex with Smad4 and this complex enters the 
nucleus to bind to the promoter region of target genes, such as Msx1, Msx2, and Vent2, 
and then activates these genes. BMP antagonists including Noggin and Chordin, can 
prevent the binding of BMP ligands with BMPR thus inhibiting BMP signalling.  
Abbreviations: BMP, bone morphogenetic protein; BMPR, BMP receptor; P, 
phosphorylation. 
(Adapted from Hardwick et al., 2008) 
 
 
Fig. 1.7. The different inhibitory mechanisms of Chordin and Follistatin.  
Chordin binds with BMP ligands to prevent the binding of these ligands to receptors, thus 
preventing BMP signalling. In contrast, Follistatin forms a trimeric complex with BMP 
ligands, and BMPR to block BMP signalling.  
Abbreviations: BMP, bone morphogenetic protein; BMPR, BMP receptor. 
(Adapted from Iemura et al., 1998) 
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Thus, studies in Xenopus, Chick and mouse show that BMP signalling needs 
to be suppressed in order for neural induction to occur.  
 
1.5 The insufficiency of default model 
The default model of neural induction proposes that the ectodermal cells 
give rise to neural tissue autonomously in the absence of BMP activation 
(for details see sections 1.3 and 1.4). Although the default model gives a 
simple and attractive way to understand the mechanism of neural induction, 
it cannot completely explain neural induction. For example, administration 
of BMP antagonists Noggin or Chordin to the non-neural embryonic 
ectoderm of chick embryos did not induce ectopic neural tissue (Streit et al., 
1998; Streit and Stern, 1999b). Therefore, in contrast to what was observed 
in Xenopus embryos, inhibition of BMP signalling is not sufficient to induce 
neural induction in chick embryos (Stern, 2005). Furthermore, it has been 
demonstrated that as well as BMP signalling discussed above, other signals 
have been shown to be involved in this process, such as FGF (Fibroblast 
growth factor), Wnt, Activin/Nodal, and calcium (Batut et al., 2005; Camus 
et al., 2006; del Barco Barrantes et al., 2003; Kuroda et al., 2005; Stern, 
2005; Wessely et al., 2001; Wilson et al., 2001). In the following sections, I 
will discuss what is known about the role these signals in neural induction of 
vertebrates. 
 
1.5.1 The role of FGF signalling in neural induction  
FGFs are a family of growth factors and are highly conserved between 
mouse and human (Bottcher and Niehrs, 2005; Itoh and Ornitz, 2004; 
Ornitz and Itoh, 2001). FGFs can be divided into 7 subfamilies: FGF1/2, 
FGF4/5/6, FGF3/7/10/22, FGF8/17/18, FGF9/16/20, FGF11/12/13/14 and 
FGF15/19/21/23 (Itoh and Ornitz, 2011), with the members of each having 
similar biological properties. Most FGFs are secreted from cells to interact 
with receptors on the cell surface (Itoh and Ornitz, 2004; Ratzka et al., 
2011), but the FGF11/12/13/14 subfamily are non-secreted proteins and 
bind to the intracellular C-terminal region of voltage-gated sodium 
channels to modulate action potentials in hippocampal neurons (Goetz et 
al., 2009; Munoz-Sanjuan et al., 2000; Smallwood et al., 1996).  
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FGF receptors (FGFRs) belong to the receptor tyrosine kinase family of 
receptors, which have an extracellular ligand-binding domain, a 
transmembrane domain and an intracellular tyrosine kinase domain 
(Schlessinger, 2004; Turner and Grose, 2010). The extracellular ligand-
binding domain of FGFR contains a heparin binding site (Schlessinger et 
al., 2000). Heparin or heparan sulfate proteoglycans promote the binding 
of FGF ligands to FGFRs (Pellegrini, 2001; Schlessinger et al., 2000), and 
the binding of heparin is required for FGF signal transduction (Lanner et 
al., 2010). There are four highly conserved Fgfr genes (Fgfr1,2,3,4) in 
vertebrates and each gene, except Fgfr4, encodes two isoforms, b and c. 
The ligand-specificities of FGFRs are shown in Table 1.1 (Itoh and Ornitz, 
2004; Turner and Grose, 2010; Zhang et al., 2006). Because the 
FGF15/19/21/23 subfamily have a lower affinity for FGFRs compared 
with other secreted FGFs (Itoh and Ornitz, 2011), this subfamily was not 
listed in Table 1.1.  
 
Table 1.1. Ligand-specificities of FGFRs 
Gene Receptor Ligand-specificity 
FGFR1b FGF1, 2, 3, 10 and 22  
Fgfr1 
FGFR1c FGF1, 2, 4, 5, 6 and 8 
FGFR2b FGF1, 3, 7, 10, and 22 
Fgfr2 
FGFR2c FGF1, 2, 4, 6, 8, 9, 17, 18, and 20 
FGFR3b FGF1 and 9 
Fgfr3 
FGFR3c FGF1, 2, 4, 8, 9, 16, 17, 18, and 20 
Fgfr4 FGFR4 FGF1, 2, 4, 6, 8, 9, 17 and 18 
 
FGF has a range of functions; in angiogenesis (Cross and Claesson-Welsh, 
2001), wound repair (Doukas et al., 2002), tumorigenesis (Grose and 
Dickson, 2005), and endocrine homeostasis (Shimada et al., 2004). FGF 
signalling also plays an important role in many aspects of development. 
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For instance, during embryonic development, FGF signalling is involved 
in cell migration (Sun et al., 1999), patterning of the cortex (Cholfin and 
Rubenstein, 2007), mesoderm induction (Schulte-Merker and Smith, 1995), 
limb development (Martin, 1998), and bone formation (Coumoul and 
Deng, 2003). Furthermore, a body of evidence shows that FGF signalling 
is required for neural induction in chick, mouse, and even Xenopus (Dang 
and Tropepe, 2010; Harland, 1994; Kengaku and Okamoto, 1993; Lamb 
and Harland, 1995; Stavridis et al., 2007; Streit et al., 2000; Wilson et al., 
2000), suggesting that FGFs are involved in the neural specification of 
ectodermal cells.  
 
1.5.1.1 FGFs induce neural induction 
Extracellular signal-regulated kinase (Erk) is the effector of FGF 
signalling and is phosphorylated while FGF signalling is active (for 
details see section 1.5.1.3). Before gastrulation, the immunostaining for 
phosphorylated Erk in wild type Xenopus embryos showed that Erk was 
active in the dorsal margin of the blastopore (organiser region) at the 
blastula stage (Christen and Slack, 1999). Further, during gastrulation, 
activated Erk was found in the developing neural plate and this 
activation could be blocked by the injection of a dominant-negative 
FGFR RNA into Xenopus embryos (Christen and Slack, 1999). This 
finding suggested that FGF signalling is active in the forming neural 
plate and that FGFs play a role in neural induction. Furthermore, reports 
have also shown that when Xenopus embryos were cultured with the 
FGFR inhibitor (SU5402), the generation of NCAM-expressing neural 
tissue was reduced, and this effect was dose dependent (Delaune et al., 
2005). This result implies that the activation of FGF signalling is 
required for neural induction in Xenopus.  
 
According to the default model, the injection of BMP antagonist Noggin 
mRNA into Xenopus embryos induced ectopic neural tissue (Molenaar et 
al., 1996; Smith and Harland, 1992). However, when the Noggin injected 
embryos were cultured with SU5402, no ectopic neural tissue was 
observed (Delaune et al., 2005). This study showed that the inhibition of 
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BMP signalling alone is not enough to induce neural induction. Similarly, 
ectopic Sox2-expressing neural tissue was induced and the generation of 
Keratin 81-expressing epidermal tissue was suppressed in Xenopus 
embryos when BMP signalling was blocked by knocking down Smad5 
(Marchal et al., 2009). Yet, when these Smad5 knock-down embryos 
were treated with SU5402 to inhibit FGF signalling, the knocking down 
Smad5 no longer induced ectopic Sox2-expressing neural tissue, but the 
epidermal marker Keratin 81 was still suppressed because of inhibition 
of BMP signalling (Marchal et al., 2009). These results suggested that 
the default model of neural induction is not the whole story, and 
activation of FGF signalling plays a pivotal role in neural induction of 
Xenopus.  
 
During Xenopus gastrulation, Fgf1, Fgf2, Fgf4, Fgf8 and Fgf20 are 
expressed in the mesoderm (Lea et al., 2009). If FGF signalling is 
required for neural induction in Xenopus embryos, then at least one of 
these five FGFs may be involved. The injection of Fgf8 mRNA into 
Xenopus embryos at the 4 to 8-cell stage to activate FGF signalling 
induced the ectopic expression of the neural plate marker Sox2 (Pera et 
al., 2003). This finding suggested that FGF8 mediated signalling can 
induce neural induction in Xenopus embryos. Similarly, culturing animal 
cap explants (details see section 1.3) with FGF2 up-regulated the 
expression of the neural marker Sox2 and this inductive effect of FGF2 
was dose dependent, while the expression of the epidermal marker 
Epidermal keratin was reduced (Hongo et al., 1999; Kengaku and 
Okamoto, 1993). Another report also confirmed these observations 
showing that exposure of animal caps to FGF2 induced the generation of 
the neural plate marker Nrp1 (Lamb and Harland, 1995). These results 
imply that activation of FGF signalling induces the generation of neural 
cells from ectodermal cells of Xenopus embryos or animal caps.  
 
Similar experiments have been carried out in chick providing evidence 
that FGF signalling is also instructive for neural induction in avian 
embryos. For example, the implantation of FGF4 soaked beads into the 
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embryonic ectoderm of chick embryo induces the formation of ectopic 
neural tissue (Rodriguez-Gallardo et al., 1997). Another two reports also 
showed that implanting FGF2 or FGF4 soaked beads into the embryonic 
ectoderm of chick embryos induced the expression of EphA7 (which is 
usually expressed in the forebrain and hindbrain of embryos (Araujo and 
Nieto, 1997)), Krox-20 (which is usually expressed in the hindbrain of 
embryos (Graham and Lumsden, 1996)), Cash4, Hoxb9 and Sax1 (which 
are expressed in the caudal neural plate of embryos (Grapin-Botton et al., 
1997; Henrique et al., 1997; Spann et al., 1994)) in non-neural ectoderm 
(Alvarez et al., 1998; Storey et al., 1998). Futher, the implantation of 
FGF8-coated beads into the embryonic ectoderm of chick embryos 
induced strong expression of ERNI an early marker of neural induction 
(Streit et al., 2000). Together, these results suggested that FGF signalling 
caused neural induction in chick embryos.    
 
Since the findings observed in Xenopus and chick embryos showed that 
FGF signalling induces neural induction in ectodermal cells, the role of 
FGF signalling in neural induction was also investigated in mouse 
embryos. In mammals, Fgf2, Fgf3, Fgf4, Fgf5, Fgf8, and Fgf17 are 
expressed prior to or at gastrulation, when neural induction occurs, so 
these FGFs may be involved in this process (Hannon et al., 1992; Haub 
and Goldfarb, 1991; Hebert et al., 1990; Maruoka et al., 1998; Penkov et 
al., 2001; Sun et al., 1999; Wilkinson et al., 1988). Fgf4 is the first 
member of the FGF family to be expressed in mouse embryos, with the 
ICM of the blastocyst already expressing Fgf4 (Niswander and Martin, 
1992; Rappolee et al., 1994). During gastrulation, the expression of Fgf4 
is restricted to the primitive streak (Niswander and Martin, 1992; 
Rappolee et al., 1994). Unfortunately, Fgf4 null mouse embryos die 
before gastrulation (Feldman et al., 1995), so it is not certain whether 
Fgf4 is required in neural induction in vivo. However, the data obtained 
from experiments using Fgf4-/- mouse embryonic stem cells (ESCs) 
reveals that Fgf4 is required for neural induction of these cells (details 
see section 1.6.2; Kunath et al., 2007).  
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The expression of Fgf2 is not detected until 10.5 dpc (days post coitum), 
which is later than the formation of neural plate at 7.5 dpc (Hannon et al., 
1992; Hebert et al., 1990). It has been shown that FGF2 regulates the 
proliferation of neural stem cells (NSCs) (Vaccarino et al., 1999; Zheng 
et al., 2004) rather than being involved in neural induction of mouse 
embryos. The expression of Fgf3 is not detected until 7.5 dpc (Wilkinson 
et al., 1988). Although Fgf3 null mouse embryos have defects in the 
caudal vertebrae and inner ear (Mansour et al., 1993), the neural tube is 
still formed, suggesting that FGF3 is not involved in neural induction 
(Wilkinson et al., 1988). Like Fgf2, the expression of Fgf5 is not 
detected until 10.5 dpc (Hebert et al., 1990), and the number of motor 
neurons generated within the spinal cord and the morphology of the 
hippocampus are normal in Fgf5 null mutants (Hebert et al., 1994). 
These finding indicated that neural induction can proceed normally in 
the absence of FGF5. Thus, Fgf2, Fgf3, and Fgf5 may not be necessary 
for neural induction in mouse. 
 
The expression of Fgf8 is first detected at 5.5 dpc before the generation 
of neural plate in mouse embryos (Mahmood et al., 1995). Although, 
Fgf8 null mutants die at 9.5 dpc, by this stage it was possible to 
determine that, in these mutants, the anterior neuroectoderm was 
generated, but not the posterior neuroectoderm (Sun et al., 1999). This 
suggested that FGF8 plays a role in the generation of the posterior 
neuroectoderm. The expression of Fgf17 is detected at 8.0 dpc (Maruoka 
et al., 1998). The Fgf17 knockout is not embryonic lethal but no obvious 
morphological defects were observed in the central nervous system of 
these Fgf17 null animals (Cholfin and Rubenstein, 2007; Xu et al., 2000), 
suggesting FGF17 is not involved in neural induction.  
 
Taken together, the in vivo expression pattern of FGFs described above 
suggests that compared with other FGFs, FGF4 and FGF8 are more 




1.5.1.2 Inhibition of FGF signalling suppresses neural induction 
As discussed in the above section, the activation of FGF signalling 
promotes neural induction in Xenopus, chick, and mouse embryos, thus, 
the inhibition of FGF signalling should suppress this action. It has been 
shown that knocking down Fgf4 by injecting antisense oligonucleotides 
into Xenopus embryos inhibited the generation of Sox2-expressing cells 
of the neural plate (Marchal et al., 2009). Similarly, the exposure of 
Xenopus embryos to the FGFR inhibitor (SU5402) inhibited the 
generation of NCAM-expressing neural tissue (Delaune et al., 2005). 
During gastrulation, Fgfr1, Fgfr2, and Fgfr4 are expressed in the three 
primary germ layers of Xenopus embryos, with expression of Fgfr4 
being higher than that of the others (Hongo et al., 1999; Lea et al., 2009). 
Further to this, the expression of Fgfr4 is relatively abundant in the 
ectoderm compared with the mesoderm (Hongo et al., 1999). The 
injection of a dominant-negative FGFR4 mRNA into Xenopus embryos 
at the 4-cell stage inhibited the generation of NCAM-expressing neural 
plate cells (Delaune et al., 2005), suggesting that Fgfr4 is important for 
neural induction in Xenopus embryos.  
 
As mentioned in section 1.5.1.1, Fgf8 injected Xenopus embryos or 
FGF2 treated animal caps can generate neural tissue without the 
inhibition of BMP signalling (Hongo et al., 1999; Kengaku and Okamoto, 
1993; Pera et al., 2003). These observations suggested that, in Xenopus, 
FGF could induce neural induction in the presence of BMP signalling. 
This finding dose not fit with the ‘default’ model (details see section 1.3). 
Further, injecting a BMP antagonist (Noggin mRNA) into Xenopus 
embryos could neuralise isolated animal cap explants, but the expression 
of the neural plate marker NCAM was suppressed when a truncated 
FGFR mRNA was injected at the same time (Launay et al., 1996). These 
observations do not fit with the default model hypothesis, revealing that 
the activation of FGF signalling is pivotal for neural induction to occur 
in Xenopus even in the absence of BMP signalling. In line with this, 
although injecting inhibitors of BMP signalling into Xenopus embryos 
caused the generation of ectopic neural tissue, this effect was inhibited 
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when embryos were treated with the FGF receptor inhibitor SU5402 
(Delaune et al., 2005; Marchal et al., 2009; Wawersik et al., 2005). Thus, 
in Xenopus, an inhibition of BMP signalling together with an instructive 
signal, FGF, is required for neural induction. However, dissociated 
animal cap explants give rise to neural tissue in the absence of FGFs or 
other growth factor being added to the culture medium (Grunz and Tacke, 
1989), and this finding is considered as a great support of default model 
(details see section 1.3). This observation can be explained by the fact 
that dissociation of animal caps causes activation of the Erk signalling 
pathway which is one of the intracellular pathways activated by FGF 
(details see section 1.5.1.3), and this in turn neuralises the dissociated 
explants (Kuroda et al., 2005). When the dissociated explants were 
treated with a MEK (Mitogen-activated Protein/Extracellular Signal-
regulated Kinase Kinase) specific inhibitor U0126 to inhibit the Erk 
signalling, the dissociated cells no longer generated neural tissue, as 
indicated by a significant reduction in expression of the neural plate 
markers NCAM and Sox2 and an up-regulation of the epidermal marker 
Cytokeratin (Kuroda et al., 2005). Therefore, signalling via the FGF/Erk 
pathway provides the instructive signal needed for neural induction of 
dissociated animal caps.  
 
Similarly to what occurs in Xenopus embryos, the inhibition of FGF 
signalling also represses neural induction in chick embryos. When 
prospective neural plate explants were isolated from the embryonic 
ectoderm of chick embryos and cultured in vitro for 40 hours, explants 
expressed neural markers Sox2 and Sox3. If the isolated explants were 
cultured with the FGFR inhibitor SU5402, then the generation of Sox2 
and Sox3-expressing neural tissue was lost (Wilson et al., 2000). This 
finding suggested that the prospective neural ectoderm of chick embryos 
fails to give rise to neural tissue if FGF signalling is inhibited. 
Experiments in whole chick embryos also showed similar results. When 
SU5402 soaked beads were implanted into the prospective neural plate 
of chick embryos, the expression of the neural plate makers ERNI and 
Sox3 were suppressed (Streit et al., 2000). This implies that inhibition of 
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endogenous FGF signalling in the prospective neural plate represses 
neural induction in chick embryos. Further, as descried above (section 
1.2) the transplantation of Hensen's node (equivalent to the organiser in 
chick) into the epiblast of host chick embryos induced the generation of 
ectopic neural tissue. However, this neural induction was inhibited when 
SU5402 soaked beads were implanted at the same time (Streit et al., 
2000). 
 
Since the findings observed in Xenopus and chick embryos show that 
inhibition of FGF signalling inhibits the neural differentiation of 
ectodermal cells, the presence of the same mechanism was also tested in 
mouse embryos. During mouse embryogenesis, the neural plate is 
detected at 7.5 dpc (Downs and Davies, 1993; Rowitch and McMahon, 
1995; Yang et al., 1998). The activation of FGF signalling by injection 
of FGF8b into the proamniotic cavity (centre of the epiblast) at 7 dpc 
increased the number of NSCs derived form the anterior neural plate at 
8.5 dpc, while, inhibiting FGF signalling by injection of the FGFR 
inhibitor SU5402 reduced the number of NSCs (Dang and Tropepe, 
2010). This finding suggests that FGF also promotes neural induction in 
mouse embryos. Although the treatment of mouse embryos with SU5402 
reduced the generation of NSCs, it did not completely inhibit neural 
induction. This may be due to insufficient SU5402 being given, the time 
of treatment not being long enough, or FGF not being the only 
instructive neural induction signal in mouse embryos (Gaulden and 
Reiter, 2008).  
 
1.5.1.3 Erk signalling is responsible for FGF-directed neural 
induction 
FGFs exert their actions via binding to heparin or heparan sulfate 
proteoglycans, which helps FGFs bind to FGFRs and cause their 
dimerisation (Pellegrini, 2001; Schlessinger et al., 2000). 
Autophosphorylation of the receptors occurs upon dimerisation (Furdui 
et al., 2006), and this leads to the activation of three intracellular signal 
transduction pathways, Erk1/2, PLC (phospholipase C gamma), and 
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PI3K (phosphoinositide 3-kinase) (Fig. 1.8; Carballada et al., 2001; Kim 
et al., 2003; Kouhara et al., 1997; Tsang and Dawid, 2004). FGF 
signalling via Erk signalling is the pathway that is most important for 
neural induction (Kuroda et al., 2005; Stavridis et al., 2007; Yoo et al., 
2011). Evidence for this statement arises from the observation that when 
FGF/PLC or FGF/PI3K signalling is inhibited during the period of 
neural induction, neural progenitors are still generated (Nutt et al., 2001; 
Stavridis et al., 2007). 
 
In FGF/PLC signalling, the activation of PLC converts 
phosphatidylinositol 4,5-bisphosphate (PIP2) to inositol 1,4,5-
triphosphate (IP3) and diacylglycerol (DAG) (Peters et al., 1992). IP3 
activates the IP3 receptor (IP3R) in the membrane of endoplasmic 
reticulum (ER) causing the release of Ca2+ into the cytosol and thus an 
increase in cytosolic Ca2+ ([Ca2+]i, for further detail on this process see 
section 1.5.4.4). DAG activates protein kinase C (PKC) and then PKC 
interacts with Raf and activates the MEK/Erk cascade (Ueda et al., 1996). 
If FGF/PLC signalling is required in neural induction, then the 
inactivation of the PLC pathway should suppress neural specificity of 
ectodermal cells. Sprouty is an intracellular antagonist of FGF/PLC 
signalling and its expression is not down-regulated in Xenopus embryos 
until the late gastrula stage by which time neural induction is complete  
(Nutt et al., 2001; Sivak et al., 2005). Therefore during gastrulation, 
FGF/PLC signalling is repressed by Sprouty, suggesting that the 
activation of FGF/PLC signalling is not crucial for neural induction in 
Xenopus. This is further supported by the observation that PLC1 null 
mouse embryos die at 9.0 dpc, but the neural tube is already formed at 
this stage (Ji et al., 1997).  
 
In FGF/PI3K signalling, the activation of PI3K phosphorylates 
phosphatidylinositol-4,5-bisphosphate and turns it into 
phosphatidylinositol-3,4,5-trisphosphate, which activates 3-
phosphoinositide dependent protein kinase-1 (PDK1) (Stitt et al., 2004). 
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In turn, PDK1 activates Akt (also known as protein kinase B) and Akt 
interacts with downstream targets, including glycogen synthase kinase 3, 
forkhead box O transcription factors, mammalian target of rapamycin 
(mTOR), p70S6K, and BCL2-associated agonist of cell death, to regulate 
apoptosis and cell cycle entry (Cross et al., 1995; Engelman, 2009; Nave 
et al., 1999; Scott and Lawrence, 1997; Stitt et al., 2004). If FGF/PI3K 
signalling is required in neural induction, then the inactivation of PI3K 
pathway should suppress neural specificity of ectodermal cells; however, 
this is not the case. In chick embryos, the implantation of LY294002 (a 
specific inhibitor of PI3K) soaked beads into the embryonic ectoderm 
did not inhibit expression of the neural plate marker Sox3 (Stavridis et al., 
2007). Furthermore, PDK1-deficient ESCs (where PI3K/PDK1/Akt 
signalling will not be activated) still express the neuroectodermal marker 
Sox1 and generate Nestin-expressing NSCs (Stavridis et al., 2007). In 
addition, PDK1 null mouse embryos die at 9.5 dpc with a normal neural 
tube having been formed (Lawlor et al., 2002). These findings suggest 





Fig. 1.8. The FGF/Erk signalling pathway. 
The binding of FGF to FGFR induces the dimerisation and autophosphorylation of 
FGFR leading to the activation of three intracellular signal transduction pathways, 
Erk1/2, PLC, and PI3K. In FGF/Erk signalling, the activated FGFR phosphorylates 
FRS2, and then recruits GRB2 and SOS to activate Ras through the exchange of bound 
GDP for GTP. Ras-GTP binds with Raf and then phosphorylates MEK. In turn MEK 
phosphorylates Erk1/2. p-Erk1/2 can phosphorylate the C-terminal domain of the 
transcription factor Elk1 (a member of the ternary complex factor family of Ets domain 
proteins), and then changes its ternary complex formation to facilitate the binding to the 
promoter region of c-fos, Mcl1, Zif268 or Bcl10, resulting in the up-regulating of genes 
that control the cell cycle. In addition, tp-Erk1/2 phosphorylates PARP-1 and induces 
the generation of neural progenitors in human ESCs.  
Abbreviations: Erk1/2, Extracellular Signal-regulated Kinase 1/2; ESC, embryonic 
stem cell; FGF, Fibroblast growth factor; FGFR, FGF receptor; FRS2, Fibroblast 
growth factor receptor substrate 2; GDP, Guanosine diphosphate; GTP, Guanosine 
triphosphate; GRB2, Growth factor receptor bound protein 2; MEK, Mitogen-activated 
Protein/Extracellular Signal-regulated Kinase Kinase; PARP-1, poly (ADP-ribose) 
polymerase 1 ; PI3K, phosphoinositide 3-kinase; PLC, phospholipase C gamma; p-
Erk1/2, phosphorylated Erk1/2; SOS, Son of sevenless.  
(Adapted from Tsang and Dawid, 2004) 
 
In FGF/Erk signalling, the activated FGFR phosphorylates FRS2 
(Fibroblast growth factor receptor substrate 2), and then recruits Grb2 
(Growth factor receptor bound protein 2) and Sos (Son of sevenless) to 
activate Ras through the exchange of bound GDP for GTP (Fig. 1.8). 
Ras-GTP binds with Raf and then phosphorylates MEK. In turn MEK 
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phosphorylates Erk1/2 (Thisse and Thisse, 2005; Tsang and Dawid, 
2004). The phosphorylated Erk1/2 (p-Erk1/2) can then phosphorylate 
specific transcription factors that regulate expression of target genes 
(Chang et al., 2003). For example, p-Erk1/2 phosphorylates the C-
terminal domain of the transcription factor Elk1, and this changes its 
ternary complex formation to facilitate the binding to the promoter 
region of c-fos, Mcl1, Zif268 or Bcl10, resulting in up-regulating genes 
expression to control the cell cycle (Boros et al., 2009; Davis et al., 2000; 
Gille et al., 1995; Huang et al., 2000; Janknecht et al., 1993). In addition, 
it has been shown that the p-Erk1/2 phosphorylates PARP-1 (poly (ADP-
ribose) polymerase 1) activating it (Kauppinen et al., 2006). Indeed, the 
activity of PARP-1 was increased during neural differentiation of human 
ESCs and was reduced by treatment with the FGFR inhibitor SU5402 or 
the MEK inhibitor U0126 (Yoo et al., 2011). Further, PARP-1 can bind 
to the promotor region of the NSC markers SOX2 and PAX6, and the 
treatment of human ESCs with a specific inhibitor of PARP-1 
significantly reduced the generation of SOX2 or PAX6-epxressing 
neural progenitors (Yoo et al., 2011), suggesting that the activation of 
PARP-1 promotes neural induction in human ESCs and FGF/Erk 
signalling may induce neural induction by activation of PARP-1.   
 
If FGF/Erk signalling is required for neural induction, then the 
inactivation of Erk1/2 should suppress the expression of neural specific 
genes in ectodermal cells. This assumption was tested using animal cap 
cells that upon dispersion give rise to neural tissue (for details see 
section 1.3, Munoz-Sanjuan and Brivanlou, 2002). When these dispersed 
ectodermal cells were cultured with the MEK specific inhibitor U0126 to 
inhibit the phosphorylation of Erk1/2, Cytokeratin-expressing epidermal 
tissue was generated instead of neural tissue (Kuroda et al., 2005). This 
suggests that the activation of Erk1/2 is pivotal in neural induction of 
Xenopus. In chicken embryos, the implantation of PD184352 (a specific 
inhibitor of MEK) soaked beads into the prospective neural ectoderm 
inhibited the expression of the neural plate markers Sox2 and Sox3 
(Stavridis et al., 2007). Further to this, the generation of Sox1-expressing 
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neuroectodermal cells form mouse ESCs or PAX6-expressing NSCs 
form human ESCs was significantly reduced when the phosphorylation 
of Erk1/2 was inhibited by PD184352 or U0126 (details see section 1.6.2; 
Stavridis et al., 2007; Yoo et al., 2011). 
 
In conclusion, form the experiments described above, it appears that 
FGF signalling via Erk is important for neural induction in vertebrates.  
 
1.5.1.4 The crosstalk between FGF/Erk and BMP signalling in 
neural induction  
As described above both FGF/Erk (for details see section 1.5.1.1 and 
1.5.1.3) and BMP signalling pathways (for details see section 1.2 and 1.3) 
are involved in neural induction in vertebrates, and data reveals that 
there is crosstalk between these two pathways (Fig. 1.9; Kuroda et al., 
2005; Pera et al., 2003). In the BMP signalling pathway, BMPs bind and 
activate their receptors, that in turn phosphorylate Smad1 at the C-
terminus (Massague and Chen, 2000). The C-ter-p-Smad1 (C-terminal 
phosphorylated Samd1) goes on to activate target genes, such as Msx1, 
Msx2, and Vent2 that inhibit neural induction (for details see section 
1.1.4; Pera et al., 2003; Phippard et al., 1996; Suzuki et al., 1997). 
Smad1 consists of MH1 (N-terminal Mad Homology 1) and MH2 (C-
terminal Mad Homology 2) domains, which are separated by a linker 
region (Pera et al., 2003; Shi and Massague, 2003). The activated BMPR 
interacts with the MH2 domain of Smad1 and this interaction results in 
the Smad1 C-terminal region being phosphorylated. C-ter-p-Smad1 
translocates to the nucleus and once there the MH1 domain binds the 
promoter region of its target genes, activating them. The linker region of 
Smad1 contains Erk1/2 phosphorylation sites (Pera et al., 2003; Sapkota 
et al., 2007). In Xenopus, mouse, and human cell lines, it has been 
demonstrated that the linker region is phosphorylated by p-Erk1/2 and 
this phosphorylation results in the inhibition of BMP signalling through 
C-ter-p-Smad1 polyubiquitination (Aubin et al., 2004; Fuentealba et al., 
2007; Kretzschmar et al., 1997a; Kuroda et al., 2005; Pera et al., 2003; 




Fig. 1.9. The BMP signalling pathway is inhibited by FGF/Erk signalling during 
Xenopus neural induction. 
Smad1 is the intracellular protein that mediates BMP signalling. It consists of MH1 and 
MH2 domains that are separated by a linker region. The activation of the BMP 
signalling pathway causes the phosphorylation of Smad1 at its C-terminus. The C-ter-p-
Smad1 goes on to activate target genes, such as Msx1, Msx2, and Vent2, and this pushes 
embryonic ectoderm towards an epidermal fate and inhibits a neural fate in Xenopus. 
The linker region of Smad1 contains Erk1/2 phosphorylation sites. When FGF/Erk 
signalling is activated, the linker region is phosphorylated by p-Erk1/2, and this causes 
polyubiquitination and degradation of Smad1, and inhibition of BMP signalling.  
Abbreviations: BMP, Bone morphogenetic protein; C-ter-p-Smad1, C-terminus 
phosphorylated Smad1; Erk1/2, Extracellular Signal-regulated Kinase 1/2; FGF, 
Fibroblast growth factor; MH1, N-terminal Mad Homology 1; MH2, C-terminal Mad 
Homology 2; p-Erk1/2, phosphorylated Erk1/2. 
(Modified from Pera et al., 2003) 
 
When the Erk1/2 phosphorylation sites of the linker region are mutated 
preventing phosphorylation by p-Erk1/2, the Smad1 C-terminal region 
can still be phosphorylated by the activation of BMP signalling 
(Kretzschmar et al., 1997a). As described in section 1.5.1.1, the injection 
of Fgf8 mRNA into Xenopus embryos induced the formation of ectopic 
Sox2-expressing neural tissue. It had been shown that this neural 
induction was blocked when a linker mutant Smad1 mRNA was co-
injected with Fgf8 (Pera et al., 2003). This occurs because the linker 
mutant Smad1 cannot be phosphorylated and therefore marked for 
degradation by p-Erk1/2, thus the inhibitory effect of BMP signalling on 
neural induction remains. Similarly, the injection of Fgf8 mRNA into 
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animal cap explants caused the up-regulation of expression of the neural 
plate marker NCAM and the down-regulated of expression of the 
epidermal markers Cytokeratin, Msx1, and Vent2. When Fgf8 and the 
linker mutant Smad1 mRNA were injected at the same time, the 
expression of the epidermal markers Cytokeratin, Msx1, and Vent2 were 
up-regulated, and the neural marker NCAM was down-regulated (Pera et 
al., 2003). These results suggest that the inhibitory effect of BMP 
signalling on neural induction in Xenopus is repressed when the linker 
region of Smad1 is phosphorylated by the activation of FGF/Erk 
signalling (Fig. 1.9). However, these experiments did not exclude the 
possibility that as well as antagonising BMP signalling, FGF/Erk 
signalling also provides an instructive cue to induce neural induction.  
 
If FGF/Erk signalling was only required for blockage of BMP signalling 
to allow neural induction to occur, then one might expect that inhibition 
of BMP signalling would induce neural induction in Xenopus regardless 
of FGF/Erk signalling. However, this is not the case, since in the absence 
of FGF signalling, inhibition of BMP signalling does not induce neural 
induction (Delaune et al., 2005; Marchal et al., 2009). Delaune et al. 
found that although the injection of Smad6 mRNA into Xenopus 
embryos induced the expression of neural plate markers Sox2 and NCAM 
in animal cap explants, which may be due to the repressive effect of 
Smad6 on BMP signalling (see section 1.4.1), this generation of Sox2 
and NCAM-expressing neural tissue was abolished when the explants 
were co-treated with Smad6 and FGFR inhibitor SU5402. This study 
showed that the inhibition of BMP signalling alone is not enough to 
induce neural induction. Similarly, ectopic Sox2-expressing neural tissue 
was induced and the generation of Keratin 81-expressing epidermal 
tissue was suppressed in Xenopus embryos when BMP signalling was 
blocked by knocking down Smad5 (Marchal et al., 2009). Further, when 
these Smad5 knock-down embryos were treated with SU5402 or injected 
with antisense oligos to Fgf4 to inhibit FGF signalling, the knocking 
down Smad5 no longer induced ectopic Sox2-expressing neural tissue, 
but the epidermal marker Keratin 81 was still suppressed because of 
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inhibition of BMP signalling (Marchal et al., 2009). In addition, 
inhibiting BMP signalling by injection of Smad7 mRNA into Xenopus 
embryos induced ectopic neural tissue and this ectopic neural induction 
was enhanced by FGF activation (Wawersik et al., 2005). These findings 
imply that FGF signalling not only acts by inhibiting BMP signalling, 
but also provides an instructive signal to the ectoderm of Xenopus to 
develop along a neural pathway (Aruga and Mikoshiba, 2011).  
 
Evidence has shown that Wnt signalling also plays a role in neural 
induction (del Barco Barrantes et al., 2003), but unlike FGF/Erk 
signalling that promotes neural induction, Wnt signalling suppresses the 
neural differentiation of embryonic ectodermal cells (Glinka et al., 1998; 
Wilson et al., 2001).  
 
1.5.2 The role of Wnt signalling in neural induction  
During early embryogenesis in Xenopus, Wnt signalling has complex roles 
in neural induction (Gaulden and Reiter, 2008). At the blastula stage, the 
organiser region expresses the BMP antagonist Chordin. The activation of 
Wnt signalling by injection of Xenopus embryos with Wnt8 or -catenin 
mRNA increased the expression of Chordin in the organiser region, and 
conversely the inactivation of Wnt signalling by injection of Xenopus 
embryos with a dominant-negative Wnt8 mRNA inhibited the expression 
of Chordin (Glinka et al., 1998; Wessely et al., 2001). These observations 
suggest that prior to the gastrulation, Wnt signalling promotes the 
formation of the organiser, which in turn enhances neural induction during 
gastrulation. However, the organiser also expresses the Wnt antagonist, 
Dickkopf-1 (Glinka et al., 1998; Kazanskaya et al., 2000). At the late 
blastula stage when the orgainser is formed, an antibody against Dickkopf-
1 was injected into the blastocoel of Xenopus embryos, and this resulted in 
the generation of embryos with severe microcephaly and even (in 5% of 
embryos) complete deletion of brain structures, suggesting that the Wnt 
antagonist Dickkopf-1 is required for neural differentiation of the 
ectoderm after the formation of the organiser (Glinka et al., 1998).  
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The animal cap of Xenopus embryos consists of embryonic ectodermal 
cells, and dissociated animal cap cells cultured in the absence of any 
growth factors give rise to neural tissue and express the neural plate 
marker NCAM (for details see section 1.2 and 1.3; Grunz and Tacke, 1989; 
Munoz-Sanjuan and Brivanlou, 2002). When the dissociated animal cap 
cells were cultured with lithium chloride to activate Wnt signalling, the 
expression of NCAM was decreased while the expression of epidermal 
marker Cytokeratin was increased (Fuentealba et al., 2007). This result 
implies that the activation of Wnt signalling in embryonic ectodermal cells 
reduces the generation of neuroectoderm. In conclusion, the above 
experiments suggest that Wnt signalling is needed at the blastula stage for 
specification of the organiser, but this signalling then needs to be 
suppressed to allow neural induction to occur. 
 
Similarly in chick and mouse, Wnt signalling also plays a role in neural 
induction (del Barco Barrantes et al., 2003; Wilson et al., 2001). 
Prospective neural ectodermal explants isolated from chick embryos do 
not express Wnt3a, Wnt8, or BMP4 (Wilson et al., 2001). When such 
explants were cultured with Wnt3a, the expression of BMP4 was induced, 
which promoted the generation of Msx1 and Msx2-expressing epidermal 
tissue, and neural tissue was no longer generated from the prospective 
neural ectodermal explants (Patthey et al., 2009; Wilson et al., 2001), 
suggesting that the activation of Wnt signalling suppresses neural 
induction in chick. Conversely, the prospective non-neural ectodermal 
explants isolated from chick embryos express Wnt3a, Wnt8, and BMP4 
(Wilson et al., 2001). When these explants were cultured with a soluble 
fragment of Frizzled protein to suppress Wnt signalling, not only was the 
expression of Msx1, Msx2, and BMP4 inhibited, but the generation of 
Sox2 and Sox3-expressing neural tissue was induced (Patthey et al., 2009; 
Wilson et al., 2001). This result suggests that inhibiting Wnt signalling 
induces neural induction in chick. Further to this, Wnt3a is expressed in 
the ectoderm of wild type mouse embryos and Wnt3a knockout mouse 
embryos develop an additional neural tube at 8 dpc (Yoshikawa et al., 
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1997). This finding implies that inhibiting Wnt signalling induces 
ectodermal cells to take on a neural phenotype. In line with this, Dickkopf-
1 null mouse embryos did not express the anterior neuroectodermal 
markers Hesx1 and Six3 (Mukhopadhyay et al., 2001). Hesx1 and Six3 are 
expressed in the anterior neural plate of wild type mouse embryos and are 
required for the development of forebrain (Dattani et al., 1998; Lagutin et 
al., 2003; Martinez-Barbera et al., 2000; Mukhopadhyay et al., 2001; 
Oliver et al., 1995).  
 
It has been shown that Activin/Nodal signalling also plays a role in neural 
induction (Wessely et al., 2001). Like Wnt and BMP signals, the activation 
of Activin/Nodal signalling suppresses the neural differentiation of 
embryonic ectodermal cells (Chang and Harland, 2007).  
 
1.5.3 The role of Activin/Nodal signalling in neural induction  
In vertebrates, Activin/Nodal signalling plays important roles in 
embryogenesis and the activation of this pathway promotes mesodermal 
and endodermal development (Agius et al., 2000; Aoki et al., 2002; Camus 
et al., 2006; Johansson and Wiles, 1995; Kispert et al., 1995; Osada and 
Wright, 1999; Poulain et al., 2006; Tremblay et al., 2000). Smad2 and 
Smad3 are the intracellular effectors of Activin/Nodal signalling (in 
contrast to BMP signalling where the effectors are Smad1/5/8, see section 
1.4.1). The activation of Activin/Nodal signalling causes the 
phosphorylation of Smad2 and Smad3, and in turn phosphorylated 
Smad2/3 forms a protein complex with Smad4 (Nakao et al., 1997). This 
complex enters the nucleus to activate target genes, such as Foxa2, 
Goosecoid, and Pitx2 (Arnold and Robertson, 2009; Faucourt et al., 2001; 
Heldin et al., 1997; Vincent et al., 2003). Foxa2 is expressed in the anterior 
primitive streak of mouse embryos, and Foxa2 null mouse embryos failed 
to develop foregut and midgut endoderm, suggesting that Foxa2 is 
required for endodermal development (Dufort et al., 1998). Goosecoid is 
expressed in anterior mesoderm during gastrulation and controls the 
migration of mesodermal cells, suggesting that Goosecoid plays an 
important role in mesodermal patterning (Blum et al., 1992; Niehrs et al., 
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1993; Niehrs et al., 1994). Pitx2 is expressed in the prospective mesoderm 
and endoderm of Xenopus embryos, and the injection of Pitx2 mRNA into 
Xenopus embryos at the 4-cell stage induced the ectopic expression of the 
mesodermal marker Goosecoid and endodermal marker Sox17, suggesting 
that Pitx2 is involved in mesodermal and endodermal induction (Faucourt 
et al., 2001).  
 
When Smad2 mRNA was injected into Xenopus embryos at the 32 to 64-
cell stage to activate Activin/Nodal signalling, ectopic MyoD-expressing 
mesodermal tissue was observed together with an inhibition of expression 
of the neural markers Sox2 and Sox3 in the neural plate (Chang and 
Harland, 2007). This result suggested that Activin/Nodal signalling 
inhibited the development of embryonic ectoderm along a neural pathway 
in Xenopus. Conversely the injection of a truncated Activin receptor IB or 
mRNA of the Nodal antagonist Lefty into Xenopus embryos to suppress 
Activin/Nodal signalling induced the generation of ectopic neural tissue, as 
assessed by the expression of the neural plate marker NCAM, and 
decreased the expression of the mesoderm markers Actin and Globin 
(Wessely et al., 2001). This result suggests that inhibition of Activin/Nodal 
signalling helps specify ectoderm along a neural pathway. Similarly Nodal 
null mouse embryos generate Sox1-expressing neuroectodermal cells 
precociously; at 6.25 dpc rather than at 7.75 dpc as observed in wild type 
embryos. Further, when the neural plate of Nodal null embryos was 
dissected and cultured for 48 hours in vitro, it generated more neuronal 
cells than did wild type embryos (Camus et al., 2006). These results 
suggest that inhibition of Activin/Nodal signalling promotes neural 
induction in mouse.  
 
Evidence has shown that calcium also plays a role in neural induction in 
Xenopus embryos (Leclerc et al., 2003; Leclerc et al., 2000), but unlike 
BMP, Wnt, and Activin/Nodal pathways that act to repress neural 
induction, an increase in [Ca2+]i helps specify ectoderm along a neural 
pathway in Xenopus embryos (Batut et al., 2005). 
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1.5.4 Calcium plays a pivotal role in neural induction of Xenopus  
In addition to FGF, an increase in cytosolic Ca2+ has also been 
demonstrated to be required for neural induction in Zebrafish and Xenopus. 
So far, most of reports regarding the role of calcium in neural induction 
have been obtained from non-mammalian models (Leclerc et al., 2011). In 
Zebrafish embryos, levels of Ca2+ have been imaged throughout early 
embryogenesis by injecting the Ca2+ indicator aequorin into eggs. Using 
this methodology it has been shown that during early gastrulation when 
neural induction occurs, [Ca2+]i is increased in the prospective neural 
ectoderm (Creton et al., 1998; Gilland et al., 1999), suggesting that an 
increase in [Ca2+]i may play a role in neural induction of Zebrafish.  
 
Furthermore, some studies have revealed that calcium also plays a role in 
neural induction in amphibians (Batut et al., 2005; Leclerc et al., 1997; 
Leclerc et al., 2003; Moreau et al., 2008). Again the Ca2+ indicator 
aequorin was used. In aequorin injected Xenopus embryos, an increase in 
[Ca2+]i was observed during gastrulation in the dorsal ectoderm, which 
contains the prospective neural ectoderm. In contrast, no increase in [Ca2+]i 
was observed in the ventral ectoderm, which will differentiate into 
epidermis (Leclerc et al., 2003; Leclerc et al., 2000). Thus an increase in 
[Ca2+]i is seen in the prospective neural ectoderm during neural induction 
in Xenopus embryos, suggesting that Ca2+ may play a role in this process, 
as reported for Zebrafish.  
 
1.5.4.1 An increase in [Ca2+]i induces neural induction in Xenopus 
Animal cap assays (see section 1.3 for details) reveal that an increase in 
[Ca2+]i induces ectodermal cells to take on a neural identity (Batut et al., 
2005). The treatment of animal cap explants with caffeine to increase 
[Ca2+]i, by activation of the RyRs (ryanodine receptors) in the membrane 
of ER (details see section 1.5.4.4; McPherson et al., 1991), up-regulated 
the expression of xPRMT1b (Xenopus protein arginine methyltransferase 
type I b) (Batut et al., 2005). xPRMT1b is a member of the protein 
arginine N-methyltransferase family that catalyses the methylation of 
arginine residues to regulate transcriptional activation (Pawlak et al., 
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2000; Wang et al., 2001). This increased expression of xPRMT1b 
activates the expression of neural genes (Zic3, Neurogenin, NCAM, and 
N-tubulin) to drive animal cap explants towards to a neural fate (Batut et 
al., 2005; Moreau et al., 2008). Further to this, injecting xPRMT1b into 
one side of a Xenopus embryo expanded the domain of Zic3 and N-
tubulin-expressing neural plate cells when compared with the uninjected 
side (Batut et al., 2005). Thus, the exposure of animal caps to caffeine 
caused an increase in [Ca2+]i that in turn increased the expression of 
xPRMT1b promoting neural induction in Xenopus. Therefore the 
increase in [Ca2+]i is an instructive signal for neural induction in 
Xenopus.  
 
1.5.4.2 Preventing the elevation of [Ca2+]i suppresses neural 
induction in Xenopus  
If an increase in [Ca2+]i induces neural induction in Xenopus, then 
preventing the increase in [Ca2+]i should suppress this process. This is 
supported by studies where Xenopus embryos were cultured with an L-
type calcium channel blocker, R(+)BayK, from the blastula stage to the 
gastrula stage. Here the Ca2+ influx from extracellular fluids into the 
cytosol through L-type calcium channels was blocked and the elevation 
of [Ca2+]i was abolished in the dorsal ectoderm (Leclerc et al., 2000). In 
this culture condition, the expression of the early neural genes Zic3 and 
Geminin was down-regulated (Leclerc et al., 2000) at the gastrula stage, 
while both genes were normally expressed in neuroectoderm of untreated 
embryos (Fujimi et al., 2006; Kroll et al., 1998; Rogers et al., 2009). The 
finding suggests that preventing the elevation of [Ca2+]i suppresses 
neural induction of Xenopus embryos. In Zebrafish embryos, the number 
of motor neurons was reduced within the spinal cord when embryos were 
treated with a Ca2+ chelator, BAPTA, to reduce the free cytosolic Ca2+ 
(Ashworth et al., 2001). This result suggested that an increase in [Ca2+]i 
is required for neurogenesis, but it is unknown whether the reduction in 
neurogenesis is due to the suppression of neural induction in Zebrafish 
embryos or the inhibition of neuronal differentiation of neural 
progenitors to generate neurons. So far, there is no published data to 
 56 
distinguish if or not the increase in [Ca2+]i is required for neural 
induction in Zebrafish embryos.  
 
Similarly, as describe above, culturing animal cap explants with a BMP 
antagonist Noggin induced the generation of neural tissue and the 
expression of the neural plate marker NCAM (see section 1.3). This 
expression of NCAM was shown to be diminished significantly by 
adding R(+)BayK or BAPTA into the culture medium to prevent an 
increased in [Ca2+]i (Batut et al., 2005; Leclerc et al., 2000). Thus 
preventing an increase in [Ca2+]i suppressed neural induction, which was 
induced by the treatment of animal cap explants with the BMP 
antagonist Noggin. When Xenopus animals cap cells were dissociated 
and grown as dispersed cells in culture in the absence of any growth 
factors or inhibitors, these dissociated cells gave rise to neural tissue, as 
detected by the expression of NCAM (see section 1.3; Grunz and Tacke, 
1989; Wilson et al., 1997). This NCAM expression could again be 
reduced by addition of the calcium chelator BAPTA into the culture 
medium (Leclerc et al., 2000). These results suggested that the increase 
in [Ca2+]i was required for neural induction, and that preventing this 
increase repressed neural induction in Xenopus embryos or animal cap 
explants.  
 
1.5.4.3 An increase in [Ca2+]i activates Erk signalling    
As discussed in section 1.5.1, the activation of FGF/Erk signalling 
induces neural induction. It has also been demonstrated that an increase 
in [Ca2+]i activates Erk signalling (Kupzig et al., 2005; Riddle et al., 
2006). RasGRP (Ras guanyl-releasing protein) is a nucleotide exchange 
factor with calcium and DAG binding motifs.  An increase in [Ca2+]i 
activates RasGRP, which in turn activates Ras through the exchange of 
bound GDP for GTP, and then Ras-GTP activates the Raf/MEK/Erk 
protein kinase cascade (Fig.1.10; Agell et al., 2002; Ebinu et al., 1998; 
Kupzig et al., 2005). This leads to a reasonable assumption that an 
increase in [Ca2+]i induces ectodermal cells in Xenopus to take on a 
neural fate via the activation of Erk signalling. Within my thesis, I 
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investigate this assumption and ask whether an increase in [Ca2+]i 
induces the activation of Erk signalling in mouse ESCs and promotes the 
generation of NSCs (see Chapter 5). 
 
Tg (thapsigargin) is a specific inhibitor of Apt2a/SERCA 
(sarcoendoplasmic reticulum Ca2+-ATPase) (Lytton et al., 1991). It 
prevents cytosolic Ca2+ being pumped into the ER by Apt2a/SERCA 
thus causing an increase in [Ca2+]i (details see section 1.5.4.4). In Hela 
cells, treatment with Tg increases the [Ca2+]i, Ras-GTP (the active form 
of Ras), and p-Erk1/2. Erk1/2 is no longer phosphorylated when Hela 
cells are treated with a MEK inhibitor, U0126 (Kupzig et al., 2005). 
These results suggest that Tg induces an increase in [Ca2+]i and activates 
Erk signalling via the Ras/Raf/MEK/Erk protein kinase cascade (Fig. 
1.10). In line with this, when human mesenchymal stem cells or Jurkat 
T-cells were treated with Tg, p-Erk1/2 was increased. The 
phosphorylation of Erk1/2 can be inhibited by the membrane permeable 
calcium chelator BAPTA-AM and the MEK inhibitor U0126, but not by 
the PLC inhibitor U73343 or the PKC inhibitor GF109203X (Denys et 
al., 2004; Riddle et al., 2006). The results imply that an interaction 
between Ca2+ and Erk signalling happens in different cell-types. If this 
interaction exists in ectodermal cells of Xenopus, then an increase in 




Fig. 1.10. An increase in [Ca2+]i activates Erk signalling pathway.   
Tg causes an increase in [Ca2+]i and in turn activates RasGRP. The active RasGRP 
activates Ras through the exchange of bound GDP for GTP. Ras-GTP activates the 
Raf/MEK/Erk protein kinase cascade. Therefore an increase in [Ca2+]i activates Erk1/2 
through this pathway. U0126 and PD184352 are inhibitors of MEK and can block the 
phosphorylation of Erk1/2 to inhibit Erk signalling.  
Abbreviations: Erk1/2, Extracellular Signal-regulated Kinase 1/2; GDP, Guanosine 
diphosphate; GTP, Guanosine triphosphate; MEK, Mitogen-activated 
Protein/Extracellular Signal-regulated Kinase Kinase; RasGRP, Ras guanyl-releasing 
protein; Tg, Thapsigargin.  
(Adapted from Cullen and Lockyer, 2002; Thomas and Huganir, 2004) 
 
1.5.4.4 The movement of Ca2+ in cells 
Since an increase in [Ca2+]i induces ectodermal cells to take on a neural 
fate in Xenopus, the movement of Ca2+ in cells should be discussed. Ca2+ 
is an important second messenger that is involved in regulating cell 
proliferation, differentiation, and apoptosis (Berridge et al., 2000; 
Boehning et al., 2003; Boyce and Ham, 1983; Rodriguez-Mora et al., 
2005). When cells are in a resting state, the [Ca2+]i is approximately 100 
nM and the extracellular Ca2+ concentration is kept at approximately 2 
mM (Fig. 1.11; Clapham, 2007). In eukaryotic cells, Ca2+ is stored in the 
ER, an intracellular network of folded membranes and flattened sacs. 
The ER is also the site of synthesis of proteins, lipids, and sterols, and 
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post-translational modification and folding of proteins (Kaufman, 1999). 
In the membrane of the ER, there are two Ca2+ channels, IP3R (inositol 
1,4,5-triphosphate receptor) and RyR, which can release Ca2+ from the 
ER into the cytosol (Clapham, 2007). When non-excitable cells are 
exposed to growth factors (such as epidermal growth factor and platelet-
derived growth factor) or neurotransmitters (dopamine, glutamate, and 
serotonin), RTKs, and G protein-coupled receptors respectively are 
activated. In turn, PLC is activated by the receptors, and this converts 
PIP2 to IP3 and DAG (Meisenhelder et al., 1989; Peters et al., 1992). The 
IP3 binds to the IP3R in the ER resulting in Ca
2+ being released into the 
cytosol (Clapham, 2007). This increase in cytosolic Ca2+ also activates 
RyR and IP3R, in a feed back loop, further increasing Ca
2+ releases from 
the ER. This feedback stimulation is called the Ca2+–induced Ca2+ 
release (Slusarski and Pelegri, 2007). Therefore IP3R and RyR play 
important roles in regulating cytosolic Ca2+. Further to this, Ca2+ can also 
be released from the ER through IP3R or RyR spontaneously by a 
process known as spontaneous calcium oscillation (Carroll and Swann, 
1992; Missiaen et al., 1991; Stern et al., 1988; Yu et al., 2008b). 
 
In addition to Ca2+ being released from the ER, Ca2+ also enters the 
cytosol from the extracellular fluid through Ca2+ channels in the plasma 
membrane of excitable cells, such as neuronal and muscle cells 
(Clapham, 2007; Gilmore et al., 2009). When these channels are 
activated by a change of membrane potential (action potential) or ligands 
(such as acetylcholine, glutamate, serotonin, and ATP) binding to their 
cell-surface receptors, then the extracellular Ca2+ flows rapidly into the 
cytosol along a large electrochemical potential gradient (Cornell-Bell et 
al., 1990; Cotrina et al., 1998; Ferezou et al., 2002; Helmchen et al., 
1996; Sharma and Vijayaraghavan, 2001). This influx of extracellular 
Ca2+ triggers the release of Ca2+ from the ER (Ca2+–induced Ca2+ release) 
by activation of the IP3R and RyR, as discussed above, resulting in an 




Fig. 1.11. Schematic diagram of the movement of Ca2+ in cells.  
At rest the Ca2+ concentration in the cytosol is low (~100nM), compared with that of 
the extracellular fluid (~2mM). (A) To maintain this low [Ca2+]i, the Ca
2+ is extruded 
by PMCA, NCX, and NCKX. The cytosolic Ca2+ is also pumped into the ER via the 
Atp2a/SERCA. Although some Ca2+ is released from the ER into the cytosol through 
IP3R or RyR automatically (the so called spontaneous calcium oscillation), [Ca
2+]i is 
kept at a low level. (B) In non-excitable cells, growth factors (for example, EGF and 
PDGF) and neurotransmitters (dopamine, glutamate, and serotonin) activate RTKs and 
GPCRs respectively. The activated RTK or GPCR activates PLC and this results in the 
conversion of PIP2 to IP3 and DAG. IP3 activates IP3R and releases Ca
2+ from the ER 
into the cytosol. The cytosolic Ca2+ also activates the RyR and causes more Ca2+ release. 
In excitable cells, there are voltage- or ligand-gated calcium channels in the plasma 
membrane. Activation of these channels by an action potential or neurotransmitters 
leads to rapid Ca2+ influx. The influx of extracellular Ca2+ also triggers the release of 
Ca2+ from the ER (Ca2+–induced Ca2+ release) by activation of the IP3R and RyR, 
resulting in an increase in [Ca2+]i. 
Abbreviations: Atp2a/SERCA, sarcoendoplasmic reticulum Ca2+-ATPase; [Ca2+]i, 
concentration of cytosolic Ca2+; DAG,  diacylglycerol; EGF, epidermal growth factor; 
ER, endoplasmic reticulum; GPCR, G protein-coupled receptor; IP3 ,inositol 1,4,5-
triphosphate; IP3R, IP3 receptor; NCKX, Na
+/Ca2+-K+ exchanger; NCX, Na+/Ca2+ 
exchanger; PDGF, platelet-derived growth factor; PIP2, phosphatidylinositol 4,5-
bisphosphate; PLC, phospholipases C; PMCA, plasma membrane Ca2+-ATPase; RTK, 
receptor tyrosine kinase; RyR, ryanodine receptor. (Adapted from Clapham, 2007) 
 
The increase in [Ca2+]i furthers the binding of cytosolic Ca
2+ to 
intracellular Ca2+-binding proteins, and then triggers Ca2+-dependent 
events (Klipp and Liebermeister, 2006). For example, calmodulin is a 
well-known intracellular Ca2+-binding protein (Chin and Means, 2000; 
Goldbeter et al., 1990). Ca2+/calmodulin has been reported to interact 
with many proteins including neuromodulin, CaM kinase II, and 
phosphodiesterase (Alexander et al., 1988; Borisy et al., 1992; De 
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Koninck and Schulman, 1998; Heinzel et al., 1992; Klee et al., 1979; 
Sobue et al., 1981). Neuromodulin is a neural-specific calmodulin 
binding protein and its expression is up-regulated during axon growth 
(He et al., 1997). The interaction between Ca2+, calmodulin, and 
neuromodulin is involved in the modulation of synaptic plasticity 
(Husson et al., 2004; Xia and Storm, 2005). CaM kinase II is activated 
by Ca2+/calmodulin (De Koninck and Schulman, 1998), and it has been 
demonstrated that CaM kinase II plays an important role in learning and 
memory (Lisman, 1994; Wei et al., 2002). Ca2+/calmodulin also activates 
phosphodiesterases that degrade the phosphodiester bond in cAMP 
(cyclic AMP) and cGMP (cyclic GMP) converting them to AMP and 
GMP respectively and inhbiting their function (Borisy et al., 1992; 
Rybalkin et al., 2003). The calmodulin-dependent phosphodiesterases 
are highly expressed in olfactory sensory neurons where 
Ca2+/calmodulin terminates the odorant-induced cAMP signalling by 
phosphodiesterase activation (Borisy et al., 1992; Yan et al., 1995). 
Therefore, through the interaction of cytosolic Ca2+ and Ca2+-binding 
proteins, the regulation of [Ca2+]i affects many aspects of biological 
function. In addition to calmodulin, intracellular Ca2+ also binds and 
activates another protein RasGRP, resulting in the activation of Erk 
signalling (see section 1.5.4.3). Because the activation of Erk signalling 
is important for neural induction (for details see section 1.5.1.3), within 
Chapter 5, I will investigate the interaction between an increase in 
[Ca2+]i and Erk signalling during neural induction.      
 
To return [Ca2+]i to the basal state, cytosolic Ca
2+ is pushed into the ER 
or out of the cell by Ca2+-ATPase pumps (Fig. 1.11). In the plasma 
membrane, the plasma membrane Ca2+-ATPase (PMCA) pump removes 
Ca2+ from the cytosol (Di Leva et al., 2008; Yamoah et al., 1998). 
Na+/Ca2+ exchangers (NCX) and Na+/Ca2+-K+ exchangers (NCKX) also 
transport cytosolic Ca2+ out of the cell (Bers and Bridge, 1989; Clapham, 
2007; Kang et al., 2005). Thus PMCA pumps, NCX, and NCKX play 
roles in maintaining the [Ca2+]i basal state of these cells (Yanagida et al., 
2004). In the ER, the Atp2a/SERCA transports cytosolic Ca2+ into the 
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internal ER store (Slusarski and Pelegri, 2007; Zhong and Inesi, 1998). 
There are three Atp2a/SERCA genes in vertebrates: ATPase, Ca2+ 
transporting, cardiac muscle, fast twitch 1 (Atp2a1) encoding 
Atp2a1/SERCA1; ATPase, Ca2+ transporting, cardiac muscle, slow 
twitch 2 (Atp2a2) encoding Atp2a2/SERCA2; and ATPase, Ca2+ 
transporting, ubiquitous (Atp2a3) encoding Atp2a3/SERCA3. In 
mammals, three Atp2a/SERCA genes encode 12 isoforms through 
alternative splicing (Pegoraro et al., 2011; Periasamy and 
Kalyanasundaram, 2007). Atp2a1a/SERCA1a is expressed in adult fast-
twitch sketetal muscles, Atp2a1b/SERCA1b is expressed in fetal fast-
twitch sketetal muscles, Atp2a2a/SERCA2a and Atp2a2c/SERCA2c are 
expressed in cardiomyocytes, Atp2a2b/SERCA2b is expressed 
ubiquitously, and Atp2a3/SERCA3 encodes 6 isoforms and are 
expressed in non-muscle cells, such as endothelial cells, lymphocytes, 
fibroblasts, platelets, and epithelial cells (Periasamy and 
Kalyanasundaram, 2007). Apt2a1/SERCA1 null mutant mice can survive 
and appear normal at birth, and Apt2a3/SERCA3 null mutant mice 
develop normally (Prasad et al., 2004). In contrast, Apt2a2/SERCA2 has 
been shown to be essential for embryonic development as 
Apt2a2/SERCA2 null mice are embryonic lethal (Periasamy et al., 1999). 
During Xenopus embryonic development, Apt2a2/SERCA2 (but not 
Apt2a1/SERCA1 and Apt2a3/SERCA3) is expressed in the neural plate 
and neural tube indicating a role for this gene in aspects of neurogenesis 
(Pegoraro et al., 2011). 
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In summary (Fig. 1.12), BMP, Wnt, and Activin/Nodal signals act as 
negative cues for neural induction in vertebrates, preventing ectodermal 
cells giving rise to neuroectoderm. The activation of BMP signalling 
activates Smad1 and its target gene Msx1, which pushes ectoderm to an 
epidermal fate and suppresses neural induction (for details see section 
1.4). The BMP antagonists (Noggin, Chordin, and Follistatin) prevent 
BMP ligands binding to their receptors, resulting in inhibition of BMP 
signalling and promotion of neural development (for details see sections 
1.2 and 1.3). As well as the BMP signal, the activation of Wnt or 
Activin/Nodal pathways keeps ectodermal cells from taking on a neural 
fate (for details see sections 1.5.2 and 1.5.3). Conversely, antagonising 
Wnt or Activin/Nodal signallings by Dickkopf1 or Lefty respectively 
helps the ectoderm become specified to give rise to neuroectoderm.   
 
In contrast, FGF/Erk and calcium signals function as positive cues for 
neural induction, with the activation of FGF/Erk signalling or an increase 
in [Ca2+]i specifying ectoderm along a neural pathway (Fig. 1.12). 
Erk1/2 is the effector of FGF signalling and the activated Erk1/2 not 
only inhibits Smad1 to suppress BMP signalling, but also has an 
instructive effect on neural induction (for details see sections 1.5.1.3 and 
1.5.1.4). Therefore the activation of FGF/Erk signalling helps convert 
ectodermal cells into neuroectodermal cells. Further, an increase in 
[Ca2+]i is required for neural induction in Xenopus embryos (for details 
see sections 1.5.4.1 and 1.5.4.2), and this increase in [Ca2+]i also 
activates Erk signalling (for details see section 1.5.4.3). Thus, the 
increase in [Ca2+]i may promote neural specification of the ectoderm by 




Fig. 1.12. Schematic representation of the mechanisms of neural induction in 
vertebrates. 
The binding of BMP ligands with their receptors activates Smad1, resulting in 
expression of its target gene Msx1 which pushes the ectoderm along an epidermal fate 
and inhibits neural induction. Conversely, the BMP antagonists (Noggin, Chordin, and 
Follistatin) prevent the binding of BMP ligands to their receptors, resulting in 
suppression of BMP signalling and promotion of neural induction. The Wnt antagonist 
Dickkopf1 suppresses Wnt signalling to help the neural specification of ectodermal 
cells. Activin/Nodal signalling activates Smad2 to prevent the ectoderm taking up a 
neural fate. Conversely, the Nodal antagonist Lefty suppresses Activin/Nodal signalling 
resulting in promotion of neural induction. The activation of FGF signalling promotes 
neural induction via activation of Erk1/2 and suppression of BMP signalling by 
inhibition of Smad1. In Xenopus embryos, an increase in [Ca2+]i may activate the 
Erk1/2, and in turn promotes neural induction.        
Abbreviations: BMP, Bone morphogenetic protein; [Ca2+]i, concentration of cytosolic 
Ca2+; Erk1/2, Extracellular Signal-regulated Kinase 1/2; FGF, Fibroblast growth factor. 
 
As discussed above, many studies on neural induction are carried out in 
amphibian and chick embryos, but only a few experiments are carried 
out in mouse embryos, because compared with amphibian and chick 
embryos, mammalian embryos are difficult to access and it is not easy to 
obtain them in large numbers or to make transgenic embryos. In order to 
solve this issue, mouse and human ESCs have been used to set up in 
vitro neural differentiation models, which provide platforms to study the 
mechanism of neural induction in mouse and humans (Abranches et al., 
2009; Chambers et al., 2009; Ying et al., 2003). 
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1.6 Neural induction in ESCs 
ESCs are derived from the ICM of the blastocyst and ESCs are pluripotent, 
being able to differentiate into all cell-types in the body (Evans and 
Kaufman, 1981; Murry and Keller, 2008). Thus, ESCs have the ability to 
differentiate into neuroectodermal cells, NSCs, NPCs, and neurons (Ying et 
al., 2003). Neural induction in ESCs is the process by which 
neuroectodermal cells or NSCs are generated (Gerrard et al., 2005; Munoz-
Sanjuan and Brivanlou, 2002). NSCs have two primary characteristics the 
ability to self-renewal and the potential to give rise to all the different cell 
types on the adult central nervous system - neurons, astrocytes and 
oligodendrocytes (Gage, 2000; Kornblum, 2007; Raff et al., 1983; Reynolds 
and Rietze, 2005).    
 
1.6.1 ESCs: a tool for studying neural induction in mammals 
In vitro ESC-based neural differentiation models use two different 
culturing techniques to drive ESCs down the neural lineage (Abranches et 
al., 2009). In the first method, ESCs are grown as aggregates, while in the 
second method ESCs are grown as a monolayer. In the aggregate culture 
system, ESCs are suspended in serum containing culture medium to form 
embryoid bodies (EBs). These EB are then differentiated by the addition of 
growth factors, such as retinoic acid and FGF2, to induce neural 
differentiation and expand the resulting neural stem and progenitor cell 
populations (Bain et al., 1995; Carpenter et al., 2001; Lee et al., 2000b). 
Ying et al. (2003) created a system where ESCs are grown as a monolayer, 
and cultured in a chemically defined, serum free, medium. By not using 
serum this system removes any experimental variability caused from using 
different serum batches (Peck and Bach, 1973), and also any problems 
associated with unspecified serum components that may affect the 
proliferation and differentiation of ESCs (Glassy et al., 1988). Thus, 
compared with the aggregate culture system, the monolayer culture system 
produces more consistent and reproducible results (Argentin et al., 1993). 
In addition, most of cells grown in a two-dimensional culture (monolayer 
culture system) are exposed to similar concentrations of signals present in 
the culture medium, but in a three-dimensional culture (aggregate culture 
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system) the inner and outer cells of the aggregate will be exposed to 
different signal concentrations due to these signals being required to 
penetrate the outer cell layers in order to reach those on the inside (Derda 
et al., 2009). Therefore, the monolayer culture model is widely used and 
provides an ideal system to study neural development of ESCs (Abranches 
et al., 2009; Stavridis et al., 2007; Sun et al., 2008). Moreover, when 
grown as a monolayer, ESCs generate neural cell in a reproducible and 
sequential manner: NSCs, neural progenitor cells (NPCs), and neurons 
after 2, 6, and 12 days of differentiation respectively (Sun et al., 2008; 
Ying et al., 2003; also see section 3.2.1). It is for the above reasons that I 
have chosen this system for my studies on neural cell development. 
 
1.6.2 Signals involved in neural induction of ESCs 
Studies on ESCs differentiation have shown that, as described above from 
studies using Xenopus, chick and mouse embryos, BMP, Activin/Nodal, 
FGF, and Wnt signalling pathways are all involved in neural induction 
(Aubert et al., 2002; Chambers et al., 2009; Gerrard et al., 2005; LaVaute 
et al., 2009). Culturing mouse or human ESCs with medium containing 
BMP4 reduced the generation of neural progenitors and neurons compared 
with cultures that received no BMP4 treatment, and this reduction of 
neural generation could be reversed by exposure to the BMP antagonist 
Noggin (Finley et al., 1999; LaVaute et al., 2009; Stavridis et al., 2007; 
Tropepe et al., 2001), suggesting that activation of BMP signalling 
suppresses the neural development of mouse and human ESCs. Similarly 
flow cytometry profiling of differentiated mouse ESCs showed that 
treatment of mouse ESCs with BMP4 not only reduced the generation of 
Sox1 or Nestin-expressing neural progenitors, but also increased the 
number of Cytokeratin 18-expressing epithelium cells (Gambaro et al., 
2006). Another report also revealed that the generation of Sox1-expressing 
neuroectodermal cells was reduced by over 90% when mouse ESCs were 
cultured with BMP4 and differentiated for three days (Stavridis et al., 
2007). These results imply that BMP signalling is a repressive signal for 
neural induction in ESCs, as observed from studies in Xenopus, chick, and 
mouse embryos (see section 1.4; Bachiller et al., 2000; Wilson et al., 1997; 
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Wilson et al., 2000). 
 
Conversely when the BMP antagonists Noggin or Chordin were over-
expressed in mouse ESCs, they promoted their neural differentiation 
(Gratsch and O'Shea, 2002). In line with this, adding the BMP antagonist 
Noggin to the culture medium of human ESCs increased the production of 
neural progenitors and reduced the generation of Cytokeratin 8-expressing 
epithelium cells when compared with Noggin untreated human ESCs 
(Gerrard et al., 2005; Itsykson et al., 2005). The results suggest that 
inhibition of BMP signalling promotes neural induction in mouse and 
human ESCs.   
 
When mouse or human ESCs are cultured with Activin A to activate 
Activin/Nodal signalling, it drives mouse and human ESCs to differentiate 
into Enolase-expressing mesodermal or Sox17 and FoxA2-expressing 
endodermal cells, and away from a neural pathway (Borowiak et al., 2009; 
Schuldiner et al., 2000). This finding implies that Activin/Nodal signalling 
is a repressive signal for neural induction in mouse and human ESCs, as 
observed in Xenopus and mouse embryos. Cripto is a co-receptor of 
Activin/Nodal signalling, so the binding of Cripto with Activin/Nodal 
ligand and receptor activates Activin/Nodal signalling in mouse ESCs 
(Minchiotti, 2005; Yan et al., 2002). Conversely when mouse ESCs were 
treated with a blocker of Cripto (Cripto BP), the generation of Nestin-
expressing NSCs was increased compared with Cripto BP untreated mouse 
ESCs (Lonardo et al., 2010). Likewise in Cripto null ESCs, the generation 
of neurons was increased compared with wild type ESCs, and adding 
Cripto to the culture medium of Cripto null ESCs reduced their ability to 
generate neurons (Parisi et al., 2003). Similarly, treatment of human ESCs 
with a specific Activin receptor inhibitor (SB431542) promotes the 
generation of MUSASHI and SOX1-expressing neural progenitors (Patani 
et al., 2009). Inhibiting Activin/Nodal and BMP signalling pathways at the 
same time by the treatment of human ESCs with SB431542 and Noggin 
robustly converts human ESCs into PAX6-expressing neural progenitors 
(Chambers et al., 2009). These results suggest that the inactivation of 
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Activin/Nodal signalling promotes neural induction in mouse and human 
ESCs. 
 
The over-expression of Wnt1 or knocking down Dickkopf-1 (Wnt 
antagonist) in mouse ESCs to activate Wnt signalling reduces the 
expression of Sox1 and decreases the generation of neurons (Aubert et al., 
2002; Verani et al., 2007). Another study also demonstrated that the 
activation of the canonical Wnt signalling pathway by introducing a 
dominant active form of -catenin not only reduced the generation of 
Sox1-expressing neural progenitors, but also increased the expression of 
non-neural markers, such as Brachyury, Cytokeratin, and Smooth muscle 
actin (Haegele et al., 2003). These findings imply that Wnt signalling is a 
suppressive signal of neural induction in mouse ESCs, just like in Xenopus, 
chick, and mouse embryos. Conversely, mouse ESCs transfected with the 
Wnt antagonist Sfrp2 (secreted frizzled-related protein 2) have been shown 
to generate more Sox1-expressing neural precursors than their wild type 
ES counterparts (Aubert et al., 2002). In line with this, when mouse ESCs 
were exposed to the Wnt antagonist Dickkopf-1, the generation of Nestin-
expressing neural progenitors was increased (Verani et al., 2007). These 
results imply that the inhibition of Wnt signalling promotes neural 
specificity of mouse ESCs. 
 
Unlike Activin/Nodal, BMP, and Wnt signalling that act to inhibit neural 
differentiation, the activation of FGF signalling promotes neural induction 
of mouse and human ESCs. The treatment of mouse ESCs with the FGF 
receptor inhibitor PD173074 reduces the generation of Sox1-expressing 
neuroectoderm (Stavridis et al., 2007). Similarly the generation of Nestin-
expressing NSCs has been shown to be significantly decreased in Fgf4-/- 
mouse ESCs compared with their wild type ESC counterparts, and the 
generation of neural progenitors and neurons form the Fgf4-/- mouse ESCs 
was regained when Fgf4-/- mouse ESCs were exposed to FGF4 (Kunath et 
al., 2007). Further to this, when human ESCs were treated with the FGF 
receptor inhibitor SU5402, the generation of PAX6-expressing neural 
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progenitors was reduced and the expression of NCAM (a marker of early 
neural progenitors) was down-regulated with the concomitant up-
regulation of expression of the epithelial marker Cytokeratin 8 (LaVaute et 
al., 2009; Yoo et al., 2011). Conversely when human ESCs were exposed 
to FGF2, the expression of NCAM was up-regulated and the expression of 
Cytokeratin 8 was down-regulated (Cohen et al., 2010). These results 
suggest that the activation of FGF signalling promotes neural induction 
while the inhibition of this signalling pathway suppresses neural induction 
in both human and mouse ESCs; similar effects for FGF signalling on 
neural induction are found in Xenopus, chick, and mouse embryos (see 
section 1.5.1).  
 
Thus, signalling pathways shown to be important for neural induction in 
mouse embryos are also important for the neural differentiation of ESCs, 
indicating that these cells provide a valid model to study the mechanisms 
of neural induction in mouse.  
 
1.7 Transcription factors and neural induction in vertebrates  
As discussed in above sections, different signalling pathways have been 
identified that induce or suppress the neural fate of embryonic ectoderm. 
However, how these pathways interact with transcription factors to regulate 
genes that control neural induction is still poorly understood (Kamiya et al., 
2011; Stern, 2006).  
 
Transcription factors have been demonstrated to play an important role 
during embryogenesis (Arnold and Robertson, 2009; Guillemot, 2007; 
Nichols et al., 1998). For example, octamere-binding transcription factor 4 
(Oct4; also known as POU5F1) and Nanog are expressed in the pluripotent 
cells of the pre-gastrulation embryo during early embryogenesis in mammals 
(Hart et al., 2004; Palmieri et al., 1994; Rosner et al., 1990). In Oct4 null 
embryos the pluripotent ICM failed to develop, instead differentiated along 
the extraembryonic trophoblast lineage (Nichols et al., 1998). Although the 
Nanog null embryo could generate ICM, these embryos failed to generate 
the pluripotent epiblast, instead generating extraembryonic endoderm 
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(Mitsui et al., 2003). Similarly, when Oct4 and Nanog were temporarily 
suppressed in mouse ESCs using RNA interference (RNAi), the generation 
of extraembryonic lineages were induced (Hough et al., 2006). Therefore, 
Oct4 and Nanog are crucial for the development and maintenance of 
pluripotent ESCs (Loh et al., 2006). When ESCs differentiated into the three 
primary germ layers, the expression of Oct4 and Nanog was down-regulated 
(Hart et al., 2004; Rosner et al., 1990). This down-regulation of both 
transcription factors is considered as the beginning of mammalian 
development (Chambers et al., 2007; Pesce and Scholer, 2001).  
 
Similar to Oct4 and Nanog, Sox2 is also expressed in pluripotent cells of the 
pre-gastrulation embryo and Sox2 null mouse embryos failed to generate 
ICM (Avilion et al., 2003). In mouse ESCs, the expression of Oct4 and 
Nanog were down-regulated when Sox2 was knocked down, suggesting that 
Sox2 is an important transcription factor to regulate the pluripotency of 
ESCs (Fong et al., 2008; Masui et al., 2007). However, unlike Oct4 and 
Nanog, that are down-regulated upon epiblast differentiation, Sox2 is still 
expressed in extraembryonic ectoderm and neural progenitors from neural 
plate stages to adulthood (Ellis et al., 2004; Ferri et al., 2004; Rex et al., 
1997; Wood and Episkopou, 1999), suggesting a role of Sox2 in neural 
development.  
 
In Xenopus embryo, Sox2 is expressed in the prospective neural ectoderm at 
the time of neural induction (Pevny and Placzek, 2005). The injection of 
Sox2 mRNA into Xenopus embryos induced the generation of ectopic 
NCAM-expression neural tissue. In contrast, the injection of dominant-
negative forms of Sox2 mRNA into Xenopus embryos inhibited the 
generation of NCAM-expression neural tissue and up-regulated the 
expression of the epidermal marker Keratin (Kishi et al., 2000). Therefore, 
Sox2 is crucial for neural induction in Xenopus, so the understanding how 
Sox2 expression is regulated is important.  
 
In the chick embryo, 25 conserved enhancers of Sox2 have been identified 
and two enhancers (N1 and N2) were found to be relevant for neural 
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induction (Papanayotou et al., 2008; Uchikawa et al., 2003) with N2 being 
expressed earlier than N1 (Uchikawa et al., 2003).The enhancer N2 was 
found to be responsible for Sox2 expression in the neural plate, and in N2 
null mouse embryos, the generation of Sox2-expression neuroectoderm was 
abolished (Iwafuchi-Doi et al., 2011). The enhancer N1 was found to be 
responsible for Sox2 expression in the future caudal hindbrain and spinal 
cord, and over-expressing N1 in the epiblast of chick embryo during early 
embryogenesis induced ectopic expression of Sox2 (Uchikawa et al., 2003; 
Uchikawa et al., 2004). These results suggested that the enhancers N1 and 
N2 activated the expression of Sox2 during neural induction of vertebrates.  
 
During the generation of ectoderm, these pluripotent factors (such as Oct4 
and Nanog) are down-regulated. When ectodermal cells further differentiate 
into neuroectodermal cells, some transcription factors (such as Zic1, Zic3, 
Churchill, Sip1, and Zfp521) are up-regulated (Dang et al., 2012; Kamiya et 
al., 2011; Nakata et al., 1997; Nakata et al., 1998; Nitta et al., 2004; Sheng et 
al., 2003). Zic1 and Zic3 encode zinc-finger proteins that are first expressed 
in the prospective neural plate during gastrulation of Xenopus embryos 
(Nakata et al., 1997; Nakata et al., 1998). The injection of Zic1 or Zic3 
mRNA into these embryos at the two-cell stage induced the ectopic 
expression of the neural plate marker NCAM in both the embryos or in 
isolated animal caps (Nakata et al., 1997; Nakata et al., 1998). However, 
knocking down the expression of either Zic1 or Zic3 by injection of 
antisense oligos into Xenopus embryos did not inhibit the generation of 
Sox2-expressing neural plate (Marchal et al., 2009). Because amino acid 
sequences of Zic1 and Zic3 are highly conserved (Furushima et al., 2000), 
their may compensate for each other during neural induction when only one 
of the genes was knocked down. Indeed, when both of these transcription 
factors were knocked down at the same time the generation of Sox2-
expressing neural tissue was suppressed (Marchal et al., 2009). These results 
suggested that Zic1 and Zic3 are involved in the neural induction of Xenopus 
embryo. As discussed in sections 1.2, 1.3, and 1.4, the suppression of BMP 
signalling is needed for neural induction. The promoter region of Zic1 was 
shown to contain a BMP inhibitor-responsive promoter module that was 
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required for activation of Zic1 upon inhibition of BMP signalling (Tropepe 
et al., 2006). The expression of Zic3 was also up-regulated by the inhibition 
of BMP signalling (Nakata et al., 1997). Therefore, interruption of BMP 
signalling may activate Zic1 and Zic3 to cause neural induction in Xenopus. 
In mouse embryos, Zic1 was first detected in the neuroectoderm during 
gastrulation and the Zic1 null embryo showed cerebellar and dorsal spinal 
cord hypoplasia (Aruga et al., 1998). Although the Zic1 null mutant 
maintained the ability to generate neural tissue, the involvement of Zic1 in 
neural induction still could not be completely ruled out because the lost 
function of Zic1 may be compensated by Zic3, which was also expressed in 
the neural plate (Elms et al., 2004; Furushima et al., 2000).  
 
Like Zic1 and Zic3, Sip1 (Smad-interacting protein 1) is also involved in 
vertebrate neural induction (Nitta et al., 2004; Sheng et al., 2003). The Sip1 
encodes a two-handed zinc-finger protein (Verschueren et al., 1999) and is 
expressed in the prospective neural ectoderm of Xenopus embryo (Eisaki et 
al., 2000; Verschueren et al., 1999). The injection of Sip1 mRNA into 
Xenopus embryos at the two-cell stage induced the expression of the neural 
marker NCAM in isolated animal caps (Eisaki et al., 2000; Nitta et al., 2004). 
In contrast, knocking down the expression of Sip1 by injection of antisense 
oligos into Xenopus embryos inhibited the generation of NCAM-expressing 
neural tissue (Nitta et al., 2004). These results suggested that Sip1 is 
involved in neural induction of Xenopus. In chick embryo, another zinc-
finger protein Churchill was found to bind to the promoter region of Sip1 
and activate its transcription, and both Churchill and Sip1 were expressed in 
the prospective neural plate (Sheng et al., 2003). When Churchill was 
electroporated into the non-prospective neural ectoderm, the expression of 
Sip1 was induced and ectopic Sox2-expressing neural tissue was generated. 
In the prospective neural ectoderm of chick embryo, knocking down the 
expression of Churchill not only inhibited the expression of Sip1, but also 
blocked the formation of neural plate (Sheng et al., 2003). Therefore, Sip1 
also plays a role in neural induction of chick.  
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During neural differentiation of human ESCs, the expression of the neural 
progenitor markers OLIG3, SOX1, and SIX1 were up-regulated by over-
expressing SIP1. In contrast, when the expression of SIP1 was knocked 
down using shRNA, the expression of OLIG3, SOX1, and SIX1 was down-
regulated and the expression of the pluripotent genes OCT4 and NANOG 
was sustained (Chng et al., 2010). These results suggested that SIP1 
promoted neural induction of human ESCs. Using chromatin 
immunoprecipitation analysis, it had been demonstrated that OCT4 and 
NANOG proteins bind to the SIP1 promoter region. Knocking down the 
expression of OCT4 or NANOG up-regulated the expression of SIP1 (Chng 
et al., 2010), suggesting that OCT4 and NANOG proteins negatively 
regulated the transcription of SIP1. Therefore, when the expression of OCT4 
and NANOG are down-regulated to initiate germ-layer formation during 
early embryogenesis, SIP1 may be up-regulated to promote neural induction. 
It has been showed that Sip1 proteins bind to the promoter region of Smad7 
(an inhibitor of BMP signallings, see section 1.4.1) and over-expressing Sip1 
up-regulated the expression of Smad7 (Weng et al., 2012), suggesting that 
Sip1 activated the expression of Smad7 to inhibit BMP signalling. In 
addition, Sip1 proteins were also shown to physically interact with Smad1, 
Smad2, and Smad5, and then inhibited the function of these Smads 
(Verschueren et al., 1999; Weng et al., 2012). Smad1/5 and Smad2 are 
intracellular effectors of BMP and Activin/Nodal signallings respectively 
(see sections 1.4.1 and 1.5.3). Because BMP and Activin/Nodal signalling 
needs to be suppressed during neural induction in vertebrates (see sections 
1.2, 1.4, and 1.5.3), Sip1 may repress these signalling pathways to promote 
neural induction.  
 
Similar to Sip1, Zfp521 also plays a crucial role in mouse neural induction 
(Kamiya et al., 2011). Zfp521 encodes a zinc-finger protein and is 
particularly expressed in the neuroectoderm of mouse embryo during 
gastrulation (Kamiya et al., 2011). During neural differentiation of mouse 
ESCs, over-expressing Zfp521 increased the generation of Sox1-expressing 
neural progenitors while Zfp521 knock-down decreased the generation of 
Sox1+ cells (Kamiya et al., 2011). Using chromatin immunoprecipitation 
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analysis, it had been demonstrated that Zfp521 proteins can bind to the 
promoter region of Sox1, Sox3, and Pax6, and up-regulate the expression of 
these neuroectodermal genes (Kamiya et al., 2011), suggesting that Zfp521 
promotes neural induction in mouse ESCs. 
 
From the above it is evident that we are beginning to identify key 
transcription factors involved in the regulation of neural induction, however, 
further investigation into the interaction of signalling pathways, transcription 
factors, and neural inductive genes is still necessary.  
 
1.8 Nnat may be involved in neural induction 
As described above, neural induction is a complicated process that cannot 
simply be a ‘default’ process as originally hypothesised by Hemmati-
Brivanlou and Melton (details see section 1.3, Fig. 1.5; Hemmati-Brivanlou 
and Melton, 1997a; Stern, 2005; Stern, 2006). Instructive cues, such as 
Calcium and FGF signalling, are of fundamental importance for neural 
induction (for details see sections 1.5.1 and 1.5.4). We are interested in 
understanding the molecular mechanisms regulating the instructive cues 
involved in this process, using mouse ESCs grown in a monolayer culture as 
a model system. Thus, we seek to discovery the genes and signalling 
pathways that are involved in the process of ESCs neural induction and 
subsequent differentiation.  
 
In order to screen for these genes, Dr. Yuh-Man Sun constructed subtractive 
cDNA libraries using cDNA collected at different time points during the 
neural induction and differentiation of ESCs using a monolayer culture 
system. Dr. Sun found a number of genes up-regulated during the neural 
induction and differentiation of ESCs into neurons. One of these genes, 
Neuronatin (Nnat), was particular interesting because of its putative function 
and expression pattern both in vitro and in vivo (during mouse 
embryogenesis). When mouse ESCs were grown in a monolayer neural 
differentiation model (Ying et al., 2003), the expression of Nnat was up-
regulated and remained high until the generation of neurons at 
differentiation day 12 (Fig. 1.13, analysed by Dr. Sun using real-time PCR). 
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This suggested that Nnat may be involved in the early neural development of 
mouse ESCs. Within this thesis, I specifically investigated the role of Nnat 
in neural induction of mouse ESCs using loss- and gain-of-function 
experiments in which the expression of Nnat had been knocked down or 
over-expressed (see Chapter 3).  
 
 
Fig. 1.13. Expression of Nnat during mouse ESC neural differentiation. 
46C and Nnat-KD ESCs were grown under differentiating conditions for 18 days and the 
total RNAs were isolated from the cells after differentiation for 0, 2, 4, 6, 8, 10, 12, 14, 16, 
and 18. The relative expression of Nnat was analysed using real-time PCR. In 46C cells, the 
expression of Nnat was low at the ESC stage (Differentiation day 0) and then its expression 
started to increase until differentiation after day 12 when neurons were generated. In Nnat-
KD cells, the expression of Nnat was very low throughout the whole differentiation process. 
Thus the efficiency of Nnat knock-down was high and persistent during differentiation.  
Abbreviations: ES, embryonic stem; Nnat-KD, Nnat-knockdown; PCR, polymerase chain 
reaction; RNA, ribonucleic acid.  
(Adapted from Lin et al., 2010) 
 
1.8.1 The in vivo expression pattern of Nnat 
Nnat (also known as Peg5) expression was first described in the neonatal 
(3 days) rat and human fetal (18-24 weeks) brain (Joseph et al., 1994). 
However, its expression was not confined to the brain since Nnat was also 
expressed, at lower levels, in the adrenal gland, pituitary gland, pancreatic 
β-cells and adipocytes (Chu and Tsai, 2005; Suh et al., 2005; Wijnholds et 
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al., 1995). Nnat is an imprinted gene and is expressed only from the 
paternal allele, while the maternal allele is silenced by methylation (John 
et al., 2001; Kagitani et al., 1997). Most imprinted genes are located in 
gene clusters, but Nnat is not closely linked to other imprinted genes (John 
et al., 2001). The Nnat locus is 1.2 kbp and is located on the distal arm of 
chromosome 2 in the mouse and chromosome 20 in human (Dou and 
Joseph, 1996; John et al., 2001; Kagitani et al., 1997). Nnat is composed of 
three exons and two introns (Joe et al., 2008; Joseph et al., 1995; Kikyo et 
al., 1997) that generate two different isoforms, α and β. Nnatα (81 amino 
acids) is encoded by all three exons and Nnatβ (54 amino acids) is only 
encoded by the first and third exons (Joseph et al., 1995).  
 
The neuron-restrictive silencer factor is a zinc-finger protein and the 
binding of this transcription factor with the neuron-restrictive silencer 
element can silence the transcription of neuronal promoters in non-
neuronal cells (Bessis et al., 1997; Chen et al., 1998). This element had 
been found in the 5'-flanking region of Nnat and this may be the reason 
that Nnat is more highly expressed in neural tissue than in non-neural 
tissue (Dou and Joseph, 1996). The promoter region of Nnat has also been 
shown to contain multiple CpG islands that are methylated to different 
extents in different tissues (Evans et al., 2001). For example, in the 
pituitary gland 50% of NNAT promoter-associated CpG islands were found 
to be methylated (Revill et al., 2009). However, the expression of NNAT 
was loss or significantly decreased in pituitary adenoma (a tumor of 
pituitary gland), and in these cells the methylation of CpG islands 
increased to 75-100% (Revill et al., 2009), suggesting that the methylation 
of the NNAT promoter region reduced the expression of NNAT. In contrast 
to the repressive effect of neuron-restrictive silencer element and 
methylation, NeuroD1 is the only known transcription factor to up-regulate 
NNAT expression (Chu and Tsai, 2005; Li et al., 2010). In NeuroD1 null 
mouse embryo, the expression of Nnat gene and protein was reduced in 
pancreatic tissue compared with wild type embryos (Chu and Tsai, 2005). 
Chromatin immunoprecipitation analysis revealed that the NeuroD1 
protein bound to the promoter region of Nnat in pancreatic -cells (Chu 
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and Tsai, 2005), suggesting that the transcription factor NeuroD1 
promoted the expression of Nnat. However, during neural development, 
the expression of NeuroD1 was first detected in the neural epithelium at 8 
dpc (after neural plate formation at 7.5 dpc) and was highly expressed 
throughout the neural tissue at 10 dpc (Cho and Tsai, 2004; Lee et al., 
2000a). This suggests that NeuroD1 is not involved in neural induction in 
mouse embryo, but may promote the expression of Nnat during 
neurogenesis.  
 
In rat embryos, Nnatα is first expressed at 7-10 dpc, when the neural plate 
is formed, while Nnatβ is first expressed at 11-14 dpc, which is 
concomitant with the period of neural tube closure and neuroepithelial 
cells proliferation (Joseph et al., 1995). The expression of both isoforms 
peaks at 16-19 dpc, the height of neurogenesis and declines when 
neurogenesis is complete (Joseph et al., 1995). According to the data from 
the Allen Developing Mouse Brain Atlas (http://developingmouse.brain-
map.org/data/Nnat.html), at 13.5 dpc Nnat is expressed in the germinal 
zones of many brain regions (cingulate cortex, preoptic, hypothalamic, 
superior tectal, isthmal, and pontine neuroepithelium) (Fig. 1.14). Its 
expression is significantly decreased in the brain of adult rat, mouse, and 
human compared with fetal brains (Dou and Joseph, 1996; Joseph et al., 
1994; Joseph et al., 1995; Kikyo et al., 1997). However, in adult mouse 
brain the expression of Nnat is still evident in the subventricular zones 
(SVZ) of the lateral ventricles and throughout the hippocampal formation, 
including the dentate gyrus (Fig. 1.14). Both the adult SVZ and the dentate 
gyrus of the hippocampus, are regions where adult neurogenesis is 
observed (Doetsch, 2003; Temple, 2001). Thus, according to the reported 
expression patterns in vivo, Nnat is present in the correct places and at the 
correct times to play a role in neural development.  
 
In mouse embryo, Nnat was expressed in ectoderm and mesoderm at 7.0 
dpc and after that maximal expression was seen in the head fold (Sousa-
Nunes et al., 2003). During later embryogenesis, Nnat is strongly 
expressed in the central and peripheral nervous system (Wijnholds et al., 
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1995). Although Nnat expression is widespread in the forebrain of mouse 
embryo at 8.5-9.5 dpc (Sousa-Nunes et al., 2003), Wijnholds et al. (1995) 
also found Nnat was expressed in rhombomeres 3 and 5 of the hindbrain of 
mouse embryo at the same period of time. Because rhombomeres 3 and 5 
are important for segmentation of the hindbrain (Wijnholds et al., 1995), 
Nnat may also be involved in this process.  
 
In addition to neural development, it has been demonstrated that Nnat also 
plays important roles in metabolism (Chu and Tsai, 2005; Joe et al., 2008; 
Li et al., 2010; Sharma et al., 2011; Suh et al., 2005; Vrang et al., 2010). 
For example, in a pancreatic -cell line (MIN6N8 cells), the expression of 
Nnat was increased by the treatment of glucose and this effect was dose 
dependent (Joe et al., 2008). NIT cells (another pancreatic -cell line) 
secrete insulin upon treatment with glucose but this secretion was 
suppressed when NNAT was knocked down in these cells using RNAi 
treatment (Chu and Tsai, 2005), suggesting that NNAT played a role in the 
secretion of insulin in pancreatic -cells. Nnat is also expressed in 
adipocytes and over-expression of Nnatα in pre-adipocytes induced their 
differentiation and caused lipid accumulation in these cells (Suh et al., 
2005). These findings suggest that Nnat may be involved in metabolic 
regulation.     
 
NNAT is endogenously expressed at low levels in normal human brain 
tissue (Xu et al., 2012), but is abundantly expressed in some types of 
tumour, such as medulloblastoma (Siu et al., 2008), glioblastoma 
multiforme (Xu et al., 2012), and pulmonary non-small cell carcinoma 
(Uchihara et al., 2007). In medulloblastoma cells, knocking down the 
expression of NNAT using RNAi resulted in a significant decrease in 
proliferation. In contrast, over-expressing NNAT in medulloblastoma cells 
caused a shift from G1 to G2/M phase in the cell cycle and increased 
colony formation when cells were grown on soft agar (Siu et al., 2008). 
Similarly, the expression of NNAT protein was higher in the high grade 
glioblastoma multiforme than in the low grade glioblastoma multiforme 
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(Xu et al., 2012). Indeed, over-expressing NNAT in U87 malignant glioma 
cells caused an increase in proliferation (Xu et al., 2012). These results 
suggested that NNAT may play a role in cellular proliferation.  
 
The data obtained from the subtractive cDNA libraries suggests a role for 
Nnat in early neural development (neural induction), while the in vivo 
expression data suggests that Nnat may also be involved in the 
differentiation of NSCs and NPCs. Thus, Nnat may play more than one 
role during neural development. Although Nnat also has a role in the 
metabolic regulation and cellular proliferation, I am specifically interested 
in its function in neural induction of mouse ESCs. In this thesis, I will 
investigate whether Nnat is indeed involved in neural induction using loss- 
and gain-of-function approaches in mouse ESCs that, as described above, 
can be differentiated into neuroectoderm, neural progenitors, and neurons 




Fig. 1.14. The expression of Nnat as shown by in situ hybridization in 13.5 dpc mouse 
embryo and P53 adult mouse brain. 
(A, D) A sagittal view of a 13.5 dpc mouse embryo revealed that Nnat was expressed in 
the developing brain and spinal cord. Nnat is highly expressed in many germinal zones, 
including the (1) cingulate cortex, (2) preoptic, (3) hypothalamic, (4) superior tectal, (5) 
isthmal, and (6) pontine neuroepithelium at 13.5 dpc. Scale bar, 3200 μm.  (B, E) A 
coronal view of a P53 adult mouse brain revealed that Nnat was expressed within the 
subventricular zone (arrow) of the lateral ventricles. Scale bar, 1680 μm. (C, F) A coronal 
view of a P53 adult mouse brain revealed that Nnat was expressed in the hippocampal 
formation (including the dentate gyrus, arrow). Scale bar, 1680 μm.  
Abbreviations: dpc, days post conception.  
(Adapted from Allen Brain Atlas, http://www.brain-map.org/) 
 
1.8.2 Putative function of Nnat  
The Nnat protein has a hydrophobic domain at N-terminus and hydrophilic 
domain at C-terminus (Dou and Joseph, 1996; Joseph et al., 1994), 
suggesting that Nnat is a membrane protein. Using immunocytochemical 
analysis, it had been demonstrated that the Nnat protein located in the ER 
(Joe et al., 2008; Oyang et al., 2011; Suh et al., 2005). The precise 
molecular role of Nnat in neural development is unclear; however, it has 
been shown that Nnat exhibits 50% homology, at the amino acid level, 
with phospholamban (Dou and Joseph, 1996). Both Nnat and 
phospholamban have an α-helical membrane domain and basic 
cytoplasmic tails (Dou and Joseph, 1996). Phospholamban is an integral 
 81 
membrane protein of the ER. Studies in muscle cells have shown that 
under resting state (low [Ca2+]i, see section 1.5.4.4), un-phosphorylated 
phospholamban interacts with the sarcoendoplasmic reticulum Ca2+-
ATPase (Atp2a/SERCA) and this interaction reduces the affinity of 
Atp2a/SERCA for Ca2+ and inhibits the action of the Ca2+-ATPase in 
pumping cytosolic Ca2+ into the ER, resulting in an increase in [Ca2+]i 
(James et al., 1989; MacLennan and Kranias, 2003). When 
phospholamban is phosphorylated by cAMP-dependent protein kinase, it 
causes the dissociation of the phospholamban-Atp2a/SERCA complex, 
and then the Atp2a/SERCA pumps cytosolic Ca2+ into the ER to decrease 
the [Ca2+]i (James et al., 1989; MacLennan and Kranias, 2003). Therefore, 
it is possible that Nnat may function by modulating [Ca2+]i through 
interactions with Atp2a/SERCA (Dou and Joseph, 1996; Joe et al., 2008; 
Li et al., 2010). In support of this idea, [Ca2+]i has been shown to be 
increased in Nnat over-expressed insulinoma cells or hippocampal neurons 
(Joe et al., 2008; Oyang et al., 2011), suggesting that Nnat may antagonise 
the action of Apt2a/SERCA resulting in less cytosolic Ca2+ being pumped 
into the ER and an increase in [Ca2+]i. 
 
In vertebrates there are three Apt2a/SERCA genes (for details see section 
1.5.4.4). During Xenopus embryonic development, Apt2a2/SERCA2 is 
expressed in the neural plate and neural tube indicating a role for this gene 
in aspects of neurogenesis (Pegoraro et al., 2011). Apt2a2/SERCA2 is also 
expressed in human and mouse ESCs (Salomonis et al., 2010). Further to 
this, Dr. Yuh-Man Sun’s unpublished data also revealed that the 
Atp2a2/SERCA2 is expressed at much higher levels compared to both 
Apt2a1/SERCA1 and Apt2a3/SERCA3 in mouse ESCs and during ESC 
neural differentiation (Fig. 1.15). Because of these observations, I 
hypothesised that Nnat suppresses the action of Apt2a2/SERCA2, which in 
turn results in the increase in [Ca2+]i resulting in the initiation of neural 
induction in mouse ESCs. In this thesis, I have investigated the molecular 
mechanisms underlying the action of Nnat and tested whether Nnat 




Fig. 1.15. The expression of Atp2a/SERCA genes during the differentiation of mouse 
ESCs along a neural lineage.   
46C ESCs were grown in differentiating conditions for 18 days and the total RNAs were 
isolated from the cells after differentiation for 0, 2, 4, 6, 8, 10, 12, 14, 16, and 18. In ESCs 
stage (Differentiation day 0), the expression of Apt2a2/SERCA2 was 10-fold over 
Apt2a1/SERCA1 and Apt2a3/SERCA3. During differentiation, the expression of 
Apt2a2/SERCA2 was increased since day 8 and peaked at day 12. The expression of 
Apt2a1/SERCA1 and Apt2a3/SERCA3 was remained low compared with 
Apt2a2/SERCA2. 
Abbreviations: Atp2a/SERCA, sarcoendoplasmic reticulum Ca2+-ATPase; ES, embryonic 
stem; RNA, ribonucleic acid.  






1.9 Aims of thesis 
Neural induction is a process by which unspecified embryonic ectoderm 
receives signals instructing it to take up a neural fate whereby the ectoderm 
differentiates into neuroectoderm. Many studies show that signals, such as 
BMP, FGF, Wnt, Activin/Nodal, and calcium, are involved in neural 
induction, but the precise molecular mechanisms which underlying this 
process in higher vertebrates are not fully understood. In order to investigate 
the molecular mechanisms underlying neural induction in mammals, an 
ESC-derived neural differentiation model has been widely used. Using this 
differentiation model, it was found that the expression of Nnat was up-
regulated when mouse ESCs differentiated into NSCs and neurons. Further 
to this, Nnat is highly expressed in developing neural tissue of mouse 
embryos and it may interact with Apt2a/SERCA to increase [Ca2+]i. In 
Xenopus, an increase in [Ca2+]i has been demonstrated to be involved in 
neural induction. However, it is not clear whether calcium plays similar roles 
in mammalian neural induction. Due to the expression pattern of Nnat and 
its putative function, I hypothesise that Nnat may play a role in neural 
induction in mouse ESCs.  
 
The work described in my thesis tests this hypothesis and also attempts to 
define the molecular mechanisms underlying the action of Nnat in the neural 
induction of mouse ESCs. Specifically, I investigated: 
 Whether the neural specification and differentiation of ESCs were 
altered when Nnat was dysregulated in mouse ESCs. 
 Whether Nnat physically interacted with Apt2a2/SERCA2, which in 
turn increased [Ca2+]i leading to neural induction in mouse ESCs. 
 Whether there are any crosstalks between Nnat and other signalling 
pathways involved in the neural induction of mouse ESCs. 
 
The experiment described within Chapter 3 studying the effects of Nnat in 
Xenopus was collaboration with Dr. Esther Bell (MRC Centre for 
Developmental Neurobiology, King’s College London). The experiment 
described within Chapter 4 describing the measurement of [Ca2+]i was 
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carried out in collaboration with Dr. Vladimir Snetkov (Department of 
Asthma, Allergy and Respiratory Science, King’s College London). In the 





















2.0 Materials and methods    
2.1 ESC lines and culture  
ESCs are derived from the ICM of the blastocyst and are pluripotent so 
ESCs can differentiate into all the different cell lineages that compose the 
embryo (Evans and Kaufman, 1981; Murry and Keller, 2008). In this study, 
the main topic was focused on how Nnat affected the differentiation of 
mouse ESCs to neural lineages. Loss- and gain-of-function experiments 
were conducted. In the loss-of-function experiment, Nnat expression was 
knocked-down in ESCs using shRNA (short hairpin RNA); in the gain-of-
function experiment, Nnat was over-expressed in ESCs.  
 
In this study the mouse 46C ESC line was used (a gift from Prof. A. Smith, 
Cambridge). This cell line was derived by knocking green fluorescent 
protein (GFP) into the open reading frame of Sox1. As Sox1 is the early 
marker of neuroectoderm this enables the identification of those ESCs 
committed to a neural fate (Camus et al., 2006; Ying et al., 2003; Zhao et al., 
2004).  
 
Nnat-knockdown (Nnat-KD) ESCs were generated from 46C mouse ESCs 
using shRNA. Nnat shRNA designed to knockdown both Nnatα and β 
isoforms was used for gene silencing to create Nnat-KD ESCs; this ESC line 
was generated by Dr. Yuh-Man Sun.  
 
All ESC lines were maintained in Glasgow minimum essential medium 
(Sigma) supplemented with 5% foetal bovine serum (PAA), 5% new born 
calf serum (GIBCO), 2mM L-glutamine (GIBCO), 1× non-essential amino 
acids (GIBCO), 1mM sodium pyruvate (GIBCO), 100μM 2-
mercaptoethanol (GIBCO), and 1000 units/ml leukaemia inhibitory factor 
(LIF, Chemicon). ESCs were grown on T25 tissue culture flasks coated with 
0.1% gelatin (Sigma) and incubated in a humidified incubator at 37°C and 
an atmosphere of 5% CO2. The ESC medium was replaced completely 
everyday. When the cells became 100% confluent, they were passaged to 




2.2 Generation of Nnat-over-expression ESC line 
2.2.1 Amplification and cloning of Nnat  
To clone Nnat, total RNA was isolated from mouse 46C ESCs (for details 
see section 2.7.1) and cDNA was obtained by reverse transcription (for 
details see section 2.7.2). The full length coding sequences for Nnatα and β 
were obtained by polymerase chain reaction (PCR) using primers (see 
Table 2.1 for sequences) designed by Dr. Yuh-Man Sun and synthesised 
by Sigma Genosys. The sequence of NnatS and NantA primers included 
HindIII and BamHI restriction sites as well as the Kozak consensus 
sequence to allow for directional cloning and efficient translation of the 
resultant PCR product. Amplification of Nnat cDNA was performed with 
5μl of 10× buffer, 5μl of 2mM dNTP, 3μl of 10μM NnatS, 3μl of 10μM 
NnatA, 0.5 μl of Taq DNA polymerase (Stratagene), 0.5μl of Taq extender 
(Stratagene) and 28μl of water. The PCR cycle parameters were:  
94°C × 3 minutes  
94°C × 15 seconds 
55°C × 20 seconds          × 10 cycles 
68°C × 3 minutes 
94°C × 15 seconds 
65°C × 20 seconds          × 25 cycles 
68°C × 3 minutes 
72°C × 10 minutes 
  4°C × 10 minutes 
The QIAquick PCR purification kit (Qiagen) was used to purify the PCR 
product after agarose gel electrophoresis. Purified PCR products were then 
directionally cloned into the HindIII and BamHI sites of the vector 
pNEBR-X1-Hygro (Appendix 1, New England Biolabs). The PCR 
products were digested with the restriction enzymes and purified from 
agarose gel using QIAquick PCR purification kit. The digested pNEBR-
X1 Hygro vector and Nnat cDNA were ligated using T4 DNA ligase 
(Roche) and the Rapid DNA Ligation Kit (Roche). The pNEBR-X1-Nnat 
vector was transformed into the competent E. coli strain DH5α 
(Invitrogen). 50μl of DH5α was mixed with 2μl ligated vector and left on 
 88 
ice for 30 minutes. The mixture was heat shocked at 42°C for 30 seconds. 
SOC medium was then added and the transformed cells incubated at 37°C 
for one hour. 40μl of transformed E. coli was then cultured at 37°C on 
standard Luria Bertani (LB) agar plate supplemented with 100µg/ml 
ampicillin overnight. The following day colonies were picked and 
individually inoculated into 3ml LB medium supplemented with 100µg/ml 
ampicillin. The tubes were placed in a shaker overnight at 37°C. The 
cultured cells were then taken and centrifuged at 13000 rpm for 5 minutes 
and the plasmid DNA purified using the Wizard Plus SV Minipreps DNA 
purification system (Promega). The plasmid DNA was digested with 
restriction enzyme HindIII and BamHI to confirm that it contained the 
Nnat. The digested samples were run on a 1% agarose gel with the 
appropriate DNA size markers (New England Biolabs). 
 
2.2.2 Sequencing of pNEB-X1-Nnat clones  
In order to determine that the isolated clones contained full length Nnat 
coding sequences with no errors the clones were sequenced. The 
sequencing reactions were performed using NnatA and RheoSwitch R-X1 
sequencing primers. 1μl of the purified plasmid DNA, 1μl of primer, 1μl 
of BigDye (Applied Biosystems), 2μl of 5× sequencing buffer, and 5μl of 
water were mixed. The PCR cycle parameters were:  
96°C × 1 minute  
96°C × 10 seconds 
50°C × 15 seconds          × 35 cycles 
60°C × 4 minutes 
 4°C × 10 minutes 
To precipitate the PCR product, 1.5μl of 2M sodium acetate and 25μl of 
100% ethanol were applied and incubated on ice for 15 minutes. This 
mixture was centrifuged at 13000 rpm for 20 minutes at 4°C and then 
washed with 20μl of 70% ethanol. After the product dried, it was sent to 
Geneservice Limited (Unit 2 Cambridge Science Park, Milton Road, 
Cambridge, CB4 0FE) for sequencing. The sequence was analysed using 
Chromas lite.  
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2.2.3 Midi preps  
The E. coli carrying the wild type mouse Nnat DNA was grown on LB 
agar plates supplemented with 100µg/ml ampicillin overnight. Colonies 
were picked from the plates and were individually inoculated into 4ml LB 
medium supplemented with 100µg/ml ampicillin. 100μl of the inoculated 
LB was added into 100ml of LB medium supplemented with 100µg/ml 
ampicillin overnight. The following day, plasmid DNA was purified using 
HiSpeed Midi Kit (Qiagen). 
 
2.2.4 Transfection of ESCs with pNEBR-X1-Nnat Vector   
The 46C ESCs were plated in a 6-well plate. When the cells had become 
40% confluent, they were transfected with the pNEBR-X1-Nnat Vector 
using Lipofectamine reagent, using the following protocol.  Three 
micrograms of pNEBR-X1-Nnat DNA was added to 500μl of Optimen 
(Invitrogen) containing 40μl of Plus Reagent (Invitrogen). 20μl of 
Lipofectamine (Invitrogen) was added to 500μl of Optimen. Both mixtures 
were left at room temperature for 10 minutes before being combined and 
the mixture left for a further 20 minutes at room temperature before adding 
2ml of Optimen.. The 46C ESCs were rinsed twice with Phosphate-
Buffered Saline (PBS, Invitrogen) and once with Optimen. The final 
mixed reagent was applied to ESCs and the cells were incubated at 37°C 
for 6 hours. The reagent was taken off and the cells were cultured with ES 
medium for 24 hours. Then ESCs were cultured in ES medium 
supplemented with Hygromycin (200μg/ml; Invitrogen) for 8 days to 
select the transfected cells. Because the pNEBR-X1 vector contained the 
Hygromycin-resistance gene, transfected cells should survive after 
Hygromycin selection. The surviving cells were pooled and re-plated onto 
gelatine-coated 10-cm culture plates (10 cells/plate). These transfected 
cells were cultured in ES medium for four days, and then 8 single-cell 






2.2.5 Confirmation of over-expression of Nnat in ESCs   
To confirm Nnat-overexpression in cells, the isolated ESC clones 
transfected with pNEBR-X1-Nnat were cultured on gelatin-coated 
coverslips in ESC medium for two days. Immunocytochemistry was used 
to detect the expression of Nnat. Nnat primary antibody (1:500; Santa Cruz 
Biotechnology) was applied to check the over-expression of Nnat (see 
section 2.4 for details). 
 
2.3 ESCs differentiation 
The monolayer and aggregate culture systems were used for the 
differentiation of ESCs into neural lineage (Abranches et al., 2009; 
Carpenter et al., 2001; Chambers et al., 2009; Ying et al., 2003). In the 
monolayer culture, ESCs were cultured with a chemical-defined medium. It 
is easy to manipulate cells using this system. The monolayer culture was 
employed to differentiate ESCs towards a neural fate, in this method ESCs 
were first differentiated into NSCs, then to neural progenitors, and finally 
into neurons (Ying et al., 2003). In aggregate culture, ESCs were grown in a 
serum-containing medium to form EBs. This system provides a three-
dimensional environment and ESCs could generate three primary germ 
layers (ectoderm, endoderm, and mesoderm). This aggregate culture is 
widely used in ESCs differentiation and three primary germ layers formation. 
To examine the influence of Nnat on the development of three primary germ 
layers, EBs were formed in 46C, Nnat-KD, and Nnat-OE ESC lines. 
 
2.3.1 Monolayer culture  
Coverslips were baked in an oven for 4 hours at 180°C. To gelatinize 
coverslips, coverslips were put into 24-well plates. 1ml of 0.1% gelatin 
(Sigma) was applied to each well and left at room temperature for 30 
minutes. ESCs were plated onto gelatinized coverslips at a density of 
6×104 cells/ml. The next day, the ESC medium was replaced with N2B27 
differentiation medium, which consisted of a 1:1 mixture of DMEM/F12 
medium (Invitrogen) supplemented with N2 and Neurobasal medium 
supplemented with B27 (Invitrogen). N2 consisted of 25 μg/ml insulin 
(Sigma),  100 μg/ml apotransferrin (SCIPAC), 6 ng/ml progesterone 
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(Sigma), 16 μg/ml putrescine (Sigma), 30 nM sodium selenite (Sigma) and 
50 μg/ml bovine serum albumin fraction V (GIBCO). The N2B27 medium 
was changed every other day. 
 
2.3.2 Aggregate culture  
To form EBs, ESCs (107 cells/dish) were cultured onto 90mm Petri Dishes 
containing 10 ml of ESC medium without LIF. The medium was changed 
every other day. In order to avoid removing EBs while changing medium, 
the dish was tilted so that the EBs would settle and then the old medium 
was replaced with fresh medium. After cultured for six days, EBs were 
collected for total RNA isolation and quantitative real-time PCR (see 
section 2.6 for details). 
 
2.3.3 Chemical manipulation of ESC neural differentiation  
Nnat might inhibit Apt2a/SERCAs to increase intracellular calcium and so 
affect ESC neural differentiation as it has been shown that calcium 
signalling may be involved in neural induction (Lee et al., 2009). 2,5-Di-t-
butyl-1,4-benzohydroquinone (BHQ) and Thapsigargin (Tg) are specific 
Apt2a/SERCA inhibitors (Johnson and Misler, 2002). 50 μM BHQ 
(Calbiochem) or 25 nM Tg (Sigma) was used to mimic the function of 
Nnat and rescue the neural development of Nnat-KD cells. During ESCs 
differentiation, cells were treated with different drugs to change 
intracellular calcium level. 2-aminoethoxydiphenyl borate (2-APB), an 
inhibitor of IP3R, blocks calcium release from ER into cytoplasm (Lang et 
al., 2007). 1,2-Bis (2-aminophenoxy) ethane-N,N,N',N'-tetraacetic acid 
tetrakis (acetoxymethyl ester) (BAPTA-AM) is a membrane permeable 
Ca2+ chelator. Dantrolene is an inhibitor of Ca2+ release from ER into 
cytoplasm through RyR. 75 μM 2-APB (Enzo Life Sciences), 20 μM 
BAPTA-AM (Calbiochem), or 100 μM Dantrolene (Sigma) was used to 
treat ESCs to decrease intracellular free Ca2+. ESCs were also cultured 
with differentiation conditions in the present of 2 mM ethylene glycol 
tetraacetic acid (EGTA) (Sigma) to chelate the extracellular Ca2+ and 
determine whether extracellular Ca2+ was needed for neural induction.  
 
 92 
FGF signalling pathway is required for neural induction in chicken and 
Xenopus (Linker and Stern, 2004; Streit et al., 2000). Fgf4 knockout 
mouse ESCs are deficient in neural induction (Kunath et al., 2007). 5ng/ml 
FGF4 (R&D Systems) or 10 ng/ml of FGF5 (R&D Systems) was applied 
to ESCs to activate FGF signalling pathway. 100ng/ml PD173074 (Sigma), 
an inhibitor of FGF receptors, and 5μM PD184352 (Axon Medchem), an 
inhibitor of MEK, were used to block FGF/Erk signalling pathway.  
 
BMP4 is one member of TFG-β superfamily. Active BMP signalling 
pathway inhibits ectoderm to differentiate into neuroepithelium and leads 
ectoderm to an epidermal fate (Munoz-Sanjuan and Brivanlou, 2002). 
Inhibition of BMP signalling pathway induces ectoderm to become 
neuroepithelium (Hemmati-Brivanlou and Melton, 1997b; Wilson et al., 
1997). 10ng/ml BMP4 (R&D Systems) was used to inhibit neural 
differentiation in ESCs. Chordin, Follistatin, and Noggin are antagonists of 
BMP (Stern, 2005). 150 or 300ng/ml of Chordin (R&D Systems), 150 or 
300ng/ml of Follistatin (R&D Systems), and 100 or 200ng/ml of Noggin 
(R&D Systems) were used to treat ESCs to induce neural development. 
 
2.4 Immunocytochemistry 
ESCs were grown on gelatin-coated coverslips and were fixed in 4% 
paraformaldehyde (Sigma) for 20 minutes at room temperature, washed 
three times with PBS, then incubated for one hour in 0.1% Triton X-100 
(Sigma) to permeabilise the cell membrane. Primary antibodies were diluted 
in 0.1% Triton X-100 and applied overnight at 4°C, followed by four washes 
in PBS. Secondary antibodies were diluted in PBS and applied for one hour 
at room temperature in the dark. The information of antibodies was listed in 
Table 2.2. For double staining, two different primary antibodies, which 
originated from different hosts, were diluted in the same solution and 
applied to cells at the same time. Corresponding secondary antibodies, 
which were conjugated with different fluorescent conjugates, were used to 
distinguish the different primary antigens. The cells were washed four times 
in PBS and submerged in double distilled water prior to mounting of 
coverslips onto slides using Vectashield mounting medium (Vector) with 
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4',6-diamidino-2-phenylindole (DAPI) to stain the nuclei. As a negative 
control, ESCs were stained with secondary antibody in the absence of 
primary antibody (see Appendix 2). Generic nail polish was used to seal 
coverslips to slides. Fluorescent microscopy images were acquired using the 
AxioImager Z1 (Carl Zeiss) and analysed using AxioVision version 4.5(Carl 
Zeiss). The ApoTome module (Carl Zeiss) was used to obtain stacks of 
confocal slices for the cultures.  
 
2.5 Quantification of cell-types 
To compare the ability of neural differentiation of Nnat-OE, Nnat-KD, and 
46C ESCs, the numbers of Sox1-GFP+/Nestin+ NSCs and NeuN+ neurons in 
different ESCs were counted. ESCs were plated on gelatin-coated coverslips 
and differentiated for 6 days or 14 days (see section 2.3.1), and then cultures 
were fixed in 4% paraformaldehyde for 20 minutes at room temperature, and 
washed three times with PBS. The expression of Sox1-GFP, Nestin, and 
NeuN were analysed by immunofluorescence analysis (see section 2.4). 
NSCs were identified by Sox1-GFP and Nestin, and neurons were identified 
by NeuN. Each coverslip was examined with a fluorescence microscope at 
magnification of ×400 and 10 microscopic fields were taken randomly. The 
percentage of Sox1-GFP+/Nestin+ NSCs and NeuN+ neurons were counted 
manually and the number of total counted cells of each coverslip was 1000 
at least. Three coverslips were counted per condition. All experiments were 
repeated three times.  
 
2.6 Quantitative real-time PCR 
The quantitative real-time PCR is one of the practical ways of both detection 
and quantification of a gene expression. The expression pattern of genes, 
which are involved in ESC differentiation, could be detected by this method. 
During ESC differentiation total RNA was collected at different time points 






2.6.1 Total RNA isolation  
Differentiated or undifferentiated ESCs were harvested using trypsin and 
were washed with PBS, collected in centrifuge tubes, and centrifuged. The 
supernatant was discarded and the cell pellet lysed in 1 ml TRI Reagent 
(Sigma) by repeated pipetting up and down. 0.2 ml chloroform was added 
and the mixture was shaken vigorously for 15 seconds, before being 
allowed to stand for 5 minutes at room temperature. The mixture was then 
separated into three phases by centrifuge at 13000 rpm for 15 minutes at 
4°C. The bottom phase contained protein, the interphase contained DNA, 
and the colourless top aqueous phase contained RNA. The top phase was 
transferred to a new tube and 0.5 ml of isopropanol was added to 
precipitate the RNA. The sample was centrifuged at 13000 rpm for 15 
minutes at 4°C. The RNA pellet was washed with 75% ethanol and 
centrifuged at 7500 rpm for 5 minutes at 4°C. The RNA pellet was dried 
and then dissolved in RNase-free water.  
 
2.6.2 cDNA synthesis  
SuperScriptTM III Reverse Transcriptase (Invitrogen) was used to synthesis 
first-strand cDNA. The reaction mixture was as followed: 2 μg RNA, 1 μl 
oligo(dT)20 primer (Invitrogen), 1 μl 10 mM dNTP (Sigma), and sterile 
water to make up a total of 14 μl. The reaction mixture was incubated at 
65°C for 5 minutes and then quenched with ice for at least one minute. 4 μl 
5X buffer, 1 μl 0.1M DTT, and 1 μl SuperScriptTM III Reverse 
Transcriptase were added and mixed gently. The reaction mixture was then 
incubated at 42°C for 2 hours before being transferred to a 70°C water 
bath for 15 minutes to inactivate the enzyme. 
 
2.6.3 Real-time PCR  
The following reaction was set up for each sample: 2 μl cDNA, 10 μl iQ™ 
SYBR® Green Supermix (Bio-Rad), 1 μl sense primer, 1 μl antisense 
primer, and 6 μl sterile water. Each sample was duplicated and each 
reaction was repeated three times independently. A Chromo4 Real-Time 
PCR Detection System (Bio-Rad) was used to carry out the PCR reactions. 
The following PCR protocol was used: 
 95 
95°C × 3 minute  
95°C × 30 seconds 
60°C × 30 seconds          × 44 cycles 
72°C × 30 seconds           
Plate read 
The melting cure from 50°C to 96°C was read every 1°C.  
 
Gene expression was relative to cyclophilin using the formula 1/2ΔCt, 
where ΔCt = unknown gene threshold cycle minus cyclophilin threshold 
cycle. In differentiated or undifferentiated ESCs, the expression level of 
cyclophilin was consistent throughout the experiments in this study so only 
this housekeeping gene was used.  
 
2.7 Western blotting 
The Western blotting is a widely used to detect specific proteins in tissue or 
cell populations. Cells were lysed and proteins were released into the lysis 
buffer. Proteins were separated by gel electrophoresis and transferred to a 
membrane. The membrane is then blotted with a protein specific antibody to 
detect the protein.  
 
2.7.1 Sample preparation 
Differentiated or undifferentiated ESCs were cultured on 10cm culture 
dishes, washed twice with ice-cold PBS, then and left on ice. One ml of 
freshly made ice-cold RIPA lysis buffer (1× protease inhibitor cocktail 
(Sigma), 1× phosphatase inhibitor cocktail (Sigma), 10 mM sodium 
fluoride (Sigma), 1 mM sodium orthovanadate (Sigma), and 1 mM β-
glycerophosphate (Sigma)) was added to the cells and the cells were then 
scraped from the surface of the dish. Cell lysates were transferred to a 
fresh tube, shaken vigorously, and left on ice for 30 minutes. The cell 
lysates were then centrifuged at 13000 rpm for 20 minutes at 4°C. The 
supernatant contained protein was aliquoted and stored at -80°C until 
required. The Qubit™ Protein Assay Kit (Invitrogen) was used to detect 
the protein concentration according to manufacturer’s instructions using a 
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NanoDrop 3300 Fluorospectrometer (Thermo Scientific) to measure the 
protein concentration in the samples. 
 
2.7.2 Gel electrophoresis 
The SDS polyacrylamide gels were used for proteins separation. Gel 
polymerization was initiated by the addition of Ammonium Persulfate 
(Sigma) along with Tetramethylethylenediamine (TEMED, Sigma). The 
percentage of gel was between 10-20%, which was determined by the 
relative size of the protein under study. As the size of the Nnatα and β 
proteins was small (9 and 6 kD respectively), 20% SDS polyacrylamide 
gels were used to identify Nnat. For other proteins, 10% SDS 
polyacrylamide gel was used. 100 μg total protein per mini-gel well was 
mixed with 2× Laemmli sample buffer (Sigma) and was heated at 90°C for 
5 minutes to denature proteins. 5 μl Novex® Sharp Protein Standard 
(Invitrogen) was loaded into a mini-gel well to determine protein size and 
also to monitor the progress of the electrophoretic run. The gel was run at 
125-150V for between 1 to 3 hours, which was again dependent on the size 
of the protein being analysed. 
 
2.7.3 Electroblotting of proteins  
The wet transfer method (MacPhee, 2010) was used to transfer the proteins 
from the SDS-gels to nitrocellulose membranes. The XCell II™ Blot 
Module apparatus (Invitrogen) was used to perform the wet transfer, 
according to manufacturer’s instructions, using 0.2 μm pore size 
Nitrocellulose membranes (Invitrogen). The transfer conditions were at a 
constant voltage of 25V for 90 minutes at 4°C. To transfer the small-size 
proteins (Nnatα and β), the transfer condition was changed to a constant 
voltage of 15V for 30 minutes at 4°C to avoid that the proteins passing 
through the membrane. 
 
2.7.4 Immunoprobing of Western Blots  
The membrane was washed twice with Tris buffered saline (TBS) for five 
minutes before blocking the membrane with either, non-fat milk or bovine 
serum albumin (BSA, Cell Signaling). To study phosphor-proteins, the 
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membranes were blocked in 5% BSA in Tris buffered saline with Tween 
20 (TBST) for one hour at room temperature; to study non-phosphor-
proteins, 5% non-fat milk in TBST was used to block the membranes. 
After blocking, the membranes were washed three times with TBST for 10 
minutes. The membranes were incubated with primary antibody diluted in 
the appropriate blocking solution overnight at 4°C. The membranes were 
then washed three times with TBST for 10 minutes and then incubated 
with secondary antibody diluted in the blocking solution for one hour at 
room temperature. The information of antibodies was listed in Table 2.3. 
The membranes were then washed three times with TBST for 10 minutes 
and the membranes were then ready for scanning. The Odyssey Infrared 
Imaging System was used to detect the far-red-fluorescent Alexa Fluor 
(Invitrogen) labelled secondary antibody bodies. Beta-actin was used as 
the internal control to ensure that the protein in each lane of the gel had 
been equally loaded. 
 
2.8 Co-Immunoprecipitation  
The molecular mechanisms and physiological functions of Nnat are still 
unclear (Li et al., 2010). In insulinoma cells, over-expression of Nnat causes 
increased intracellular calcium (Joe, Lee et al. 2008). The amino acid 
sequence of Nnat is about 50% homologous to phospholamban (Dou and 
Joseph, 1996). Therefore, it might function in a similar way to 
phospholamban, that is, to regulate Apt2a/SERCAs and to cause an increase 
in intracellular calcium. In order to test this hypothesis, Co-
immunoprecipitation (Co-IP) and Duolink in-situ proximity ligation assay 
(see section 2.9) were used to examine whether Nnat directly interacts with 
Apt2a/SERCAs. 
 
Co-IP is a technique for precipitating a specific protein complex out of a 
whole cell or tissue protein lysate. The protein complex is precipitated using 
an antibody that is specific to one of the proteins found within the complex. 
The other members of the protein complex can then be identified from the 
immunoprecipitated product. Therefore, Co-IP is a widely used technique to 
analyse protein-protein interactions. Normally, a non-ionic detergent is used 
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in the cell lysis buffer so the native protein conformation can be maintained. 
The Apt2a2/SERCA2 is expressed in mouse ESCs. If Nnat binds to 
Apt2a2/SERCA2, both will form a protein complex in the cell lysate. This 
complex could be precipitated using anti-Nnat antibody. Western blotting 
could be used to confirm that the Apt2a2/SERCA2 is a part of the protein 
complex. 
 
Co-IP was performed using the Universal magnetic Co-IP kit (Active Motif, 
www.activemotif.com/), according to the manufacturer’s instructions. 46C 
ESCs were grown in differentiating conditions for 12 days and cultures were 
lysed with freshly prepared complete whole-cell lysis buffer and incubated 
on ice for 30 minutes. The sample was centrifuged at 13000 rpm for 20 
minutes at 4°C. The supernatant (whole-cell extract) was aliquoted and 
stored at -80°C. 500 μg whole-cell extract was mixed with 10 μg of three 
different anti-Nnat antibodies individually (Santa Cruz, goat; Santa Cruz, 
rabbit; Abcam, rabbit), and incubated for one hour at 4°C on a rotator. 25 μl 
Protein G Magnetic Beads was added to each sample and incubated for four 
hours at 4°C on a rotator. The beads were washed with TPST and pulled 
down by magnetic force. The beads were mixed with 20μl 2× reducing 
loading buffer and boiled at 90°C for 5 minutes. Western blotting was 




All data are presented as the mean ± the standard error (SE) from 
experiments that have been repeated three times. Student t-test was 
performed to compare data between two conditions.  One-way analysis of 
variance (ANOVA) was used to identify significant differences between 
three subjects. All reported p-values are two-tailed, and p < 0.05 was 












































Table 2.2. Antibodies used for Immunocytochemistry  
Primary antibodies 
Specificity Supplier (catalogue number) Dilution  Host 
Brachyury Chemicon (#04-135) 1:500 Mouse 
CK18 Chemicon (MAB3234) 1:500 Mouse 
MAP2 Abcam (ab24640) 1:400 Rabbit 
Nestin Chemicon (MAB353) 1:500 Mouse 
NeuN Chemicon (MAB377) 1:500 Mouse 
Nnat Abcam (ab27266) 1:500  Rabbit 
Oct4 
Santa Cruz Biotechnology (sc-
5279)  
1:500 Mouse 
RC2 Hybridoma bank 1:500 Mouse 
Apt2a2/SERCA2 




Specificity Supplier (catalogue number) Format Dilution  Host 
Mouse IgG Chemicon (AP124C) Cy3 1:500 Goat 
Mouse IgG Chemicon (AP124S) Cy5 1:500 Goat 
Rabbit IgG Chemicon (AP183C) Cy3 1:500 Goat 
Rabbit IgG Chemicon (AQ132F) FITC 1:500 Goat 
Goat IgG Chemicon (AP180C) Cy3 1:500 Donkey 
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Table 2.3. Antibodies used for Western blotting  





Dilution  Dilution buffer Host 
-actin Sigma (A2228) 1:10000 




























1:1000 5% BSA in TPST Rabbit 
pSmad1 (Ser206) Cell Signaling 
(#9553) 






























Chapter 3. Nnat promotes the neural 




3.0 Nnat promotes the neural induction of mouse ESCs 
3.1 Introduction 
Neural induction is a process by which unspecified embryonic ectoderm 
receives signals from the underlying mesoderm instructing it to take up a 
neural fate (details see section 1.1; Hemmati-Brivanlou and Melton, 1997b; 
Munoz-Sanjuan and Brivanlou, 2002; Stern, 2005). During gastrulation, the 
central embryonic ectoderm region acquires neural properties and forms the 
neural plate (neuroectoderm) while the peripheral embryonic ectoderm 
forms epidermis. The neural plate then folds creating the neural groove and 
finally develops into a tubular structure called the neural tube (Clarke et al., 
1991; Greene and Copp, 2009). The caudal region of the neural tube gives 
rise to the spinal cord while the rostral region gives rise to the brain (Downs 
and Davies, 1993; Greene and Copp, 2009). Therefore neural induction is the 
initial step in the generation of the vertebrate central nervous system. Within 
this Chapter, I will describe data showing that the gene Nnat plays an 
important role in the neural induction of mouse ESCs. 
 
The origin of the neural inductive signals that leads to the differentiation of 
the central nervous system is a long-standing question in vertebrate 
embryology. Over the past decades, many studies carried out in amphibian 
embryos have tried to answer this question (Munoz-Sanjuan and Brivanlou, 
2002; Wilson and Edlund, 2001). Based on data obtained from these 
experiments, the ‘default model’ of neural induction was developed (see 
section 1.3). This popular model proposes that ectodermal cells will adopt a 
neural fate autonomously in the absence of BMP signalling (Hemmati-
Brivanlou and Melton, 1997a). However, this default model does not take 
into account results showing that instructive signals are also required for 
ectodermal cells to give rise to neuroectodermal cells (see section 1.5). For 
example, FGF/Erk signalling is active in the developing neural plate of 
Xenopus embryos during gastrulation (Christen and Slack, 1999), and  when 
this signalling is inhibited by culturing Xenopus embryos with the FGFR 
inhibitor (SU5402) the generation of tissue expressing the neural plate 
marker NCAM is reduced (Delaune et al., 2005). This observation suggested 
that FGF/Erk signalling is an instructive cue for neural induction and, 
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without the activation of FGF/Erk signalling, neural specification is 
restricted. In addition to FGF/Erk signalling, an increase in [Ca2+]i is also 
required for neural induction of Xenopus embryos (see section 1.5.4). 
Elevated [Ca2+]i is observed in the prospective neural ectoderm during 
gastrulation, while no such increase is observed in the prospective non-
neural ectoderm (Leclerc et al., 2003; Leclerc et al., 2000), suggesting that 
an increase in [Ca2+]i plays a pivotal role in neural induction. Further to this, 
the treatment of Xenopus embryos with a calcium channel blocker to prevent 
an increase in [Ca2+]i down-regulated the expression of the early neural 
genes Zic3 and Geminin (Leclerc et al., 2000). This suggests that an increase 
in [Ca2+]i is also an instructive cue for neural induction in Xenopus embryos. 
Therefore, both FGF and calcium are instructive signals for neural induction 
suggesting that regulation of this process is more complex than originally 
thought and cannot simply be explained by the ‘default’ hypothesis. 
 
Many studies on neural induction in vertebrates reveal that BMP, FGF, 
calcium, Wnt, and Activin/Nodal signals are involved in this process (see 
sections 1.3, 1.4, and 1.5). Yet, despite extensive research into neural 
induction, the precise molecular mechanisms that govern this process in 
higher vertebrates have yet to be fully elucidated. In order to investigate the 
mechanisms that control neural induction in mouse and humans, in vitro 
neural differentiation models have been created using mouse and human 
ESCs (see section 1.6.1; Abranches et al., 2009; Chambers et al., 2009; Ying 
et al., 2003). As part of a larger study carried out by Dr. Yuh-Man Sun to 
discover genes and signalling pathways that regulate neural induction and 
subsequent differentiation in mouse ESCs, a number of genes were 
identified that were up-regulated during the differentiation of ESCs into 
neural stem cells, and one of these genes, Nnat, is the focus of this thesis. 
Nnat is of particular interesting because of its putative function and 
expression pattern both in vitro and in vivo (see section 1.7). During mouse 
ESCs neural induction in vitro, the expression of Nnat was up-regulated and 
remained high throughout the period of neurogenesis. Similarly in vivo Nnat 
is highly expressed in developing neural tissue (see section 1.7.1), 
suggesting that Nnat may be involved in the early neural development. In 
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addition to its expression pattern, Nnat shares significant homology with the 
calcium regulator Phospholamban (an inhibitor of SERCA) and so Nnat may 
function as an inhibitor of Apt2a/SERCA2, causing an increase in [Ca2+]i 
(see section 1.7.2). Because an increase in [Ca2+]i is known to be an 
instructive signal for neural induction in Xenopus embryos, Nnat, by 
regulating [Ca2+]i,  may provide a similar instructive signal in mouse. The 
work described in this Chapter tests the hypothesis that Nnat is involved in 
neural induction of mouse ESCs.  
 
In order to study the role of Nnat in neural induction, loss- and gain-of-
function experiments were carried out using ESCs in which the expression 
of Nnat had been knocked down (Nnat-KD ESCs, generated by  Dr. Yuh-
Man Sun) or over-expressed (Nnat-OE ESCs, generated as part of my thesis 
research). According to the data obtained from subtractive cDNA libraries 
(see section 1.7), Nnat expression is up-regulated during ESC neural 
differentiation and so it may be required for the differentiation of ESCs 
towards a neural fate. If this reasoning is correct then ESCs in which Nnat 
has been knockdown should show an impaired ability to generate neural 
cells, while over-expression of Nnat in ESCs should promote the generation 
of neural cells.  
Specifically, this chapter describes: 
1) The expression of Nnat during ESC-derived neural differentiation 
2) The generation of Nnat-OE ESCs 
3) The phenotypic changes of Nnat-mutant cells during the neural 
development 




3.2.1 Neural differentiation of ESCs using an in vitro monolayer 
culture system  
Ying et al. (2003) created a monolayer cell-culture system that 
recapitulates the process of in vivo neural development in mouse ESCs; 
generating NSCs, NPCs, and neurons sequentially. In order to confirm that 
this model behaves as reported in my hands, immunocytochemistry using 
stage-specific markers was used to characterise the cell-types generated as 
ESCs differentiated along the neural pathway. The pluripotent marker 
Oct4 is a transcription factor that is highly expressed in mouse ESCs 
(Hwang et al., 2004; Loh et al., 2006), so Oct4 was used to identify 
undifferentiated ESCs. Sox1 and Nestin were used to identify NSCs 
(Johansson et al., 1999; Murayama et al., 2002), and the Radial glial cell 
marker-2 (RC2) used to define radial glial cells (Gates et al., 1995). 
Neurons were identified by their expression of the Neuronal nuclear 
antigen (NeuN) or Microtubule-associated protein 2 (MAP2) (Chen et al., 
2001). The 46C ESCs used throughout this thesis are Sox1-GFP knock-in 
mouse ESCs, in which GFP is activated concomitantly with Sox1 
expression. As Sox1 is an established early neuroectodermal marker in 
mammals, GFP can be used as the readout of neuroectodermal cell 
production (Ying et al., 2003). 
 
To analyse the neural differentiation of 46C ESCs, these cells were plated 
on gelatin-coated coverslips at a concentration of 6×104 cells/ml and 
cultured in non-differentiating medium supplemented with LIF (1000 
units/ml) for one day to allow the cells to adhere to the coverslips (see 
Material and Methods, section 2.1). To initiate neural differentiation, the 
medium was switched to differentiating (N2B27) medium (see Material 
and Methods, section 2.3.1). The ESCs were cultured in differentiating 
medium for a further 14 days, and the medium was changed every other 
day.  At specific time points during this differentiation process (0, 2, 6, 9, 
12, and 14 days), cultures were fixed and analysed to determine the types 
of neural cells present in the culture using the antibodies described above.  
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Undifferentiated 46C ESCs highly expressed the pluripotent marker Oct4 
(Fig. 3.1A). After 2 days of differentiation, Sox1-GFP expressing 
neuroectodermal cells (early NSCs) were observed (Fig. 3.1B) and these 
cells had increased in number by differentiation day 6 (compare Fig. 3.1B 
to C). Cells expressing Nestin, a NSCs marker, were seen after 6 days of 
differentiation (Fig. 3.1C) and after 9 days of differentiation, RC2 
expressing radial glial cells appeared (Fig. 3.1D). Neurons, as identified by 
expression of NeuN and MAP2, were observed after 12 days of 
differentiation (Fig. 3.1E-F). Thus, using cell-type specific markers we 
observed that upon differentiation 46C cells generated neuroectoderm, 
NSCs, radial glial, and neurons sequentially, recapitulating the events seen 
during neural development in vivo (Abranches et al., 2009; Ying et al., 
2003). From these observations we defined differentiation day 0-1 as being 
the ES stage, 2-6 as being the NSC stage, 6-12 as being the NPCs stage 




Fig. 3.1. The expression of neural stage-specific markers during ESC-derived neural 
development in vitro. 
46C ESCs (Sox1-GFP knock-in mouse ESCs) were plated on gelatin-coated coverslips 
and cultured in non-differentiating medium for 24 hours after which time the medium 
was then switched to differentiating medium. After 2, 6, 9, 12, and 14 days of 
differentiation, cells were fixed to analyse the expression of neural stage-specific 
markers. (A) Oct4 (red) was highly expressed in undifferentiated ESCs. (B) Sox1-GFP+ 
neuroectoderm (green, see arrows), (C)  Sox1-GFP+ (green) and Nestin+ (red) NSCs, (D) 
RC2+ radial glial (red, see arrows), (D) NeuN+ neurons (red) and (E) MAP2+ neurons 
(red) were generated by 2, 6, 9, 12, and 14 days of differentiation respectively, as seen 
in vivo. All nuclei were stained with DAPI (blue). Scale bar, 20 μm. 
Abbreviations: DAPI, 4',6-diamidino-2-phenylindole; ESC, embryonic stem cell; GFP, 
green fluorescent protein; MAP2, microtubule-associated protein 2; NeuN, neuronal 
nuclear antigen; NSC, neural stem cell; NPC, neural progenitor; RC2, radial glial cell 
marker-2; Sox1, SRY (sex determining region Y)-box 1. 
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3.2.2 Nnat expression is up-regulated as ESCs generate NSCs 
If Nnat is required for neural development, its expression should correlate 
with the generation of neural cells. To confirm the hypothesis, the 
expression of Nnat protein was analysed as ESCs differentiated along a 
neural pathway.  
 
The expression level of Nnat was observed to be low in ESCs grown under 
proliferating conditions, compared with cells that had been differentiated 
for 2 days (Fig. 3.2A-C). Thus, initiating neural differentiation causes the 
expression of Nnat protein to be up-regulated, which is consistent with the 
increased expression of Nnat mRNA seen during ESC neural 
differentiation (see section 1.7). After two days of differentiation, Nnat 
expression was restricted to Sox1-GFP expressing neuroectodermal cells 
(Fig. 3.2D-F). At day 6, the NSC stage, Nnat expression co-localised with 
Nestin (Fig. 3.3A-C), while after 14 days of differentiation, Nnat 
expression was found in NeuN expressing neurons (Fig. 3.3D-F). At day 
14, as expected, NeuN was expressed in the nucleus (Fig. 3.3F, arrow), 
surrounded by Nnat expression in the cytosol (Fig. 3.3D, arrow), as would 
be expected if Nnat is located in the ER where it can interact with 
Atp2a/SERCA (discussed in section 1.7.2). These data showed that up-
regulation of Nnat expression correlated well with the generation of cells 
belonging to the neural lineage. This led us to hypothesise that Nnat may 





Fig. 3.2. Nnat is expressed in neuroectodermal cells. 
46C ESCs were plated on gelatin-coated coverslips and cultured in non-differentiating 
medium for 24 hours to allow the ESCs to adhere to the coverslips. The medium was then 
switched to differentiating medium. After 1 or 2 days of differentiation, cells were fixed 
to analyse the expression of Nnat using immunocytochemistry. (A) The expression of 
Nnat (red) was low in undifferentiated ESCs. (B) After 1 day of differentiation, the 
expression of Nnat (red) remained low. (C) After 2 days of differentiation, the expression 
of Nnat (red) was increased (compare C and D with A and B). (D) Nnat expression (red, 
arrows) co-localised with (E) Sox1-GFP (green, arrows) expression after 2 days of 
differentiation, as indicated by (F) the merging of red and green to become orange 
(arrows). All nuclei were visualised by staining with DAPI (blue). Scale bar, 20 μm. 
Abbreviations: D1, 1 day of differentiation; D2, 2 days of differentiation; DAPI, 4',6-
diamidino-2-phenylindole; ESC, embryonic stem cell; GFP, green fluorescent protein; 




Fig. 3.3. Nnat is expressed in NSCs and neurons. 
ESCs were plated on gelatin-coated coverslips and cultured in non-differentiating 
medium for 24 hours to allow the ESCs to adhere to the coverslips. The medium was then 
switched to differentiating medium. After 6 or 14 days of differentiation, cells were fixed 
to analyse the expression of Nnat, Nestin, and NeuN using immunocytochemistry. (A-C) 
Co-localisation of Nnat (A, pink, arrows) with the NSC marker Nestin (B, red, arrows) 
was noted after 6 days of differentiation. (D-F) Co-localisation of Nnat (D, green, arrows) 
with the neuronal marker NeuN (E, red, arrows) was noted after 14 days of differentiation. 
NeuN was expressed in the nucleus (E, F) and surrounded by Nnat expression in the 
cytosol (D, arrows). All nuclei were stained with DAPI (blue). Scale bar, 20 μm. 
Abbreviations: D6, 6 days of differentiation; D14, 14 days of differentiation; DAPI, 4',6-
diamidino-2-phenylindole; ESC, embryonic stem cell; GFP, green fluorescent protein; 
NeuN, neuronal nuclear antigen; NSC, neural stem cell; Sox1, SRY (sex determining 
region Y)-box 1. 
 
3.2.3 Nnat over-expressing increases the generation of neural cells  
To investigate the function of Nnat during neural development, loss- and 
gain-of-function approaches were employed. Before my involvement in 
the Nnat project, our group had already generated the Nnat-KD ESCs (see 
Material and Methods, section 2.1). In these cells Nnat was knocked down 
using Nnat short hairpin RNA (shRNA), designed to knock down both 
Nnatα and Nnatβ isoforms. To fully elucidate the effect of Nnat on neural 
development, Nnat-OE ESCs were generated as part of my study (see 
Material and Methods, section 2.2). If my hypothesis that Nnat is needed 
during neural development is correct, then I would expect that, Nnat over-
expression will promote neural development while Nnat knock down will 




3.2.3.1 Generation of Nnat-OE ESC lines   
46C ESCs were used to create stably transfected pNEBR-Nnatα or 
pNEBR-Nnatβ ESCs (see Material and Methods, section 2.2). After 
Hygromycin selection, 16 single-cell clones were generated. To check 
whether Nnat was overexpressed in these clones, all clones and 46C 
ESCs were plated onto gelatinised coverslips and grown in non-
differentiating condition for two days. Cultures were fixed with 4% PFA 
and the expression of Nnat was analysed using immunocytochemical 
analysis (see Appendix 3). Nnatα-OE clone 7 and Nnatβ-OE clone 4 
were chosen to carry out all of the experiments described in this thesis. 
 
To compare Nnat expression by western blot analysis, 46C, Nnat-KD, 
Nnatα-OE, and Nnatβ-OE ESCs were cultured in non-differentiating 
medium until 100% confluent and then whole cell lysates were collected 
for electrophoresis. After gel electrophoresis, proteins were transferred 
to a nitrocellulose membrane and the presence of Nnat detected by 
immunoblotting using an anti-Nnat antibody (see Material and Methods, 
section 2.7). 46C and Nnatβ-OE ESCs expressed Nnatα weakly 
compared with Nnatα-OE ESCs. Neither 46C nor Nnatα-OE ESCs 
expressed Nnatβ (Fig. 3.4). According to the expression of Nnat in vivo, 
Nnatα is expressed earlier than Nnatβ (see section 1.7), so 46C ESCs 
may represent a developmental stage before Nnatβ is expressed. No 
expression of either isoform was observed in the Nnat-KD ESCs (Fig. 
3.4). The results confirmed that Nnat was over-expressed in Nnat-OE 




Fig. 3.4. Nnat protein expression in 46C and Nnat-mutant ESCs. 
46C, Nnatα-OE, Nnatβ-OE, and Nnat-KD ESCs were cultured under non-
differentiating conditions until they reached 100% confluency and then whole cell 
protein lysates were collected to analyse the expression of Nnat by Western blotting 
using an antibody that detected both isoforms. 46C ESCs weakly expressed Nnatα and 
did not expressed Nnatβ. Nnatα-OE ESCs expressed higher Nnatα compared with the 
parent 46C cells. Nnatβ-OE ESCs not only expressed a low level of Nnatα like 46C, but 
also expressed Nnatβ. Nnat-KD ESCs did not express Nnatα or Nnatβ. The results 
confirmed that Nnat was over-expressed or knocked down in Nnat-OE or Nnat-KD 
ESCs.  
Abbreviations: ESC, embryonic stem cell; kD, kiloDalton; Nnat-KD, Nnat-knockdown; 
Nnatα-OE, Nnatα-overexpression; Nnatβ-OE, Nnatβ-overexpression. 
 
3.2.3.2 Nnat over-expression enhances the generation of NSCs and 
neurons 
To determine whether over-expression of Nnatα or Nnatβ in ESCs 
influenced their ability to differentiate into NSCs, 46C, Nnatα-OE and 
Nnatβ-OE ESCs were cultured under differentiating conditions for 6 
days (see sections 2.3.1 and 3.2.1). Sox1 and Nestin are both markers of 
NSCs (Camus et al., 2006; Murayama et al., 2002; Ying et al., 2003; 
Zhao et al., 2004). However, Sox1 is also expressed in the lens during 
gastrulation in mouse embryos (Aubert et al., 2003), and Nestin is also 
expressed in astrocytes, developing pancreatic cells, and muscle 
precursors (Clarke et al., 1994; Messam et al., 2000; Selander and 
Edlund, 2002; Zimmerman et al., 1994). Thus, I stained these with two 
markers at the same time to verify that these cells were NSCs. After 6 
days of differentiation, Nnatα-OE and Nnatβ-OE ESCs generated more 
Sox1-GFP+/Nestin+ NSCs than did 46C ESCs (Fig. 3.5A-C) indicating 
that over-expression of Nnat enhanced the generation of NSCs. This 
observation was confirmed by quantifying the numbers of Sox1-
GFP+/Nestin+ NSCs (see Material and Methods, section 2.5), showing 
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that the percentage of NSCs generated by Nnatα-OE cells was two-fold 
greater than the percentage generated by 46C cells (Fig. 3.5D, 66.7% v.s. 
24.2%, n = 3, p < 0.01). Because the effect of NSC generation by Nnatα 
or Nnatβ over-expression was similar, I did not count the NSCs derived 
from Nnatβ-OE ESCs. 
 
 
Fig. 3.5. Over-expression of Nnat promotes the generation of NSCs. 
46C, Nnatα-OE and Nnatβ-OE ESCs were grown in monolayer culture and 
differentiated for 6 days. (A) 46C ESCs generated Sox1-GFP+ (green) and Nestin+ (red) 
NSCs. (B, C) Nnatα-OE and Nnatβ-OE ESCs generated more Sox1-GFP+ and Nestin+ 
NSCs compared with 46C ESCs. (D) The numbers of both Sox1-GFP and Nestin-
expressing NSCs cells were quantified. 46C ESCs generated less NSCs than Nnatα-OE 
ESCs (24.2 ± 3.6% and 66.7 ± 6.7%, respectively, p < 0.01, n=3, two-tailed Student’s t 
test). Thus, the over-expression of Nnat promoted the generation of NSCs. All nuclei 
were stained with DAPI (blue). Scale bar, 20 μm. 
Abbreviations: DAPI, 4',6-diamidino-2-phenylindole; ESC, embryonic stem cell; GFP, 
green fluorescent protein; Nnatα-OE, Nnatα-overexpression; Nnatβ-OE, Nnatβ-
overexpression; NSC, neural stem cell; Sox1, SRY (sex determining region Y)-box 1. 
 
To determine whether over-expression of Nnatα or Nnatβ in ESCs 
influenced neuronal differentiation, 46C, Nnatα-OE and Nnatβ-OE ESCs 
were cultured under differentiating conditions for 14 days (see sections 
2.3.1 and 3.2.1) to investigate their ability to generate neurons (identified 
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by their expression of MAP2). As expected, MAP2 expressing neurons 
were observed in cultures of differentiated 46C ESCs after 14 days (Fig. 
3.6A). However, many more MAP2 expressing neurons were observed 
in differentiated Nnatα-OE and Nnatβ-OE ES cultures than in 
differentiated 46C ES cultures (Fig. 3.6B-C). Again this was confirmed 
by quantification of neuronal numbers (see Material and Methods, 
section 2.5) after ESCs had been differentiated for 14 days. For 
quantification, neurons were identified by NeuN instead of MAP2 
because NeuN is located in the nucleus and is convenient for cell 
counting. The number of neurons generated by Nnatα-OE cells was two-
fold higher that the number generated by 46C ESCs after 14 days of 




Fig. 3.6. Nnat promotes neuronal development. 
46C, Nnatα-OE and Nnatβ-OE ESCs were grown in monolayer culture and 
differentiated for 14 days. (A) 46C ESCs generated MAP2+ (red) neurons by 14 days. 
(B, C) Increased numbers of MAP2+ (red) neurons was observed in differentiated 
Nnatα-OE and Nnatβ-OE ES cultures. (D) After 14 days of differentiation, neurons 
were identified by NeuN expression and quantified. 46C ESCs generated less neurons 
than did Nnatα-OE ESCs (21.4 ± 2.5% and 60.2 ± 12.1%, respectively, p < 0.01, n=3, 
two-tailed Student’s t test). All nuclei were stained with DAPI (blue). Scale bar, 20 μm.  
Abbreviations: DAPI, 4',6-diamidino-2-phenylindole; ESC, embryonic stem cell; 
MAP2, microtubule-associated protein 2; NeuN, neuronal nuclear antigen; Nnatα-OE, 
Nnatα-overexpression; Nnatβ-OE, Nnatβ-overexpression. 
 
These studies show that over-expressing Nnat enhances the 
differentiation of ESCs along a neural pathway, resulting in an increase 
in the generation of NSCs and subsequently neurons. However, these 
data were obtained using a single clone of Nnatα-OE and Nnatβ-OE 
ESCs. Therefore, it is potentially possible that a mutation caused by the 
genomic insertion of the transfected vector resulted in the increased 
generation of NSCs by Nnat-OE ESCs. Nevertheless, in the next section, 
I show that the effect of Nnat knockdown results in a reduction in the 
generation of neural cells, an opposite effect to that observed after Nnat 
over-expression, providing support for the conclusions I draw from the 
experiments described in this chapter.  
 117 
 
3.2.4 Nnat knocked-down restricts the generation of neural cells   
Since Nnat over-expression increased the generation of NSCs and neurons, 
I hypothesised that Nnat knocked-down would suppress neural induction 
in ESCs and hence reduce the generation of neurons. To test this 
hypothesis, the ability of Nnat-KD ESCs to differentiate into NSCs and 
neurons was evaluated.  
 
3.2.4.1 Nnat-KD cells exhibit protracted Oct4 expression during 
neural differentiation 
Undifferentiated ESCs tend to form compact colonies (Yu et al., 2007). 
Both undifferentiated 46C and Nnat-KD ESCs did form compact 
colonies and also highly expressed the pluripotent marker Oct4 (Fig. 
3.7A-B). After 6 days of differentiation, 46C cells no longer formed 
compact colonies and the expression of Oct4 was decreased (Fig. 3.7C). 
However, Oct4 was still highly expressed in Nnat-KD cells at this stage 
(Fig. 3.7D). After 12 days of differentiation, Oct4 was no longer 
expressed in 46C (Fig. 3.7E), but Nnat-KD cells still retained Oct4 
expression (Fig. 3.7F). Unlike 46C cells, Nnat-KD colonies maintained a 
compact morphology, characteristic of undifferentiated ESCs, 
throughout the differentiation procedure. The observed morphology of 
Nnat-KD cells together with their Oct4 expression indicated that the 




Fig. 3.7. Oct4 expression is protracted in Nnat-KD cells.  
46C and Nnat-KD ESCs were grown in monolayer culture under non-differentiating 
conditions where they form compact colonies. (A, B) The pluripotent marker Oct4 (red) 
was highly expressed in undifferentiated 46C and Nnat-KD ESCs. (C) After 6 days of 
differentiation, the expression of Oct4 was down-regulated in 46C cells (compare C 
with A). and cells within these cultures had spread out. (E) After 12 days of 
differentiation, 46C cells no longer expressed Oct4. (D) After 6 days of differentiation, 
Oct4 was still highly expressed in Nnat-KD ESCs and these cells still grew as colonies 
like undifferentiated ESCs. (F) Even when cultured in differentiating conditions for 12 
days, Oct4 expression was retained by Nnat-KD ESCs. All nuclei were stained with 
DAPI (blue). Scale bar, 20 μm. 




3.2.4.2 Nnat knock-down curbs neural development 
To test whether knocking down Nnat affected ESC differentiation into 
NSCs and neurons, 46C and Nnat-KD ESCs were plated on gelatin-
coated coverslips and then cultured in differentiating conditions for 6 or 
14 days (see sections 2.3.1 and 3.2.1). The cells were fixed and analysed 
for the ability to generate NSCs after 6 days of differentiation (identified 
using the Sox1-GFP and Nestin) and neurons after 14 days of 
differentiation (identified using the MAP2 or NeuN). The 
undifferentiated 46C and Nnat-KD ESCs did not express the NSC 
markers, Sox1-GFP and Nestin (Fig. 3.8A-B). After 6 days of 
differentiation, 46C ESCs generated NSCs, whereas the generation of 
NSCs was significantly reduced in Nnat-KD ESCs (Fig. 3.8C-D), as 
confirmed by cell counts (Fig. 3.8G, 2.4% v.s. 20.2%, n = 3, p < 0.01). 
In addition, although Nnat-KD cells did generate some Sox1-GFP 
expressing cells, these did not appear to significantly increase in number 
from day 6 to day 14 (Fig. 3.8D, F).  
 
As might be expected, after 14 days of differentiation, 46C cells 
generated neurons, whereas very few such cells were generated by Nnat-
KD ESCs (Fig. 3.8E-F). As before, NeuN expression was used for the 
quantification of neurons in these cultures (see section 3.2.3.3), revealing 
a significant reduction in the ability of Nnat-KD ESCs to generate these 





Fig. 3.8. Nnat knocked-down restricted neural development. 
46C and Nnat-KD ESCs were grown in monolayer cultures. (A, B) The 
neuroectodermal marker Sox1 (green) and NSC marker Nestin (red) were not expressed 
by undifferentiated 46C and Nnat-KD ESCs. (C) After 6 days of differentiation, 46C 
ESCs generated Sox1-GFP+ and Nestin+ NSCs. (D) The generation of NSCs were 
significantly reduced in Nnat-KD cells. (G) Quantification of NSCs in Nnat-KD and 
46C differentiated cultures (2.4 ± 1.2% and 24.2 ± 3.6%, respectively, p < 0.01, n=3, 
two-tailed Student’s t test). (E) After 14 days of differentiation, 46C ESCs generated 
MAP2+ neurons but (F) Nnat-KD ESCs generated few if any MAP2+ neurons. (H) The 
percentage of NeuN+ neurons was counted. Nnat-KD cells generated less neurons than 
did 46C cells (0.8 ± 0.03% and 21.4 ± 2.5%, respectively, p < 0.01, n=3, two-tailed 
Student’s t test). This data suggested that Nnat knockdown restricted neural 
development. All nuclei were stained with DAPI (blue). Scale bar, 20 μm. 
Abbreviations: DAPI, 4',6-diamidino-2-phenylindole; ESC, embryonic stem cell; GFP, 
green fluorescent protein; MAP2, microtubule-associated protein 2; NeuN, neuronal 
nuclear antigen; Nnat-KD, Nnat-knockdown; SRY (sex determining region Y)-box 1. 
 
In summary, Oct4 expression was protracted in Nnat-KD ESCs even 
after 12 days of differentiation and the generation of Sox1-GFP+/Nestin+ 
NSCs and NeuN+ or Map2+ neurons was significantly reduced compared 
with wild type ESCs. This indicates that Nnat knock-down disturbs the 
neural induction of ESCs, limiting their ability to generate neural cells. 
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3.2.5 Nnat re-expression rescues the Nnat-knockdown phenotype   
In order to confirm that the knocked-down phenotype described above was 
not due to off-target RNA interference, Nnat-KD ESCs were transfected 
with pNEBR-Nnatα or pNEBR-Nnatβ vectors (see Materials and Methods, 
section 2.2.4) to determine whether Nnatα or Nnatβ re-expression could 
rescue the Nnat-KD phenotypes, which manifest as a reduction of the 
generation of NSCs and hence neurons. 
 
Nnat-KD ESCs were transfected with pNEBR-Nnatα or pNEBR-Nnatβ 
vectors using Lipofectamine and then stably transfected cell lines were 
generated (see Materials and Methods, section 2.2). The resultant ES lines 
were cultured on gelatin-coated coverslips and then differentiated towards 
NSCs and neurons (see sections 2.3.1 and 3.2.1). The expression of Nnat 
was analysed by immunofluorescence staining and Nnat-KD/Nnatα or 
Nnat-KD/Nnatβ ESCs were found to express Nnat protein highly, whereas, 
as expected, Nnat-KD cells were negative (Fig. 3.9A-C). After 6 days of 
differentiation, Nnat-KD/Nnatα and Nnat-KD/Nnatβ ESCs were able to 
generate significantly more Sox1-GFP+/Nestin+ NSCs compared with 
Nnat-KD ESCs (Fig. 3.9D-F) and similarly, after 14 days of differentiation, 
they generated significantly more MAP2+ neurons (Fig. 3.9G-I). However, 
the neuron production by both types of Nnat-KD/Nnat cells was less than 
that observed when wild type ESCs were differentiated (compare Fig. 3.8 
with Fig. 3.9). This may be due to the silencing effect of Nnat shRNA still 
present in the Nnat-KD cells. These results showed that Nnatα or Nnatβ re-
expression could rescue the ability of Nnat-KD cells to generate neural 
cells, suggesting that the phenotypic change of Nnat-KD ESCs was caused 




Fig. 3.9. Nnat re-expression rescues the ability of Nnat-KD ESCs to generate neural 
cells. 
Nnatα or Nnatβ stably transfected ESC lines were generated from parent Nnat-KD 
ESCs. Nnat-KD, Nnat-KD/Nnatα, and Nnat-KD/Nnatβ ESCs were grown in monolayer 
culture and differentiated for 6 or 14 days. The expression of Nnat, Nestin, and MAP2 
in the undifferentiated day 6-differentiated and day 14-differentiated cells were 
analysed respectively by immunocytochemistry. (A) Nnat (red) was not expressed in 
the undifferentiated Nnat-KD ESCs. (B) Nnatα (red) was re-expressed in the 
undifferentiated Nnat-KD/Nnatα ESCs and (C) Nnatβ (red) was re-expressed in the 
undifferentiated Nnat-KD/Nnatβ ESCs. (D) After 6 days of differentiation, Nnat-KD 
ESCs only generated a few Sox1-GFP+ (green) and Nestin+ (red) NSCs. (E, F) After 
Nnatα or Nnatβ was re-expressed in Nnat-KD cells, the generation of NSCs was 
increased compared with the parent Nnat-KD cells. (G) After 14 days of differentiation, 
Nnat-KD ESCs generate few, if any, neurons.  (H, I) After Nnatα or Nnatβ re-
expression, ESCs regained their ability to generate neurons. All nuclei were stained 
with DAPI (blue). Scale bar, 20 μm.  
Abbreviations: DAPI, 4',6-diamidino-2-phenylindole; ESC, embryonic stem cell; GFP, 
green fluorescent protein; MAP2, microtubule-associated protein 2; Nnat-KD, Nnat-
knockdown; Sox1, SRY (sex determining region Y)-box 1. 
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3.2.6 Nnat-KD ESCs still have the ability to generate the three 
primary germ layers   
Normally wild type ESCs differentiate into primitive ectoderm and then 
into the three primary germ layers (ectoderm, mesoderm, and endoderm) 
(Fig. 10; Desbaillets et al., 2000; Fok and Zandstra, 2005; Keller, 2005; 
Rathjen et al., 1999). Ectodermal cells will further differentiate into 
neuroectodermal cells and epithelial cells (Desbaillets et al., 2000; Greber 
et al., 2010). Nnat-KD ESCs are impaired in their ability to generate 
neuroectodermal cells, and hence NSCs and neurons (see the section 
3.2.4.2). To examine whether this impairment was attributed to the fact 
that Nnat-KD ESCs simply failed to differentiate efficiently into any of the 
three primary germ layers or were pushed along a non-neural lineage, 46C, 
Nnatα-OE, and Nnat-KD ESCs were grown under conditions known to 
promote differentiation into the three primary germ layers (aggregate 
culture; Fok and Zandstra, 2005). In this culture system, ESCs differentiate 
in a three dimensional mode and form EBs, which have the ability to 
differentiate into the three primary germ layers. The differentiation of EBs 
mimics early mammalian embryogenesis and provides a platform to study 
the impact of genetic manipulations, during early embryonic development 
(Desbaillets et al., 2000; Fok and Zandstra, 2005). After culture for 6 days, 
EBs were collected for total RNA isolation and quantitative real-time PCR 
was used to analyse the expression pattern of markers for primitive 
ectoderm, ectoderm, mesoderm and endoderm. Fgf5, a marker of primitive 
ectoderm, was expressed in 46C and Nnatα-OE cells, but was expressed at 
much higher levels in Nnat-KD cells (Fig. 3.11A). Thus, Nnat-KD cells 
may generate more primitive ectoderm than the other cell types. Brachyury 
and Mesp1 (mesoderm), Hnf4 (endoderm), and Otx2 (ectoderm) were also 
expressed in 46C, Nnatα-OE, and Nnat-KD cells (Fig. 3.11B-E). Thus, 
Nnat-KD ESCs could differentiate into primitive ectoderm, and the three 
germ layers like 46C and Nnatα-OE ESCs. As expected, the expression of 
the neuroectodermal marker Sox1 was significantly lower in Nnat-KD 
ESCs compared with 46C and Nnatα-OE ESCs (Fig. 3.11F, p < 0.05). 
Nnatα-OE cells showed an increase in the expression of Brachyury 
compared with 46C ESCs (Fig. 3.11B, p < 0.05). A similar result also was 
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found in Xenopus embryos, where over-expression of mouse Nnatα or 
Nnatβ increased the expression of the mesodermal marker nxk2.5 (see 
section 3.2.7 and Fig. 3.13). These results suggest that Nnat may also 
promote the generation of mesodermal cells (see section 3.3.3 for a 
discussion of this observation).  
 
 
Fig. 3.10. Schematic diagram of ESCs differentiation.  
ESCs give rise to primitive ectoderm and the primitive ectoderm generates ectoderm and 
primitive streak. The ectoderm further differentiates into neuroectoderm and epithelium to 
generate neural and skin cells, respectively. The primitive streak differentiates into 
mesoderm and definitive endoderm. The mesoderm forms cardiovascular system and 
skeletal muscles. The definitive endoderm forms lung, liver, pancreas, and intestine.  
Abbreviations: ESC, embryonic stem cell. 




Fig. 3.11. The competence of Nnat-mutant ESCs to give rise to the three primary germ 
cells. 
The generation of neuroectoderm by Nnat-KD ESCs was significantly reduced in the 
monolayer culture system. In order to rule out the possibility that this impairment of 
neural development was attributed to the fact that Nnat-KD ESCs simply failed to 
generate primitive ectoderm and three primary germ layers, 46C, Nnatα-OE, and Nnat-
KD ESCs were cultured to form EBs using aggregate culture. After 6 days, EBs were 
collected to examine the expression of different genes using real-time PCR. (A) 46C, 
Nnatα-OE, and Nnat-KD ESCs all expressed the primitive ectoderm marker Fgf5 but 
expression was significantly higher in Nnat-KD ESCs (p < 0.05, one-way ANOVA test). 
(B) 46C, Nnatα-OE, and Nnat-KD ESCs all expressed the mesoderm marker Brachyury 
with expression being highest in Nnatα-OE ESCs (p < 0.05, one-way ANOVA test). 46C, 
Nnatα-OE, and Nnat-KD ESCs all expressed (C) the mesoderm marker Mesp1, (D) the 
ectodermal marker Hnf4 and (E) the ectoderm marker Otx2. (F) The expression of the 
neuroectoderm marker Sox1 was higher in Nnatα-OE ESCs than 46C and Nnat-KD ESCs 
(p < 0.01, one-way ANOVA test), and also 46C expressed higher Sox1 than did Nnat-KD 
ESCs (p < 0.05, one-way ANOVA test).  
Abbreviations: ANOVA, analysis of variance; EB, embryoid body ; ESC, embryonic 
stem cell; Fgf, fibroblast growth factor; Hnf4, Hepatocyte Nuclear Factor 4; Mesp1, 
mesoderm posterior 1; Nnat-KD, Nnat-knockdown; Nnatα-OE, Nnatα-overexpression; 
PCR, polymerase chain reaction; Sox1, SRY (sex determining region Y)-box 1. 
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In order to analyse the protein expression of Brachyury (a marker of 
mesoderm) and Keratin 18 (a marker of epithelial tissue), EBs were 
dissociated and re-plated on coverslips for immunocytochemical analysis. 
46C, Nnatα-OE, and Nnat-KD ESCs generated Brachyury-expressing 
mesodermal cells, as expected, and also Keratin 18-expressing epithelial 
cells (Fig. 3.12). Therefore, the impairment of Nnat-KD ESCs to generate 
neuroectodermal cells is not attributable to the fact that Nnat-KD ESCs fail 




Fig. 3.12. Nnat-mutant ESCs generate mesodermal and epithelial cells in the same way as 
do wild-type ESCs.  
46C, Nnatα-OE, and Nnat-KD ESCs were cultured to form EBs. After 6 days, EBs were 
dissociated with trypsin and re-plated on coverslips. After being cultured for 24 hours, the 
expression of the mesodermal marker Brachyury and epithelial marker Keratin 18 were 
analysed by immunocytochemistry. (A-C) 46C, Nnatα-OE, and Nnat-KD ESCs all 
generated Brachyury-expressing mesoderm. (D-F) 46C, Nnatα-OE, and Nnat-KD ESCs 
all generated Keratin 18-expressing epithelial cells. All nuclei were stained with DAPI 
(blue). Scale bar, 20 μm. 
Abbreviations: DAPI, 4',6-diamidino-2-phenylindole; EB, embryoid body ; ESC, 
embryonic stem cell; Nnat-KD, Nnat-knockdown; Nnatα-OE, Nnatα-overexpression. 
 
It is possible that the anti-keratin antibody may cross react with actin 
and/or collagen (Baboonian et al., 1991). In order to rule out any false 
positive effects from using this antibody, 46C and Nnatα-OE ESCs were 
grown in differentiating conditions for 4 days with or without the 
treatment with BMP4 (10 ng/ml for four days). BMP4 is an epidermal 
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inducer and neural inhibitor (Wilson and Hemmati-Brivanlou, 1995), so 
treatment of 46C ESCs with BMP4 suppressed the generation of Sox1-
GFP+ neural progenitors (see section 5.2.5), but induced the generation of 
Keratin 18+ epidermal cells, acting as a positive control for the anti-keratin 
antibody. However, BMP4 treated Nnatα-OE ESCs still preserved the 
ability to generate Sox1-GFP+ neural progenitors (see section 5.2.5). If the 
anti-Keratin 18 antibody cross reacted with actin, the Sox1-GFP+ cells 
should be stained with the antibody. After fixation, immunocytochemical 
analysis was performed and the same anti-keratin 18 antibody was applied. 
The Sox1-GFP+ neural progenitors were not stained with Keratin 18 while 
the BMP4 treated cells generated large Sox1-GFP--/keratin 18+ cells, 
suggesting that the anti-keratin antibody did not bind non-specifically (see 
Appendix 4). 
 
3.2.7 Nnat over-expression neuralises ectoderm in Xenopus laevis 
As showed in the previous sections, Nnat over-expression promoted mouse 
ESCs differentiation towards a neural fate in vitro. However, the results of 
in vitro experiments do not always correlate with the in vivo situation. To 
examine whether Nnat over-expression also affects neural development in 
vivo, we collaborated with Dr. Esther Bell (MRC Centre for 
Developmental Neurobiology, King’s College London) to look at the 
effects of Nnat over-expression in Xenopus laevis. These experiments were 
carried out by Dr. Esther Bell and her group. Her results are shown for the 
completeness of my thesis.   
 
The Xenopus neural induction model is a widely used and well-established 
model (Bell et al., 2003; Munoz-Sanjuan and Brivanlou, 2002). To over-
express Nnat in Xenopus embryos, Nnatα or Nnatβ mRNAs were injected 
into the embryos at the 2-cell stage and the embryos left to develop to 
early tadpole stage. Nnatα or Nnatβ over-expression resulted in enlarged 
brain tissue and expansion of the expression domain of the neural marker 
NCAM at the early tadpole stage (Fig. 3.13A-C). The animal cap assay 
(see section 1.3) also demonstrated that mouse Nnat over-expression 
caused neural induction in Xenopus. The isolated animal cap explants have 
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the potential to differentiate into the three primary germ layers, so are used 
to study the factors that direct differentiation along different lineages 
(Agius et al., 2000; Sasai et al., 1996). The isolated animal caps give rise 
to neural cells after treatment with neural inducers (Grunz and Tacke, 1989; 
Munoz-Sanjuan and Brivanlou, 2002). In the animal cap assay, the mouse 
Nnat mRNA was injected into Xenopus embryos at the 2-cell stage and 
then animal cap explants were cut at the blastula stage (before neural 
induction occurs in the gastrula stage, see section 1.3) and cultured in vitro. 
Explants were harvested at last gastrula stage and the neural and 
mesodermal markers were analysed by RT-PCR (reverse transcriptase 
PCR) (Fig. 3.13D). Nnatα or Nnatβ over-expression up-regulated the 
neural plate marker nrp1. Therefore, Nnat overexpression neuralises 
animal cap explants in Xenopus. Nnatα or Nnatβ over-expression also 
increased the expression of nxk2.5 (a heart/mesoderm marker). This result 
was similar to the increased expression of the mesoderm marker 
Brachyury in Nnatα-OE cells (Fig. 3.11B) with both Xenopus and mouse 
systems showing that Nnat also increases mesoderm production. These in 





Fig. 3.13. The effects of Nnatα and Nnatβ on neural induction in Xenopus. 
(A-C) To determine whether Nnat causes neural induction in vivo, 1 ng Nnatα or Nnatβ 
mRNA was injected into Xenopus embryos at the 2-cell stage, and then embryos were left 
to develop to the early tadpole stage. (A) In un-injected embryos, the neural marker 
NCAM (blue) was expressed in neural tissue of the tadpole. (B, C) Injecting Nnatα or 
Nnatβ enlarged the brain tissue and the expression domain of NCAM in the injection side 
(*). (D) In animal cap assay, 1ng Nnat mRNA was injected into the embryos at the 2-cell 
stage and then animal cap explants were cut at blastula stage and cultured in vitro. 
Explants were harvested at last gastrula stage and the neural (nrp1) and mesodermal 
(nkx2.5) markers were analysed by RT-PCR. Embryos at stage 23 and RT- (no reverse 
transcriptase) were the positive and negative control, respectively. Nkx2.5 and nrp1 were 
up-regulated in the injected explants compared with un-injected explants. ODC was used 
as a loading control. 
Abbreviations: NCAM, neural cell adhesion molecule; ODC, ornithine decarboxylase; 
RT-, no reverse transcriptase; RT-PCR, reverse transcription polymerase chain reaction. 
(Adapted from Lin et al., 2010) 
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3.3 Discussion  
3.3.1 Summary of main findings 
In summary, Nnat expression is up-regulated when ESCs begin to 
differentiate along the neural lineage in vitro. Gain- and loss-of-function 
experiments show that ESCs in which Nnat expression had been knocked-
down have a dramatically decreased ability to generate NSCs, and 
subsequently neurons, while ESCs in which Nnat is over-expressed 
generate an excess of NSCs and hence neurons. These in vitro results were 
consistent with the in vivo experiments showing that microinjecting Nnat 
mRNA into Xenopus embryos increased the generation of neural cells. 
Thus, these results suggest that Nnat is needed for the neural induction and 
subsequent neural development of mouse ESCs.  
 
3.3.2 Nnat is an intrinsic factor for neural induction 
During gastrulation, ectoderm will be induced to give rise to neural tissue 
by molecules that are called neural inducers (Harland, 1994). Neural 
inducers also cause the neuralisation of isolated animal cap explants (Pera 
et al., 2003; Stern, 2005). The known neural inducers include BMP 
antagonists (Noggin, Chordin, and Follistatin), Wnt antagonist (Dickkopf-
1), and FGFs (Ang et al., 1994; Doniach, 1995; Glinka et al., 1998; Holley 
et al., 1995; Kuroda et al., 2005; Lee et al., 2006; Slack, 1994). BMP 
antagonists are secreted by the organiser region which is a part of the 
mesoderm (see section 1.3; Gaulden and Reiter, 2008; Lebreton and Jones, 
2006; Leyns et al., 1997). The treatment of Xenopus embryos with BMP 
antagonists (Noggin, Follistatin or Chordin) induces the generation of 
neural cells from embryonic ectoderm (Batut et al., 2005; Hemmati-
Brivanlou et al., 1994; Knecht et al., 1995; Lamb et al., 1993; Sasai et al., 
1995). During early gastrulation, the Wnt antagonist, Dickkopf-1, is first 
expressed in the organiser region of Xenopus, and in the animal cap assay, 
Dickkopf-1 induces the expression of the neural marker NCAM (Glinka et 
al., 1998). These results suggest that BMP and Wnt antagonists are not 
generated within the prospective neural ectoderm during early neural 
development, so these antagonists could be regarded as extrinsic factors 
that regulate neural induction.  
 131 
 
The expression of Nnat in mammalian embryos was first seen before the 
formation of the neural plate and maximal expression was seen in neural 
tissue during gastrulation (details see section 1.7; Sousa-Nunes et al., 
2003), suggesting that Nnat may have a role in neural induction. Gain- and 
loss-of function experiments (see sections 3.2.3 and 3.2.4) showed that 
Nnat knocked-down in mouse ESCs suppressed the generation of neural 
cells, and conversely Nnat over-expression in mouse ESCs enhanced the 
formation of neural cells. These results suggest that Nnat expression is 
needed for the neural induction of mouse ESCs, and Nnat promotes ESCs 
differentiation along the neural lineage. Further to this, injecting mouse 
Nnat mRNA into Xenopus embryos increased the generation of neural 
tissue in Xenopus embryos and up-regulated neural plate markers in animal 
cap explants (see section 3.2.7), suggesting that Nnat has the property of a 
neural inducer. However, unlike BMP and Wnt antagonists, which are 
secreted by the organiser region, Nnat is highly expressed within the 
developing neural tissue (see section 1.7). My work also revealed that 
Nnat is expressed in cells that belong to the neural lineage when mouse 
ESCs differentiate along a neural differentiation pathway (see section 
3.2.2). Furthermore, Nnat is a membrane protein localised within the ER 
(Dou and Joseph, 1996; Joe et al., 2008), and so far, there is no evidence 
that cells can secrete Nnat. These findings suggest that Nnat initiates 
neural development of mouse ESCs internally and it can therefore be 
considered as an intrinsic regulator of neural induction.  
 
When BMP4 was electroporated into the prospective neural plate of chick 
embryos in vivo, the expression of the neural plate markers Sox2 and Sox3 
in the normal neural domain were inhibited (Linker and Stern, 2004), 
suggesting that BMP is a negative cue for neural induction (see sections 
1.2, 1.3, and 1.4). In contrast, the injection of Fgf8 mRNA into Xenopus 
embryos to activate FGF signalling induced ectopic neural tissue (Pera et 
al., 2003), suggesting that FGF acts as a positive cue for neural induction 
(see section 1.5.1). Within this Chapter, gain- and loss-of-function 
experiments revealed that the generation of NSCs was increased when 
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Nnat was over-expressed in mouse ESCs, and conversely the generation of 
NSCs was reduced significantly when Nnat expression was knocked-down, 
suggesting that Nnat has a positive effect on neural induction in mouse 
ESCs. Similarly, Fgf4-/- mouse ESCs have been shown to generate 
significantly fewer Nestin-expressing NSCs than wild type ESCs after 6 
days of differentiation - the same differentiating condition used in my 
study (Kunath et al., 2007). At the same time, over 90% of Fgf4-/- mouse 
ESCs still express the pluripotent marker Oct4 after 6 days of 
differentiation. My results also show that the generation of NSCs was 
reduced and the expression of Oct4 was protracted in the Nnat-KD ESCs 
even after 12 days of differentiation (see section 3.2.4). Thus, like FGF, 
Nnat is a positive cue that promotes the neural induction of mouse ESCs. 
 
3.3.3 Nnat may also affect the generation of primitive ectoderm and 
early mesoderm 
ESCs have the ability to differentiate into primitive ectoderm and then into 
the three primary germ layers sequentially (Fok and Zandstra, 2005; Keller, 
2005; Rathjen et al., 1999). My experiments show that when wild type and 
Nnat-mutant ESCs were grown in suspension culture to form EBs, they 
expressed markers representative of primitive ectoderm and all three germ 
layers (Fgf5, primitive ectoderm marker; Brachyury, mesodermal marker; 
and Keratin 18 epithelial marker) (see section 3.2.6). These results imply 
that knocking down Nnat does not inhibit the formation of ectodermal 
cells. Thus, the reduction of Nnat-KD ESCs to generate neuroectodermal 
cells which are generated from ectodermal cells is not due to the fact that 
Nnat-KD ESCs fail to differentiate into ectodermal cells. However, as 
shown in Figure 3.11A, Nnat-KD cells express higher levels of Fgf5 in 
EBs than either 46C or Nnatα-OE cells (see section 3.2.6). This may be 
due to the up-regulation of BMP4 expression observed in Nnat-KD ESCs 
that in turn promotes the expression of Fgf5. Indeed, I will go on to show 
in Chapter 5 that Nnat knocked-down resulted in an increased expression 
of BMP4. The disruption of growth differentiation factor-3 (GDF3, a BMP 
inhibitor) expression by gene trap in mouse ESCs causes Fgf5 up-
regulation in EBs (Levine and Brivanlou, 2006). This suggests that the 
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activation of BMP signalling, by inhibiting the expression of GDF3, 
increases the expression of Fgf5. Compared with 46C and Nnatα-OE ESCs, 
Nnat-KD ESCs expresses higher level of BMP4 and its target genes (see 
section 5.2.6). Thus, the up-regulation of Fgf5 in Nnat-KD cells may be 
due to the fact that BMP signalling is up-regulated in Nnat-KD cells. 
Conversely, however, Zhang et al. (2010) showed that BMP4-treatment 
decreased Fgf5 expression in EBs (Zhang et al., 2010). This opposite result 
may be due to the difference between the two culture conditions. In the 
latter study, EBs were cultured in serum free medium supplement with 10 
ng/ml BMP4 for two days. In my experiments, EBs were cultured with 
serum containing medium for 6 days, conditions similar to those used by 
Levine and Brivanlou who obtained results similar to mine.  
 
Brachyury is an early marker of mesoderm induction (Smith et al., 1991; 
Wilson et al., 1995). The expression of Brachyury is increased in animal 
cap explants exposed to FGF2 compared with untreated explants (Smith et 
al., 1991). Conversely, the injection of Xenopus embryos with a dominant-
negative FGF receptor to inhibit FGF signalling reduces the expression of 
Brachyury (Schulte-Merker and Smith, 1995). These results suggest that 
the activation of FGF signalling up-regulates the expression of the 
mesodermal marker Brachyury.  In Fig. 3.11B, Nnatα-OE cells express a 
higher level of Brachyury than do 46C and Nnat-KD cells. This may be 
due to the FGF/Erk signalling being activated by Nnat. In Chapter 4 and 5, 
I will show that Nnat increases cytosolic calcium levels and this results in 
the activation of FGF/Erk signalling. Thus, Brachyury may be up-
regulated in Nnatα-OE cells because of the activation of FGF/Erk 
signalling. As shown in Fig. 3.13D, injecting Nnat mRNA into Xenopus 
embryos increased the expression of the mesodermal marker nkx2.5 in 
animal cap explants. Therefore, Nnat may also be involved in mesoderm 






3.3.4 Nnat plays different roles in different stages of neural 
development 
The in vivo expression pattern of Nnat (see section 1.7) shows that Nnat is 
expressed from the beginning of neural induction to the end of 
neurogenesis. Neural induction is the initial step of neural development 
whereby the ectoderm differentiates into NSCs (Wilson and Edlund, 2001). 
Nnat knocked-down significantly reduces the generation of NSCs from 
mouse ESCs. In contrast, Nnat over-expression increases the generation of 
NSCs. These results suggest that Nnat plays a pivotal role in the neural 
induction of mouse ESCs. Neurogenesis is the process by which neurons 
are generated from NSCs and NPCs, so neural induction is followed by 
neurogenesis during neural development (Gaspard and Vanderhaeghen, 
2010). In our in vitro model, Nnat is still expressed in NSCs, NPCs, and 
neurons (see sections 1.7 and 3.2.2). Therefore, after neural induction, 
Nnat may have other roles during neurogenesis. Although more neurons 
are generated from Nnat-OE ESCs, it is not clear whether this is due to the 
fact that Nnat actively promotes neurogenesis or simply due to the fact that 
Nnat-OE cells produce more NSCs. In order to determine the role of Nnat 
throughout neurogenesis, another two experiments could be carried out. 
First, Nnat conditional knocked-down ESCs could be generated. After 
ESCs differentiate into NSCs, Nnat could then be knocked down. 
Alternatively, Nnat could be simply knocked down in NSCs by 
transfection of RNAi (RNA interference). If Nnat expression is required 
for further neural development then the generation of neurons will be 
reduced. Second, Sox1-expressing NSCs could be sorted out (by 
fluorescence activated cell sorting) from Nnat-OE, Nnat-KD, and wild 
type ESCs after 6 days of differentiation, and then equal numbers of NSCs 
generated from different ESCs could be re-plated and differentiated into 
neurons. If Nnat expression is required for neurogenesis, fewer neurons 
would be generated in Nnat-KD cells. Using these two approaches, the 
function of Nnat in neurogenesis could be further analysed.  
 
During development, as well as generating neurons, neural progenitor cells 
also generate glial cells (astrocytes and oligodendrocytes) (Kornblum, 
 135 
2007; Raff et al., 1983). Within my thesis, I focused on the role of Nnat in 
neural induction, NPC formation and neuronal development, thus, I did not 
analyze the generation of glial cells. So far, it is unknown whether glial 
cells express Nnat or not; however, as mention in the introduction (section 
1.8.1) NNAT was shown to be highly expressed in glioblastoma 
multiforme, the most malignant variant of human glial tumors (Xu et al., 
2012). Furthermore, increasing expression of NNAT in malignant glioma 
cells promoted their proliferation, suggesting that Nnat may affect the self-
renewal of glial cells. 
 
3.3.5 Flow cytometry and cell counting 
In this chapter, the numbers of Sox1-GFP+/Nestin+ NSCs and NeuN+ 
neurons were counted manually. Compared with this, flow cytometry may 
be considered a more efficient way to quantify NSCs and neurons. Flow 
cytometry is a biophysical technology frequently used in cell counting and 
biomarker detection (Davey and Kell, 1996; Fukuda et al., 2006; Lyons 
and Parish, 1994). Indeed, flow cytometry was initially used to count the 
Sox1-GFP+/Nestin+ NSCs and NeuN+ neurons; however, it was observed 
that the percentages of Nestin or NeuN-expressing cells determined using 
this method was decreased compared with manual counting, although the 
proportion of each cell-types remained similar. Also, when compared with 
previous report where the same ESCs and differentiation method was used 
as in my experiments (Kunath et al., 2007), the percentage of Nestin+ cells 
in my experiments when analysed by flow cytometry appeared to be 
significantly underestimated. One possible reason for these lower cell 
counts could be due to the formation of cell aggregates. Both Nestin and 
NeuN are intracellular proteins, so permeabilisation was required for 
intracellular staining. Permeabilised cells can become sticky and aggregate 
to form cell clumps (Gujral et al., 2009) and such clumps would be filtered 
out prior to flow cytometry. This could potentially result in decreased 
numbers of Nestin or NeuN-expressing cells in the sample. In addition, 
low cell counts may also be due to the large fluorochrome which was 
conjugated to the secondary antibody. A Cy3-labeled secondary antibody 
was used in my experiments. Cy3 is a large molecular weight 
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fluorochrome and according to the applications guide of fluorochrome 
conjugates for flow cytometry (www.caltagmedsystems.co.uk/downloads/ 
Caltag_Fluorochromes.pdf), this large molecular weight fluorochrome will 
reduce antibody motility and thus its entry into cells, resulting in a weak 
fluorescence intensity. Therefore, low molecular weight fluorochrome, 
such as Allophycocyanin and R-Rhycoerythrin, should be used to detect 
intracellular proteins.  
 
3.3.6 The role of NNAT in neural induction of human ESCs  
As shown in section 3.2.7, the ability of Nnat over-expression to promote 
neural development is conserved in Xenopus and mouse ESCs. If the 
mechanisms of neural induction are similar in all vertebrates, then NNAT 
may also be needed for the neural induction of human ESCs. According to 
the NCBI protein database, there is only one amino acid difference 
between human and mouse Nnat proteins 
(http://www.ncbi.nlm.nih.gov/protein/?term=Nnat). Thus to test the 
hypothesis that NNAT may also play a role in the neural induction of 
human ESCs, similar loss- and gain-of-function experiments to those 
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4.0 Nnat promotes neural development by modulating intracellular calcium 
levels  
4.1 Introduction 
As shown in Chapter 3, mouse ESCs grown in a monolayer differentiation 
system sequentially differentiated into neuroectodermal cells, NSCs, NPCs, 
and neurons. Nnat expression was up-regulated when mouse ESCs began to 
differentiate along this neural lineage. Furthermore, experiments showed 
that mouse ESCs in which Nnat expression had been knocked-down were 
restricted in their ability to generate NSCs, and subsequently neurons, while 
ESCs that over-expressed Nnat generated an excess of NSCs and hence 
neurons. Therefore, these results suggested that Nnat is needed for the neural 
induction and subsequent neuronal differentiation of mouse ESCs. 
 
Although the precise molecular mechanisms underlying Nnat action is 
unknown, it has been shown that Nnat exhibits a 50% amino acid sequence 
homology with phospholamban, suggesting that these proteins may have 
similar functions (Dou and Joseph, 1996). Phospholamban is an inhibitor of 
Atp2a/SERCA which pumps cytosolic Ca2+ into the ER to decrease [Ca2+]i 
(James et al., 1989), so Nnat may also antagonise the action of 
Apt2a/SERCA to cause an increase in [Ca2+]i (details see section 1.7.2). In 
vertebrates, there are three Apt2a/SERCA genes (details see section 1.5.4.4). 
During Xenopus embryonic development, Apt2a2/SERCA2 is prominently 
expressed in the neural plate and neural tube, indicating a role for this gene 
in aspects of neurogenesis (Pegoraro et al., 2011). Further to this, Dr. Yuh-
Man Sun’s unpublished data also revealed that the Atp2a2/SERCA2 is 
expressed at much higher levels compared to both Apt2a1/SERCA1 and 
Apt2a3/SERCA3 in mouse ESCs and during ESCs neural differentiation 
(see section 1.7.2). Because of these observations, I hypothesised that Nnat 
acts by suppressing the action of Apt2a2/SERCA2, which in turn causes an 
increase in [Ca2+]i resulting in the initiation of neural induction in mouse 
ESCs.  
 
As detailed in section 1.5.4, an increase in [Ca2+]i is known to play a pivotal 
role in neural induction in Xenopus (Batut et al., 2005; Moreau et al., 2008). 
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During Xenopus gastrulation, frequent increases in [Ca2+]i are observed in 
the prospective neural ectoderm, and the treatment of Xenopus embryos with 
calcium channel blockers to prevent the increase in [Ca2+]i suppressed the 
neural specification of ectoderm  (Leclerc et al., 2003; Leclerc et al., 2000). 
This finding implied that an increase in [Ca2+]i is needed for neural induction 
of Xenopus embryos. However, it is unknown whether or not neural 
induction in mammals requires an increase in [Ca2+]i. In this chapter, I will 
report novel data suggesting that Nnat interacts with Apt2a2/SERCA2 to 
modulate cytosolic Ca2+ levels and promote the neural differentiation of 
mouse ESCs.  
 
In order to investigate the molecular mechanisms underlying the action of 
Nnat, Co-IP and Duolink in-situ PLA experiments were carried out to test 
whether Nnat physically interacts with Apt2a/SERCA. We reasoned that if 
Nnat interacts with Apt2a/SERCA to suppress the function of Apt2a/SERCA, 
resulting in an increase of [Ca2+]i, then a specific inhibitor of Apt2a/SERCA 
should function like Nnat and restore the ability of Nnat-KD ESCs to 
generate neural cells. In contrast, preventing an increase in [Ca2+]i of wild 
type ESCs should reduce the generation of NSCs from wild type ESCs.  
Specifically, this chapter describes: 
1) The protein-protein interaction of Nnat and Apt2a2/SERCA2 
2) The effect of Nnat on the [Ca2+]i of mouse ESCs 
3) That Nnat acts as an inhibitor of Apt2a/SERCA 
4) That an increase in [Ca2+]i is required for neural induction in mouse 
ESCs 
5) The source of cytosolic Ca2+ for neural induction 
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4.2 Results   
4.2.1 Nnat interacts with Atp2a2/SERCA2 in mouse ESCs 
Because Nnat shares a high degree of homology with phospholamban 
(Dou and Joseph, 1996), a known interacting partner for Atp2a/SERCA, 
I hypothesise that Nnat physically interacts with Atp2a/SERCA to 
regulate [Ca2+]i in mouse ESCs. Since Atp2a2/SERCA2 is the 
Atp2a/SERCA family member that is most highly expressed in mouse 
ESCs and their neural derivatives (see section 1.7), I focused on studying 
the interaction of Nnat with Apt2a2/SERCA2 using various methods - 
immunocytochemical analysis, Co-IP and Duolink in-situ PLA. 
 
4.2.1.1 Nnat colocalises with Atp2a2/SERCA2 
Nnat and Atp2a2/SERCA2 should colocalise within cells if Nnat 
physically interacts with Apt2a2/SERCA2. To determine whether this 
is the case I employed immunocytochemistry.   
 
46C ESCs were plated onto gelatin-coated coverslips and cultured 
under non-differentiating conditions for two days (see Material and 
Methods, section 2.1). After fixation in 4% PFA, cells were stained 
with primary antibodies for Nnat and Atp2a2/SERCA2 and each 
primary antibody was visualised using a secondary antibody tagged 
with a fluorochrome. This revealed that some ESCs expressed Nnat 
(Fig. 4.1A, arrows) and most cells expressed Apt2a/SERCA2 (Fig. 
4.1B). Both Nnat and Atp2a2/SERCA2 were located in the cytosol 
and Nnat staining colocalised with the staining of Atp2a2/SERCA2 
(Fig. 4.1D, arrows), suggesting that these proteins occupy the same 
cellular location. However, this result is not, in itself, evidence of a 
physical interaction between the two proteins. To prove that a protein-
protein interaction exists between Nnat and Atp2a2/SERCA2 a more 




Fig. 4.1. Colocalisation of Nnat with Atp2a2/SERCA2. 
46C ESCs were plated on gelatin-coated coverslips and cultured in non-
differentiating conditions for two days. After fixation in 4% PFA, 
immunocytochemistry was carried out using primary antibodies for Nnat and 
Apt2a2/SERCA2, (A) Nnat (green, arrows) and (B) Apt2a2/SERCA2 (red) were 
located in the cytosol. (C) The nuclei were stained with DAPI (blue). (D) The 
overlay is shown in orange (arrows) indicates that Nnat colocalised with 
Apt2a2/SERCA2. Scale bar, 50 μm.  
Abbreviations: Atp2a/SERCA, sarcoendoplasmic reticulum Ca2+-ATPase; DAPI, 
4',6-diamidino-2-phenylindole; ESC, embryonic stem cell; PFA, paraformaldehyde. 
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4.2.1.2 Nnat physically interacts with Apt2a2/SERCA2 
In order to investigate whether or not Nnat and Apt2a2/SERCA2 
physically interact with each other, Co-IP and Duolink in-situ PLA 
were used.  
 
Although Co-IP is frequently used in the detection of protein-protein 
interaction, a disadvantage of this technique is that relatively high 
concentrations of proteins are needed to facilitate detection (Hou et al., 
2002). As discussed in section 1.7, the expression of Nnat is low in 
un-differentiated 46C ESCs, and its expression is increased when 
ESCs differentiate along a neural pathway, peaking at differentiation 
day 12. Similarly, the expression of Apt2a2/SERCA2 peaks at 
differentiation day 12 (see Fig. 1.15). Therefore, in order to facilitate 
the detection of interactions between Nnat and Apt2a2/SERCA2 
proteins, 46C cells were plated on gelatin-coated 10cm culture dishes 
and cultured under differentiating conditions for 12 days. To carry out 
the Co-IP experiments (Fig. 4.2), whole cell lysates were prepared 
from differentiated 46C cells (see Material and Methods, section 2.8) 
and mixed with anti-Nnat antibodies. If Nnat physically interacts with 
Apt2a2/SERCA2, then these proteins will form a complex that can be 
recognised by an anti-Nnat antibody. Protein G Magnetic Beads were 
then mixed with the samples to precipitate the protein/protein-
antibodies complexes. The precipitated products were analysed by 
Western blotting using an anti-Apt2a2/SERCA2 antibody to examine 




Fig. 4.2. Schematic representation of Co-IP experiments. 
46C cells were grown in differentiating conditions for 12 days, at time when the 
expression of Nnat (blue) and Apt2a2/SERCA2 (green) proteins is maximal. The 
differentiated 46C cells were lysed, and then an anti-Nnat antibody was mixed with 
the whole cell lysate. If Nnat physically interacts with Apt2a2/SERCA2, then Nnat, 
Apt2a2/SERCA2, and the anti-Nnat antibody would form a protein complex 
allowing the protein G Magnetic Beads (brown) to bind with the anti-Nnat antibody 
and pull the protein complex down by magnetic force. The precipitated products 
were then analysed by immunoblotting using an anti-Apt2a2/SERCA2 antibody to 
examine whether the protein complex contains Apt2a2/SERCA2. 
Abbreviations: Atp2a2/SERCA2, sarcoendoplasmic reticulum Ca2+-ATPase 2; Co-
IP, co-immunoprecipitation; Nnat, neuronatin.  
 
In Figure 4.3, Lane A (input) represented 5% of the whole cell lysate 
used in the Co-IP experiment, and revealed that Atp2a2/SERCA2 was 
expressed in 46C cells and thus could be considered as a positive 
control. For a negative control Co-IP was carried out using 10μg of 
rabbit IgG (Santa Cruz) and under these conditions no 
Atp2a2/SERCA2 specific band was observed. Samples in Lane B-D 
represented Co-IP products using 10μg of three different anti-Nnat 
antibodies individually (B: Santa Cruz, goat; C: Santa Cruz, rabbit; D: 
Abcam, rabbit), and the three lanes all revealed a band at 100 kD, the 
expected size of Atp2a2/SERCA2, when the blot was probed with an 
anti-Atp2a2/SERCA2 antibody. Thus, Atp2a2/SERCA2 could be 
precipitated by anti-Nnat antibodies indicating that Nnat physically 
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interacts with Apt2a2/SERCA2 and forms a protein complex. As well 
as the Atp2a2/SERCA2 specific band at 100 kD, a second broader 
band was observed at 110 kD in lanes B-D. This band may represent a 
modified Apt2a2/SERCA2. For example, it has been reported that 
Apt2a2/SERCA2 protein could be modified through glutathionylation, 
non-enzymatic glycation, and glycosylation, resulting in a protein of 
increased molecular weight (Belke and Dillmann, 2004; Gallogly and 
Mieyal, 2007; Li and Camacho, 2004). In addition, the possibility 
could not be ruled out that this band resulted from some proteins in 
the cell lysate attaching to the Protein G Magnetic Beads non-
specifically and then being pulled down in the Co-IP experiments 
because they contained a similar amino acid sequence to that targeted 
by the anti-Apt2a2/SERCA2 antibody (a non-specific interaction).  
 
Fig. 4.3. Nnat physically interacts with Atp2a2/SERCA2. 
46C ESCs were plated on gelatin-coated 10cm culture dishes and grown in 
differentiating conditions for 12 days. 46C cells were lysed to prepare whole cell 
lysates. 10μg of rabbit IgG (Santa Cruz) was used in IP as a negative control. (B-D) 
10μg of three different anti-Nnat antibodies (B: Santa Cruz, goat; C: Santa Cruz, 
rabbit; D: Abcam, rabbit) were used to IP Nnat proteins. The IP products were 
examined by Western blotting using an anti-Atp2a2/SERCA2 antibody (Santa Cruz, 
goat). (A) The input, representing 5% of the whole cell lyate used in the Co-IP 
experiment. Lanes A-D all revealed a band at 100 kD specific for the 
Atp2a2/SERCA2 protein. Thus, Atp2a2/SERCA2 could be pulled down by anti-
Nnat antibodies indicating that Nnat physically interacts with Atp2a2/SERCA2.  
Abbreviations: Atp2a/SERCA, sarcoendoplasmic reticulum Ca2+-ATPase; ESC, 
embryonic stem cell; Co-IP, co-immunoprecipitation; IgG, Immunoglobulin G; IP, 




4.2.2 Nnat acts as an inhibitor of Apt2a/SERCA to increase [Ca2+]i in 
mouse ESCs  
The Apt2a/SERCA is a calcium ATPase located in the ER that pumps 
Ca2+ from the cytosol into the ER keeping [Ca2+]i low. Although the 
results obtained from Co-IP and Duolink in-situ PLA experiments 
indicate that Nnat physically interacts with Apt2a2/SERCA2, they do not 
address whether this interaction influences the activity of 
Apt2a2/SERCA2, and if so whether the [Ca2+]i is increased or not after 
this interaction. Since Nnat has 50% amino acid sequence homology 
with phospholamban (Dou and Joseph, 1996), an inhibitor of the 
Apt2a/SERCA, I hypothesised that Nnat may also act in this manner. 
Further support for this hypothesis comes from the observations that 
over-expression of Nnat in insulinoma or 3T3 cells causes [Ca2+]i to 
increase (Joe et al., 2008; Suh et al., 2005), suggesting that Nnat may 
inhibit the Apt2a/SERCA resulting in less cytosolic Ca2+ being pumped 
into the ER and an increase in [Ca2+]i. 
 
To determine whether Nnat inhibits the Apt2a2/SERCA2 to cause an 
increase in [Ca2+]i, the [Ca
2+]i of ESCs was measured in collaboration 
with Dr. Vladimir Snetkov (Department of Asthma, Allergy and 
Respiratory Science, King’s College London). 46C, Nnatα-OE, and 
Nnat-KD ESCs were cultured to confluence on laminin-coated glass 
coverslips, and then the [Ca2+]i of ESCs with different Nnat expression 
levels were recorded. Gelatine was used to prepare coverslips throughout 
my thesis except in experiments of [Ca2+]i measurement, because I 
followed the protocol provided by Dr. Vladimir Snetkov (Snetkov et al., 
2010) that used laminin as a substrate. If Nnat inhibits the action of 
Apt2a2/SERCA2, then Nnatα-OE ESCs should have higher [Ca2+]i than 
wild type and Nnat-KD ESCs. Before the [Ca2+]i of the various ESC 
lines were measured, 46C, Nnatα-OE, and Nnat-KD ESCs were 
incubated with a Ca2+ sensitive indicator (Fura PE-3/AM) in the dark for 
40 minutes. Then coverslips were mounted in an imaging chamber and 
continuously perfused with a physiological salt solution. Calcium 
imaging was carried out using an inverted microscope equipped with a 
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microspectrofluorimeter and the [Ca2+]i was represented by fluorescence 
intensity. In Figure 4.4A-C, calcium imaging revealed that the [Ca2+]i of 
Nnatα-OE ESCs was higher than that of 46C and Nnat-KD ESCs. The 
histogram (Fig. 4.4D) of calcium imaging experiments showed that the 
peak of fluorescence intensity of Nnatα-OE (pink arrow) ESCs was 
shifted to the right toward higher fluorescent values compared with wild 
type (blue arrow) ESCs, and conversely the peak of Nnat-KD (green 
arrow) ESCs was left-shifted towards lower values. This result suggested 
that the over-expression of Nnatα increases the [Ca2+]i of ESCs. Thus, 
these results fit with my hypothesis that Nnat inhibits Apt2a2/SERCA2 




Fig. 4.4. Nnat over-expression increases [Ca2+]i. 
46C, Nnatα-OE, and Nnat-KD ESCs were cultured to confluence on laminin-coated 
glass coverslips. Coverslips were rinsed twice with HEPES-buffered PSS, and 
incubated with 0.5 µM Fura PE-3/AM in the dark for 40 minutes. Coverslips were 
mounted in the imaging chamber and placed on the inverted microscope equipped with 
a microspectrofluorimeter to measure [Ca2+]i. The [Ca
2+]i of (A) 46C, (B) Nnatα-OE, 
and (C) Nnat-KD ESCs were monitored with the Ca2+ sensitive indicator (Fura PE-
3/AM). The [Ca2+]i was represented according to fluorescence intensity. The [Ca
2+]i of 
Nnatα-OE ESCs was higher than Nnat-KD and 46C ESCs. (D) The graph showed that 
the peak of fluorescence intensity of Nnatα-OE ESCs (pink arrow) was right-shifted to 
higher values compared with wild type ESCs (blue arrow). In contrast, the peak of 
Nnat-KD ESCs (green arrow) was left-shifted to lower values, suggesting that over-
expression Nnatα increases the [Ca2+]i of ESCs. Scale bar, 20 μm. 
Abbreviations: [Ca2+]i, cytosolic Ca
2+ concentration, ESC, embryonic stem cell; HEPES, 
(4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid ); Nnatα-OE, Nnatα-
overexpression; Nnat-KD, Nnat-knockdown; PSS, physiological salt solution. 
(Provided by Dr. Vladimir Snetkov) 
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4.2.3 Specific inhibitors of Apt2a/SERCA mimic the function of Nnat      
The results obtained from Co-IP, Duolink in-situ PLA experiments (see 
section 4.2.1) and calcium imaging (see section 4.2.2) suggest that Nnat 
physically interacts with Apt2a2/SERCA2 and antagonises the action of 
Apt2a2/SERCA2 to decrease cytosolic Ca2+ movement into the ER, thus 
increasing [Ca2+]i. As shown in Chapter 3, the knocked-down of Nnat in 
ESCs (Nnat-KD ESCs) markedly decreased the ability of these cells to 
generate NSCs compared with wild type ESCs (see section 3.2.4.). This 
ability was restored by re-expressing Nnat (see section 3.2.5). If my 
hypothesis that Nnat inhibits Apt2a2/SERCA2 to increase [Ca2+]i is 
correct, then specific inhibitors of Apt2a/SERCA should, like Nnat, act 
to rescue the generation of neural cells from Nnat-KD ESCs. Thus, in 
this section, I will show evidence that specific inhibitors of 
Apt2a/SERCA increase [Ca2+]i in Nnat-KD ESCs, and mimic the 
function of Nnat to restore the ability of Nnat-KD ESCs to generate 
neural cells.  
 
Thapsigargin (Tg) and 2,5-Di-t-butyl-1,4-benzohydroquinone (BHQ) are 
specific inhibitors of Apt2a/SERCA (Lopez et al., 2008; Lytton et al., 
1991). To determine what concentration and the duration of the Tg or 
BHQ treatment to use, Nnat-KD ESCs were plated onto gelatin-coated 
coverslips and allowed to adhered before being treated with different 
concentrations of Tg or BHQ for different times under differentiating 
conditions. 100, 50, 25, and 5 nM of Tg was added into the culture 
medium for 0.5, 2, 4, and 24 hours. Concentrations of Tg above 25 nM 
and exposure times lasting longer than 30 minutes caused cell death. Tg 
is an irreversible inhibitor of Apt2a/SERCA, but the interaction of BHQ 
with Apt2a/SERCA is reversible (Lytton et al., 1991; Shimazaki et al., 
1999; Tse et al., 1994). Thus the suppressive action of Tg is still 
continued even after Tg is removed from the medium (Doutheil et al., 
1999), and conversely, the function of Apt2a/SERCA is restored once 
BHQ has been removed (Shimazaki et al., 1999; Tse et al., 1994). 
Therefore, BHQ should be present over the whole time course of 
inhibition. 100, 50, 25, and 5 µM of BHQ were added into the culture 
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medium for 1 and 2 days. Concentrations of BHQ above 50 µM and 
exposure times over 1 day caused cell death. Therefore, 25 nM Tg for 30 
minutes or 50 µM BHQ for 24 hours was used to treat Nnat-KD ESCs to 
investigate their effects on [Ca2+]i and their ability to rescue the neural 
phenotype of Nnat-KD ESCs. 
 
4.2.3.1 Specific inhibitors of Apt2a/SERCA increase [Ca2+]i  
Atp2a/SERCA is located in the ER and pumps cytosolic Ca2+ into the 
ER to reduce [Ca2+]i, so inhibiting Atp2a/SERCA will increase [Ca
2+]i. 
Although the specific Apt2a/SERCA inhibitors Tg and BHQ have 
been shown to increase [Ca2+]i in many different cell-types, such as 
3T3, cardiac, COS, DRG, muscle, pancreatic, PC12 and CCE mouse 
ESCs (Dolnikov et al., 2006; Krause et al., 1996; Lytton et al., 1991; 
Razani-Boroujerdi et al., 1994; Sauer et al., 1998), I wanted to show 
that 25 nM Tg or 50 µM BHQ also increases [Ca2+]i in Nnat-KD 
ESCs. To do this, the [Ca2+]i of Nnat-KD ESCs were measured after 
25 nM Tg or 50 µM BHQ treatment. These [Ca2+]i measurements 
were carried out by my collaborator Dr. Vladimir Snetkov 
(Department of Asthma, Allergy and Respiratory Science, King’s 
College London).  
 
For these measurements, Nnat-KD ESCs were cultured to confluence 
on laminin-coated glass coverslips. We observed that after a 25 nM 
Tg or 50 µM BHQ treatment, the [Ca2+]i of Nnat-KD ESCs increased 
within 2 minutes (Fig. 4.5A-B). Even when cells were left in calcium-
free medium, Tg and BHQ treatment still elevated the [Ca2+]i, but the 
potency and duration of this response were diminished (Fig. 4.5C-D), 
indicating that the source of cytosolic Ca2+ was not only from the 




Fig. 4.5. Specific Apt2a/SERCA inhibitors, Tg and BHQ, increase [Ca2+]i levels in 
Nnat-KD ESCs. 
Nnat-KD ESCs were cultured to confluence on laminin-coated glass coverslips. The 
ESCs were treated with specific Apt2a/SERCA inhibitors and [Ca2+]i were measured. 
In calcium-containing medium, (A) 25 nM Tg or (B) 50 µM BHQ treatment 
increased [Ca2+]i of Nnat-KD ES within 2 minutes when compared to cells that had 
not received any treatment. In 0.1 mM EGTA calcium-free medium, (C) 25 nM Tg 
and (D) 50 µM BHQ treatment still elevated [Ca2+]i, but the potency and duration 
were diminished. The results reveal that specific Apt2a/SERCA inhibitors, Tg and 
BHQ, increased [Ca2+]i levels in Nnat-KD ESCs.  
Abbreviations: BHQ, 2,5-Di-t-butyl-1,4-benzohydroquinone; [Ca2+]i, cytosolic Ca
2+ 
concentration; EGTA,  ethylene glycol tetraacetic acid; ESC, embryonic stem cell; 
Nnat-KD, Nnat-knockdown; Atp2a/SERCA, sarcoendoplasmic reticulum Ca2+-
ATPase; Tg, thapsigargin. 
(Adapted from Lin et al., 2010) 
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4.2.3.2 Specific inhibitors restore the ability of Nnat-KD ESCs to 
generate NSCs and neurons 
If Nnat interacts with Apt2a2/SERCA2 and suppresses its activity, 
then specific inhibitors of Apt2a/SERCA should act to rescue the 
generation of NSCs from Nnat-KD ESCs. In order to prove this 
assumption, Nnat-KD ESCs were treated with 25 nM Tg for 30 min 
or 50 M BHQ for 24 hr on the first day of differentiation and the 
ability of Nnat-KD ESCs to generate NSCs was analysed after 6 days 
of differentiation. If Tg and BHQ restore the production of NSCs and 
neurons from Nnat-KD ESCs, this suggests that these specific 
Apt2a/SERCA inhibitors mimic the action of Nnat during neural 
induction. 
 
As shown in Chapter 3, 46C ESCs generated Sox1-GFP and Nestin-
expressing NSCs after being differentiated for 6 days while Nnat-KD 
ESCs did not (Fig. 4.6A-B, also see section 3.2.4.). However, after 
treatment with Tg or BHQ, the Nnat-KD cells regained the ability to 
generate Sox1-GFP and Nestin-expressing NSCs (Fig. 4.6C-D). 
Because the efficiency of Tg or BHQ to rescue Nnat-KD cells was 
similar, I chose to quantify the results obtained from Tg only. 
Quantification of these results revealed that the generation of 
Nestin+/Sox1-GFP+ NSCs in Nnat-KD ESCs was significantly 
increased from 3.2% to 21.4% after Tg treatment (n = 3, p < 0.05) 
(Fig. 4.6E).  
 
These results indicate that the generation of NSCs by Nnat-KD ESCs 
can be restored by treatment with Tg and BHQ, specific inhibitors of 
Apt2a/SERCA, suggesting that Tg and BHQ act in a similar fashion 
to Nnat during neural induction. These results help confirm the 
hypothesis that Nnat acts as an inhibitor of Apt2a/SERCA to increase 




Fig. 4.6. Tg and BHQ treatment rescue the generation of NSCs from Nnat-KD ESCs. 
46C or Nnat-KD ESCs were differentiated for 6 days. On the first day, Nnat-KD 
ESCs were treated with 25 nM Tg for 30 minutes or 50 µM BHQ for 24 hours, and 
then the culture medium was replaced with fresh medium without Tg or BHQ. After 
fixation, cultures were stained with the NSC marker Nestin (red). (A) 46C ESCs 
could generate Sox1/GFP+ and Nestin+ NSCs after differentiation for 6 days. (B) 
The generation of Nestin+ NSCs declined in Nnat-KD ESCs. (C) With 25 nM Tg 
treatment or (D) 50 µM BHQ treatment, the ability of Nnat-KD ESCs to generate 
Sox1/GFP+ and Nestin+ NSCs was restored. (E) The percentage of both Sox1-GFP 
and Nestin positive NSCs cells was counted. Nnat-KD cells generated significantly 
fewer NSCs than 46C ESCs (3.2 ± 1.8% vs. 22.6 ± 4.2%, p < 0.05, two-tailed 
Student’s t test), and the generation of NSCs in Nnat-KD ESCs was significantly 
increased to 21.4 ± 4.6% after Tg treatment (n = 3, p < 0.05, two-tailed Student’s t 
test). There was no difference in the percentage of NSC between 46C and Tg treated 
Nnat-KD ESCs. All nuclei were stained with DAPI (blue).  Scale bar, 20 μm. 
Abbreviations: BHQ, 2,5-Di-t-butyl-1,4-benzohydroquinone; DAPI, 4',6-diamidino-
2-phenylindole; ESC, embryonic stem cell; GFP, green fluorescent protein; Nnat-
KD, Nnat-knockdown; NSCs, neural stem cells; Sox1, sex determining region Y-
box 1; Tg, thapsigargin. 
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To determine whether the effect of Tg and BHQ in restoring the 
ability of Nnat-KD cells to generate Nestin-expressing NSC resulted 
in the subsequent development of neurons in these cultures, the same 
experiments were carried out as described above, but cultures were 
allowed to differentiate for 14 days instead of 6 days. After this time 
46C ESCs generated many NeuN expressing neurons, while Nnat-KD 
ESCs, as expected, did not (Fig. 4.7A-B, also see section 3.2.4.). After 
treatment with Tg or BHQ, the ability of Nnat-KD cells to generate 
NeuN expressing neurons was restored (Fig. 4.7C-D), but the number 
of neurons observed was fewer than seen in wild type cultures. 
Quantification of these results revealed that the generation of NeuN 
expressing neurons from Nnat-KD ESCs was significantly increased 
after Tg treatment from 2.1% to 11.0% (n = 3, p < 0.05) (Fig. 4.7E), 
but not to the levels seen in differentiated 46C ESCs (20.8%, n = 3, p 
< 0.05). Since there was no difference in the percentage of NSCs 
between the 46C and Tg treated Nnat-KD ESCs after 6 days 
differentiation (Fig. 4.6E), one might presume that similar numbers of 
neurons would be generated under these conditions. This difference in 
neuronal number observed may be due to the fact that only a single 
dose of Tg was given on the first day of differentiation and its effects 
were not fully sustained through the whole course of neurogenesis. 
The in vivo and in vitro expression patterns of Nnat reveal that Nnat is 
still highly expressed after neuroectoderm is formed (see sections 1.7 
and 3.2.2). This implies that Nnat may be still be required when 
neuroectodermal cells differentiate into neurons, thus I conclude that 
administration of Tg only on the first day of differentiation of Nnat-
KD cells was not sufficient to restore neuronal levels to that seen in 
differentiated wild type 46C cell. Therefore, this observation revealed 
that, in addition to the early role in neural induction, Nnat might also 




Fig. 4.7. Tg or BHQ exposure rescue the ability of Nnat-KD ESCs to generate 
neurons.  
46C or Nnat-KD ESCs were differentiated for 14 days. On the first day of 
differentiation, Nnat-KD ESCs were treated with 25 nM Tg for 30 minutes or 50 
µM BHQ for 24 hours, and then the culture medium was replaced with fresh 
medium without Tg or BHQ. After fixation, cultures were stained with the nuclear 
neuronal marker NeuN (red). (A) 46C ESCs could generate NeuN+ neurons after 14 
days of differentiation. (B) The generation of NeuN+ neurons was significantly 
decreased in Nnat-KD ESCs. (C) With 25 nM Tg or (D) 50 µM BHQ treatment the 
ability of Nnat-KD ESCs to generate NeuN+ neurons was restored. (E) The 
percentage of NeuN+ neurons was counted. Nnat-KD cells generated significantly 
fewer neurons than 46C ESCs (2.1 ± 1.1% vs. 20.8 ± 1.5%, p < 0.01, two-tailed 
Student’s t test). The generation of neurons in Nnat-KD ESCs was significantly 
increased to 11.0 ± 1.9% after Tg treatment (n = 3, p < 0.05, two-tailed Student’s t 
test), but did not reach the level observed in differentiated 46C ESC cultures (p < 
0.05, two-tailed Student’s t test). All nuclei were stained with DAPI (blue).  Scale 
bar, 20 μm.  
Abbreviations: BHQ, 2,5-Di-t-butyl-1,4-benzohydroquinone; DAPI, 4',6-diamidino-
2-phenylindole; ESC, embryonic stem cell; NeuN, neuronal nuclei; Nnat-KD, Nnat-
knockdown; Tg, thapsigargin. 
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4.2.4 Intracellular Ca2+ is important for the neural induction of 
ESCs  
An elevation in [Ca2+]i has been demonstrated to be important for neural 
induction in Xenopus (Batut et al., 2005; Moreau et al., 2008), but 
whether calcium is similarly involved in neural induction in mammals is 
still unknown. To test the involvement of calcium in the neural induction 
of mouse ESCs, 46C ESCs were grown under monolayer differentiation 
conditions in the presence of BAPTA-AM, a membrane permeable 
calcium chelator that chelates both intracellular and extracellular Ca2+ 
(Bouchard et al., 2001; Collatz et al., 1997; van Der Luit et al., 1999). If 
calcium is necessary for mouse ESCs to differentiate along a neural 
lineage, the generation of NSCs by 46C should be inhibited by the 
presence of the calcium chelator.    
 
To decide the concentration and duration of BAPTA-AM treatment to 
use, 46C ESCs were cultured in differentiating conditions and were 
treated with 80, 60, 40, 30, 20, 15, or 10 μM BAPTA-AM for 4, 6, 8, 24, 
or 48 hours. Concentrations of BAPTA-AM above 10 μM and treatment 
durations of over 24 hours caused cell death. Thus, I used 10 μM 
BAPTA-AM for 24 hours to treat 46C ESCs.  
 
In order to determine whether BAPTA-AM blocks the neural induction 
of 46C ESCs, these cells were cultured under differentiating conditions 
for 3 days. On the first day, cultures were treated with 10 μM BAPTA-
AM for 24 hours, and then the medium was replaced (without BAPTA-
AM) and cultured for a further 2 days. Normally the NSC marker Sox1-
GFP is first expressed in 46C cells after differentiation for 2 days (see 
section 3.2.1), but it is more apparent after differentiation for 3 days. 
Thus I fixed cells after 3 days and analysed the expression of Sox1-GFP. 
As shown in Figure 4.8, the generation of Sox1-GFP-expressing NSCs 
was dramatically reduced by the treatment of 46C cells with BAPTA-
AM, suggesting that Ca2+ is required on the first day of differentiation 




Fig. 4.8. BAPTA-AM restricts the generation of NSCs. 
46C ESCs were differentiated for 3 days. On the first day, experimental cultures were 
treated with 10 μM BAPTA-AM (a membrane permeable calcium chelator) for 24 
hours and then the culture medium was replaced with fresh medium without BAPTA-
AM. Control cultures did not receive any BAPTA-AM. After differentiation for 3 days, 
cells were fixed to check for expression of Sox1-GFP, a marker of NSCs. (A) 46C 
ESCs generated Sox1-GFP+ NSCs after differentiation for 3 days. (B) Following 
BAPTA-AM treatment, the generation of Sox1-GFP+ NSCs was restricted in 46C ESCs, 
suggesting that Ca2+ is required on the first day of differentiation for neural induction of 
mouse ESCs. All nuclei were stained with DAPI (blue). Scale bar, 20 μm.  
Abbreviations: BAPTA-AM, 1,2-Bis (2-aminophenoxy) ethane-N,N,N',N'-tetraacetic 
acid tetrakis (acetoxymethyl ester)  ; DAPI, 4',6-diamidino-2-phenylindole; ESC, 
embryonic stem cell; GFP, green fluorescent protein; NSCs, neural stem cells; Sox1, 
sex determining region Y-box 1. 
 
Because BAPTA-AM chelates both intracellular and extracellular Ca2+, 
the results described above could not determine which source of Ca2+ is 
important for neural induction. In order to solve this question, 46C ESCs 
were grown under monolayer differentiation conditions in the presence 
of EGTA to chelate the extracellular Ca2+ and determine whether 
extracellular Ca2+ was needed for neural induction. EGTA is a membrane 
impermeable calcium chelator and is used to bind extracellular Ca2+ 
(Artursson and Magnusson, 1990; Tsien et al., 1982). The Ca2+ 
concentration of solution containing EGTA can be calculated accurately 
using a special equation (Bers, 1982). Using this equation, I calculated 
that, under my differentiating condition, the addition of EGTA to a final 
concentration of 2 mM would chelate 99.9% of the Ca2+ within the 
differentiation medium.  46C ESCs were cultured in differentiating 
conditions for 3 days. On the first day, the cells were treated with 2 mM 
EGTA, in differentiation medium, for 24 hours, then the medium was 
replaced with fresh medium lacking EGTA and cultures were maintained 
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for a further 2 days.  The cells were then fixed to check for their ability 
to generate Sox1-GFP-expressing NSCs. Under these conditions 46C 
ESCs still generated Sox1-GFP expressing NSCs (Fig. 4.9). This 
indicates that extracellular Ca2+ is not necessary for the neural induction 
of mouse ESCs. As shown in Figure 4.8, the exposure of 46C cells to 
BAPTA-AM (chelates both intracellular and extracellular Ca2+) on the 
first day of differentiation reduced the expression of Sox1-GFP, but 
when 46C cells were exposed to EGTA (only chelates extracellular Ca2+) 
on the first day of differentiation, the generation of Sox1-GFP-
expressing cells was not inhibited. This suggests that calcium released 




Fig. 4.9. Extracellular Ca2+ removal does not inhibit neural development. 
46C ESCs were grown in monolayer culture and differentiated for 3 days. On the first 
day, experimental cultures were treated with 2 mM of EGTA (a membrane non-
permeable calcium chelator) for 24 hours, while control cultures did not receive any 
EGTA. Cultures were then maintained in differentiating conditions without EGTA for a 
further 2 days before being fixed to check for expression of Sox1-GFP, a marker of 
NSCs. (A) 46C ESCs generated Sox1-GFP+ NSCs after 3 days in differentiation 
medium. (B) Following EGTA treatment to chelate extracellular Ca2+, the generation of 
Sox1-GFP+ NSCs was preserved, suggesting that Ca2+ from internal stores is sufficient 
to activate neural induction of mouse ESCs. All nuclei were stained with DAPI (blue). 
Scale bar, 20 μm. 
Abbreviations: DAPI, 4',6-diamidino-2-phenylindole; EGTA, ethylene glycol 
tetraacetic acid; ER, endoplasmic reticulum; ES, embryonic stem; GFP, green 
fluorescent protein; NSCs, neural stem cells; Sox1, sex determining region Y-box 1. 
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4.2.5 Calcium release from the ER is necessary for neural induction 
of ESCs 
As shown above, an increase in [Ca2+]i is needed for neural induction of 
mouse ESCs. However, when a cell is in a basal state, the [Ca2+]i is kept 
low because Ca2+ is pumped into the ER, or pushed out of cells into the 
extracellular fluid (Clapham, 2007). The source of Ca2+ for increasing 
[Ca2+]i is either the extracellular fluid or the ER, or both. However, 
preventing the influx of Ca2+ from extracellular fluid by treating 46C 
ESCs with EGTA did not inhibit neural induction (see section 4.2.4), 
suggesting that the source of Ca2+ for neural induction may be the ER. In 
order to confirm this hypothesis, 46C ESCs were grown under 
differentiating conditions and treated with an inhibitor of IP3R or RyR. 
These receptors are located in the ER and it is through them that Ca2+ 
leaves the ER and enters the cytosol (see section 1.5.4.4). Thus inhibiting 
these receptors will block Ca2+ release from the ER, and if this inhibition 
blocks the generation of NSCs, then the source of cytosolic Ca2+ for 
neural induction is the ER. 
 
2-aminoethoxydiphenyl borate (2-APB) blocks Ca2+ release from the ER 
into the cytosol through inhibition of IP3R (Lang et al., 2007), and 
Dantrolene blocks Ca2+ release from the ER through inhibition of the 
RyR (Charles et al., 1993). Thus, both of these chemicals can be used to 
prevent an increase in [Ca2+]i by inhibiting its release from the ER and 
can therefore be used to test whether this is the source of Ca2+ used to 
generate the increase in [Ca2+]i required for neural induction.  
 
To decide the concentration of 2-APB and Dantrolene to be used in these 
experiments, 46C ESCs were cultured in differentiating conditions and 
were exposed to 150, 75, or 25 μM 2-APB or 200, 100, 50, or 25 μM 
Dantrolene for 24 hours. The highest concentration of 2-APB and 
Dantrolene used was found to cause cell death. Thus 75 μM 2-APB or 
100 μM Dantrolene was used in these experiments. On the first day of 
differentiation, ESCs were treated with 75 μM 2-APB or 100 μM 
Dantrolene for 24 hours, and then the medium was replaced with fresh 
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medium without 2-APB or Dantrolene. After differentiation for 3 days, 
cells were fixed to check for expression of Sox1-GFP. As shown in 
Figure 4.10, the generation of Sox1-GFP-expressing NSCs were 
inhibited by 2-APB or Dantrolene treatment, suggesting that Ca2+ 
released from the ER on the first day of differentiation is necessary for 
neural induction. I also treated 46C ESCs with 75 μM 2-APB plus 100 
μM Dantrolene for 24 hours, but this caused cell death, suggesting that 
inhibition of both RyR and IP3R together is too harsh and cells fail to 
survive under this condition. Maybe when the action of only one of these 
receptors is blocked, some Ca2+ still can be released form the ER through 
the un-blocked receptor but this is not enough to trigger neural induction 




Fig. 4.10. Inhibition of Ca2+ release from the ER blocks neural development. 
46C ESCs were grown in monolayer culture under differentiated conditions. On the 
first day, experimental cultures were treated with 75 μM 2-APB (an inhibitor of IP3R) 
or 100 μM Dantrolene (an inhibitor of RyR) for 24 hours, and then the culture medium 
was replaced with fresh one without 2-APB or Dantrolene, while control cells received 
no such treatments. After a further 2 days, cultures were fixed to check for the 
expression of Sox1-GFP, a marker of NSCs. (A) In the absence of inhibitors, 46C ESCs 
generated Sox1-GFP+ NSCs after differentiated for 3 days. (B,C) Following 2-APB or 
Dantrolene treatment, the generation of Sox1-GFP+ NSCs was inhibited in 46C ESCs. 
This suggests that the inhibition of calcium releasing from the ER through IP3R or RyR 
on the first day of differentiation blocked neural development. All nuclei were stained 
with DAPI (blue). Scale bar, 20 μm. 
Abbreviations: 2-APB, 2-aminoethoxydiphenyl borate; DAPI, 4',6-diamidino-2-
phenylindole; ER, endoplasmic reticulum; ESC, embryonic stem cell; GFP, green 
fluorescent protein; IP3R, Inositol 1,4,5-trisphosphate receptor; Nnatα-OE, Nnatα-
overexpression; NSCs, neural stem cells; RyR, ryanodine receptor; Sox1, sex 
determining region Y-box 1.  
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4.2.6 Nnat initiates neural induction via increasing [Ca2+]i  
As shown in Figure 4.6 and 4.7, exposure of Nnat-KD ESCs to Tg and 
BHQ rescued the ability of Nnat-KD cells to generate NSCs and 
subsequently neurons (see section 4.2.3). Furthermore, the treatment of 
Nnat-KD ESCs with Apt2a/SERCA inhibitors Tg and BHQ caused an 
increase in [Ca2+]i (see section 4.2.3.1). These data suggest that the 
Apt2a/SERCA inhibitor rescues the generation of neural cells from 
Nnat-KD ESCs via an increase in [Ca2+]i. If this is the case, then the 
membrane permeable calcium chelator, BAPTA-AM, should prevent the 
increase in [Ca2+]i in Tg treated Nnat-KD ESCs and inhibit the 
generation of NSCs.  
 
To test the above hypothesis, Nnat-KD ESCs were treated with 25 nM of 
Tg or 10 μM of BAPTA-AM alone or in combination for 30 minutes on 
the first day of differentiation, and then the medium was replaced with 
fresh medium without Tg and/or BAPTA-AM. After differentiation for 3 
days, the cells were fixed to check for expression of Sox1-GFP. Without 
BAPTA-AM treatment, the treatment of Nnat-KD ESCs with 25 nM of 
Tg for 30 minutes rescued the development of Sox1-GFP expressing 
NSCs (Fig. 4.11A-C). However, following BAPTA-AM treatment, Tg 
failed to rescue the ability of Nnat-KD ESCs to generate these cells  (Fig. 
4.11C-D). This confirms that Tg rescue is via the increase in [Ca2+]i of 




Fig. 4.11. BAPTA-AM prevents Tg rescuing the ability of Nnat-KD ESCs to generate 
NSCs.  
Nnat-KD ESCs were grown in monolayer culture under differentiation conditions. On 
the first day, experimental cultures were treated with 25nM Tg or 10 μM BAPTA-AM 
(a membrane permeable calcium chelator) for 30 minutes, and then the culture medium 
was replaced with fresh medium without Tg and/or BAPTA-AM while control cells 
received no such treatment. After a further 2 days, cultures were fixed to check for the 
expression of Sox1-GFP, a marker of NSCs. (A) Without or (B) with the BAPTA-AM 
treatment, Nnat-KD ESCs did not generate Sox1-GFP+ NSCs. (C) With the Tg 
treatment, Nnat-KD ESCs could generate Sox1-GFP+ NSCs. (D) When Tg treatment 
was carried out in the presence of BAPTA-AM, the generation of Sox1-GFP+ NSCs 
was prevented, suggesting that Tg rescued the generation of Sox1-GFP+ NSCs from 
Nnat-KD ESCs via an increase in [Ca2+]i. All nuclei were stained with DAPI (blue). 
Scale bar, 20 μm.  
Abbreviations: BAPTA-AM, 1,2-Bis (2-aminophenoxy) ethane-N,N,N',N'-tetraacetic 
acid tetrakis (acetoxymethyl ester)  ; DAPI, 4',6-diamidino-2-phenylindole; ESC, 
embryonic stem cell; GFP, green fluorescent protein; Nnat-KD, Nnat-knockdown; 





4.3.1 Summary of main findings 
In summary, my results indicate that Nnat physically interacts with 
Apt2a2/SERCA2 and causes an increase in [Ca2+]i. Furthermore, I reveal 
that Tg and BHQ, inhibitors of Atp2a/SERCA, mimic the action of Nnat to 
rescue the ability of Nnat-KD ESCs to generate neural cells. Using a 
membrane permeable calcium chelator (BAPTA-AM) to prevent an 
increase in [Ca2+]i, on the first day of differentiation, reduced the 
generation of NSCs from wild type mouse ESCs, and also abolished the 
Tg-restored neural induction in Nnat-KD ESCs. Thus, I have confirmed 
my theory that Nnat antagonises the action of Apt2a2/SERCA2, which in 
turn increases [Ca2+]i and leads to neural induction in mouse ESCs. 
 
4.3.2 Nnat physically interacts with Apt2a2/SERCA2 to increase 
[Ca2+]i and initiate neural induction of mouse ESCs 
Apt2a/SERCA is a Ca2+ ATPase pump that sits in the membrane of the ER 
and pumps cytosolic Ca2+ back to the ER to maintain a stable and low 
[Ca2+]i (Slusarski and Pelegri, 2007; Zhong and Inesi, 1998). Under this 
basal condition, the inhibition of Apt2a/SERCA induces an increase in 
[Ca2+]i (James et al., 1989; MacLennan and Kranias, 2003). There are 
three members of the Apt2a/SERCA gene family, Atp2a2/SERCA2 is 
expressed at much higher levels compared to Apt2a1/SERCA1 and 
Apt2a3/SERCA3 in mouse ESCs and during ESC neural differentiation 
(see section 1.7). My novel findings obtained from Co-IP and Duolink in-
situ PLA experiments revealed that Nnat physically interacts with 
Apt2a2/SERCA2 in mouse undifferentiated ES or differentiated cells (see 
section 4.2.1.2). I also found that over-expressing Nnat increased [Ca2+]i, 
whereas knocking down Nnat reduced [Ca2+]i (see section 4.2.2). My 
findings fit well with the idea that Nnat inhibits the action of 
Apt2a2/SERCA2, resulting in an increase in [Ca2+]i, which in turn leads to 
neural induction in ESCs. These findings were corroborated using blockers 
of Apt2a/SERCA, Tg and BHQ. Without the treatment of Nnat-KD ESCs 
with Tg or BHQ, Nnat-KD ESCs generated less neural cells compared 
with wild type ESCs. Treatment of Nnat-KD ESCs with Tg or BHQ 
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caused an increase in [Ca2+]i and recued the ability of Nnat-KD ESCs to 
generate neural cells (see section 4.2.3).  This suggests that the function of 
Nnat mimics that of the Apt2a/SERCA inhibitors. This rescue could be 
disrupted by the treatment of Tg treated Nnat-KD ESCs with a membrane 
permeable calcium chelator BAPTA-AM, suggesting the rescue is via an 
increase in [Ca2+]i (see section 4.2.6). These results show that Nnat acts to 
inhibit the action of Apt2a2/SERCA2 resulting in an increase in [Ca2+]i 
that initiates neural induction in mouse ESCs. Thus, the increase in [Ca2+]i 
is important for neural induction in mouse ESCs as well as in Xenopus.  
 
4.3.3 Nnat modulating [Ca2+]i plays a role in neurogenesis of NSCs 
Previously, Yu et al. (2008) had reported that the movement of 
intracellular Ca2+ is important in neurogenesis of mouse ESCs. In this 
report, ESCs isolated from the RyR2 null mouse embryo were employed to 
investigate the role of RyR2 in neuronal differentiation. As already 
mentioned, RyR is a Ca2+ channel located in the ER and upon activation 
RyR releases Ca2+ from the ER into the cytosol. In RyR2 null ESCs, the 
expression of the neuronal transcription factor NeuroD and generation of 
MAP2 positive neurons were reduced (Yu et al., 2008a). Although this 
report highlights the importance of Ca2+ release from the ER through RyR2 
during ESC neural differentiation, it does not show whether the observed 
reduction in neurogenesis is due to the inhibition of neural induction in 
ESCs or the inhibition of NSCs to generate NPCs and neurons. My 
experiments expand the observation made by Yu et al., by showing that 
Nnat modulates [Ca2+]i by regulating Apt2a2/SERCA2 and Nnat-
knockdown prevents neural induction of mouse ESCs (see section 3.2.4). 
Although an increase in cytosolic Ca2+ plays a pivotal role in neural 
induction of mouse ESCs, this does not rule out the possibility that Ca2+ 
release from the ER is also important in the neuronal generation from 
neural progenitors. In line with this, treatment of the developing neocortex 
(isolated from mouse embryos at 16 dpc) with Suramin (an ATP receptor 
antagonist) in vitro to suppress the generation of IP3 and reducing IP3-
mediated Ca2+ release from the ER, repressed the proliferation of radial 
glial cells (neural progenitors) in the ventricular zone (Weissman et al., 
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2004). The antiproliferative effect of Suramin could be rescued in the 
presence of PMT (a PLC activator) to induce the generation of IP3. Further, 
the treatment of radial glial cells with 2-APB, an inhibitor of IP3R, 
disrupted the proliferation of these neural progenitors, while treatment 
with the extracellular calcium chelator EGTA (2mM) had no effects. 
These results suggests that the Ca2+ released from the ER, resulting in an 
increase in [Ca2+]i, is also important in the proliferation of NPCs 
(Weissman et al., 2004).  
 
In addition to neural induction, Nnat, by regulating [Ca2+]i, may also play a 
role in controlling the generation of NPCs and neurons from NSCs. As 
shown in section 4.2.3, when [Ca2+]i of Nnat-KD ESCs is increased by 
exposure to Tg, on the first day of the differentiation process, Nnat-KD 
ESCs generate similar numbers of NSCs as wild type ESCs. Thus, one 
might presume that similar numbers of neurons would be generated under 
these conditions, if Nnat regulation of [Ca2+]i was not needed during 
neurogenesis. However, these Tg-treated Nnat-KD ESCs generated less 
neuron than their wild type counterparts (see Fig. 4.7E). Therefore, the 
assumption that Nnat regulation of [Ca2+]i was not needed during 
neurogenesis appeared not to be correct. In order to prove this, Tg could be 
administered to Nnat-KD ESCs not only on the first day of differentiation, 
but also at the sixth day of differentiation after the formation of NSCs. If 
Tg treatment after the formation of NSCs can increase the generation of 
neurons, this will indicate that the regulation of [Ca2+]i by Nnat also plays 
a role in neurogenesis.    
 
4.3.4 Ca2+ releasing from the ER is crucial for neural induction of 
mouse ESCs 
As discussed in section 1.5.4.4, the source of cytosolic Ca2+ in cells is 
either from the extracellular fluid through the calcium channels in the 
plasma membrane or from the ER through IP3R or RyR. As shown in 
section 4.2.4 and 4.2.5, an increase in [Ca2+]i was required on the first day 
of differentiation for the neural induction of mouse ESCs, and when this 
Ca2+ release from the ER was blocked in wild type ESCs using antagonist 
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of IP3R or RyR, the generation of NSCs was reduced. In contrast, 
removing extracellular Ca2+ on the first day of differentiation of mouse 
ESCs, using EGTA, did not inhibit the generation of NSCs. Thus, the 
source of cytosolic Ca2+ required for neural induction is from the ER. In 
Xenopus embryos, neural induction was suppressed when embryos were 
cultured with an L-type calcium channel blocker, R(+)BayK, to inhibit 
Ca2+ influx from extracellular fluids into the cytosol through the L-type 
calcium channels in the plasma membrane (see section 1.5.4.2). At present, 
there is no data suggesting that Ca2+ release from the ER is required for 
neural induction in Xenopus embryos. However, from my studies it 
appears that extracellular Ca2+ is not as important for neural induction in 
mouse ESCs as it is in Xenopus embryos.   
 
4.3.5 How cytosolic Ca2+ elevation initiates neural induction in mouse 
ESCs 
When a membrane permeable calcium chelator BAPTA-AM was added 
into the culture medium to reduce the concentration of free Ca2+ in the 
cytosol of mouse ESCs, cultures failed to generation NSCs (see section 
4.2.4). In contrast, if a specific Apt2a/SERCA inhibitor Tg was added into 
the culture medium to increase [Ca2+]i of Nnat-KD ESCs, the ability to 
generate NSCs was restored (see section 4.2.3). Therefore, an increase in 
cytosolic Ca2+ is pivotal for neural induction of mouse ESCs. It has been 
demonstrated that an increase in [Ca2+]i by treatment with Tg activates Ras 
through the exchange of bound GDP for GTP, and this in turn activates 
Erk1/2 (see section 1.5.4.3; Agell et al., 2002; Ebinu et al., 1998; Kupzig 
et al., 2005). Since the activation of Erk signalling is required for neural 
induction in mouse ESCs (see section 1.5.1), it is possible that the 
treatment of Nnat-KD ESCs with Tg rescues the ability of Nnat-KD ESCs 
to generate neural cells via the activation of Erk signalling. The interaction 
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5.0 Nnat promotes neural induction in mouse ESCs by increasing positive 
signalling and attenuating negative signalling  
5.1 Introduction 
During Xenopus gastrulation, FGF/Erk signalling is active in the forming 
neural plate (Christen and Slack, 1999), and the injection of Fgf8 mRNA 
into Xenopus embryos in order to activate Erk signalling has been shown to 
induce the generation of ectopic neural tissue (Pera et al., 2003). Similarly 
the implantation of FGF4 soaked beads into the embryonic ectoderm of 
chick embryos induced the formation of ectopic neural tissue (Rodriguez-
Gallardo et al., 1997). Conversely culturing Xenopus embryos with the 
FGFR inhibitor (SU5402) suppressed neural plate formation (Delaune et al., 
2005), and the expression of the neural plate makers ERNI and Sox3 were 
suppressed when SU5402 soaked beads were implanted into the prospective 
neural plate of chick embryos (Streit et al., 2000). Thus, these results 
suggested that FGF/Erk signalling is required for neural induction in 
Xenopus and chick embryos (see section 1.5.1).  
 
In addition to FGF/Erk signalling, BMP signalling also plays an important 
role in neural induction, but the action of BMP is opposite to that of 
FGF/Erk in that BMP is a negative cue (details see sections 1.2 and 1.4). 
During gastrulation, the organiser region of Xenopus embryos secrets BMP 
antagonists, such as Noggin, Chordin, and Follistatin, to induce the neural 
specification of dorsal ectoderm (Hemmati-Brivanlou et al., 1994; Sasai et 
al., 1994; Smith and Harland, 1992), and the injection of Noggin, Chordin or 
Follistatin mRNAs into Xenopus embryos induced the generation of a 
second neural axis and expanded neural tissue (Iemura et al., 1998; Pera et 
al., 2003; Piccolo et al., 1996; Sasai et al., 1994). These results imply that 
inhibition of BMP signalling induces neural induction in Xenopus embryos. 
Further, similar observations have also been found in other vertebrates (see 
section 1.4; Di-Gregorio et al., 2007; Wilson et al., 2000). 
 
As discussed, both FGF/Erk and BMP signallings play pivotal roles in 
neural induction, and data reveals that there is crosstalk between these two 
pathways (details see section 1.5.1.4; Kuroda et al., 2005; Pera et al., 2003). 
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The activation of BMP signalling caused the phosphorylation of Smad1 at 
the C-terminus (Massague and Chen, 2000), enabling the C-ter-p-Smad1 to 
activate target genes and inhibit neural induction in Xenopus embryos (Pera 
et al., 2003; Phippard et al., 1996; Suzuki et al., 1997). However, the 
activation of FGF/Erk signalling induced phosphorylation of Smad1 at the 
linker region, inhibiting the action of C-ter-p-Smad1 and promoting neural 
specification (Kuroda et al., 2005; Pera et al., 2003). This finding suggested 
that the ability of BMP signalling to block neural induction in Xenopus was 
repressed by the activation of FGF/Erk signalling, but these experiments did 
not exclude the possibility that FGF/Erk signalling also provided an 
instructive cue to induce neural induction. For example, the injection of 
Smad7 mRNA into Xenopus embryos to inhibit BMP signalling induced 
ectopic neural tissue, and this ectopic neural induction was enhanced by the 
activation of FGF signalling (Wawersik et al., 2005). This finding implies 
that FGF signalling not only acts by inhibiting BMP signalling, but also 
provides an instructive signal to the ectoderm of Xenopus to develop along a 
neural pathway (Aruga and Mikoshiba, 2011).  
 
In this chapter, I will show that Nnat affects both pathways to facilitate 
neural induction of mouse ESCs. As shown in Chapter 3 and 4, Nnat is 
required for the neural induction of mouse ESCs, and this is brought about 
by Nnat’s ability to increase [Ca2+]i by regulating Atp2a/SERCA. Here, I 
will demonstrate that an increase in [Ca2+]i activates FGF/Erk signalling, and 
may also down-regulate the expression of BMP4, thus initiating  neural 
induction.   
 
Specifically, this chapter describes experiments that show: 
1) How FGF/Erk signalling is needed in the neural induction of mouse 
ESCs 
2) An increase in [Ca2+]i by a specific Atp2a/SERCA inhibitor Tg 
activates FGF/Erk signalling, and the activation of FGF/Erk signalling 
restores the generation of neural cells from Nnat-KD ESCs 
3) Activation of BMP signalling inhibits neural induction of mouse ESCs 
4) Nnat may down-regulate the expression of BMP4  
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5.2 Results 
5.2.1 The inhibition of FGF/Erk signalling prevents ESCs from 
undergoing neural induction 
To test the requirement of FGF/Erk signalling in the neural induction of 
mouse ESCs, 46C ESCs were grown under monolayer differentiation 
conditions in the presence of PD173074 (a FGFR inhibitor), or PD184352 
(a MEK inhibitor) to block FGF/Erk signalling. If FGF/Erk signalling is 
necessary for mouse ESCs to differentiate along a neural pathway, the 
generation of NSCs from 46C ESCs should be inhibited by the presence of 
FGFR or MEK inhibitors.  
 
To carry out experiments in this Chapter, I established the differentiation 
paradigm represented in Fig. 5.1. ESCs were plated on gelatin-coated 
coverslips and cultured in non-differentiating condition for 24 hours to let 
ESCs adhere to the coverslips, and then the medium was switched to 
differentiation medium. As shown in section 3.2.1, Sox1-GFP-expressing 
neuroectodermal cells developed when wild type ESCs were grown in this 
differentiation conditions for two days. This suggests that the first 2 days 
of differentiation represent a crucial time window for neural induction of 
mouse ESCs. Thus, the ESCs were treated with PD173074 or PD184352 
for the first 2 days (in experiments described later in this chapter 
treatments with growth factors were similarly carried out, see Fig. 5.1). 
The medium was then replaced with fresh medium lacking PD173074 or 
PD184352 and the cells cultured for a further 4 days.  The cells were then 
fixed to check for their ability to generate Sox1-GFP and Nestin-




Fig. 5.1. Treatment with growth factors or inhibitors during ESCs neural differentiation. 
ESCs were plated and adhered to gelatin-coated coverslips in non-differenitating 
conditions. At D0, culture medium was changed to differentiating medium. On D2, wild 
type ESCs generated Sox1-GFP+ neuroectodermal cells, suggesting that the first 2 days of 
differentiation represent a crucial time window for neural induction of mouse ESCs. Thus 
ESCs were treated with FGF4, FGF5, BMP4, PD173074 (an inhibitor of FGFR) or 
PD184352 (an inhibitor of MEK) on the first 2 days, and then the medium was replaced 
with fresh medium lacking growth factors or inhibitors and the cells cultured for a further 
4 days. On D6, cultures were fixed for immunocytochemical analysis to check for 
expression of the NSC marker Nestin. 
Abbreviations: BMP, Bone morphogenetic protein; D, differentiation day; ESC, 
embryonic stem cell; FGF, Fibroblast growth factor; FGFR, FGF receptor; GFP, green 
fluorescent protein; MEK, Mitogen-activated Protein/Extracellular Signal-regulated 
Kinase Kinase; NSC, neural stem cell; Sox1, SRY (sex determining region Y)-box 1. 
 
PD173074 and PD184352 are selective inhibitors of FGFR kinase and 
MEK activity respectively, and both reduce the phosphorylation of Erk1/2 
and suppress Erk signalling (Grand et al., 2004; Yao et al., 2003). 100 
ng/ml PD173074 can inhibit Erk1/2 phosphorylation in 46C ESCs 
(Stavridis et al., 2007), and the same ESCs were used in my experiments, 
so the same concentration of this inhibitor was used here. To determine the 
concentration of PD184352 to use, 46C ESCs were treated with different 
concentrations under differentiating conditions. 10, 5, and 1 μM 
PD184352 were applied to the cells for 2 days as shown in Figure 5.1; 10 
μM PD184352 caused severe cell death. However, treating 46C ESCs with 
5 ng/ml of FGF4 and 5 μM PD184352 together, showed that the FGF4-
induced phosphorylation of Erk1/2 was inhibited by PD184352 (as 
assayed by Western blotting, Appendix 5). Thus, 5 μM PD184352 was 
used in my experiments to inhibit the activation of Erk1/2.  
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46C ESCs were grown under differentiation conditions (see section 3.2.1 
for details) for six days and 100 ng/ml PD173074 or 5 μM PD184352 was 
added into the culture medium for the first two days.  After 6 days of 
differentiation, 46C cells were fixed and analysed for expression of NSC 
markers, Sox1-GFP and Nestin. As expected (see sections 3.2.1 and 3.2.3), 
wild type ESCs generated many Sox1-GFP and Nestin-expressing NSCs 
(Fig. 5.2A). However, few, if any, of Sox1-GFP and Nestin-expressing 
NSCs were observed when 46C cells were exposed to PD173074 or 
PD184352 for the first two days of differentiation. Thus, the activation of 
FGF/Erk signalling is needed for the neural induction of mouse ESCs. 
 
 
Fig. 5.2. The activation of FGF/Erk signalling is required for neural induction of mouse 
ESCs.  
46C ESCs were differentiated for 6 days. Cells were exposed to 100 ng/ml PD173074 (an 
inhibitor of FGFR) or 5 μM PD184352 (an inhibitor of MEK) for the first two days of 
differentiation to inhibit the FGF/Erk signalling. After six days of differentiation, 46C 
cells were fixed and analysed for expression of the NSC markers, Sox1-GFP and Nestin. 
(A) 46C ESCs generated Sox1-GFP+ (green) and Nestin+ (red) NSCs. (B, C) Only a few 
Sox1-GFP+ and Nestin+ NSCs were observed when 46C cells were exposed to PD173074 
or PD184352 for the first two days of differentiation. Thus, the activation of FGF/Erk 
signalling is needed for the neural induction of mouse ESCs. All nuclei were stained with 
DAPI (blue). Scale bar, 20 μm 
Abbreviations: DAPI, 4',6-diamidino-2-phenylindole; Erk, Extracellular Signal-regulated 
Kinase; ESC, embryonic stem cell; FGF, Fibroblast growth factor; FGFR, FGF receptor; 
GFP, green fluorescent protein; MEK, Mitogen-activated Protein/Extracellular Signal-




5.2.2 FGF4 and FGF5 rescue the ability of Nnat-KD ESCs to generate 
NSCs and neurons  
If Nnat functions by increasing [Ca2+]i that in turn activates FGF/Erk 
signalling to initiate neural induction, then directly activating FGF/Erk 
signalling should bypass the need to increase [Ca2+]i and restore the ability 
of Nnat-KD ESCs to generate NSCs and neurons. 5 ng/ml of FGF4 or 10 
ng/ml of FGF5 has been used to activate FGF/Erk signalling in the same 
mouse ESCs used in my experiments (Kunath et al., 2007). Therefore, to 
test whether or not activation of FGF/Erk signalling restored the ability of 
Nnat-KD ESCs to generate NSCs, 5 ng/ml of FGF4 or 10 ng/ml of FGF5 
was used to treat Nnat-KD ESCs over the first 2 days of differentiation 
(Fig. 5.1). Cells were fixed after 6 days of differentiation for 
immunocytochemical analysis. As shown in section 3.2.4.2, Nnat 
knocked-down in 46C ESCs significantly reduced the formation of NSCs 
(Fig. 5.3A-B). Treatment with FGF4 or FGF5 restored the ability of Nnat-
KD ESCs to generate Sox1-GFP+/Nestin+ NSCs (Fig. 5.3C-D). 
Quantification of these results revealed that the generation of 
Nestin+/Sox1-GFP+ NSCs in Nnat-KD ESCs was significantly increased 
from 5.6% to 14.4% and 15.6% after FGF4 or FGF5 treatment for the first 
two days of differentiation respectively (n = 3, p < 0.05, Fig. 5.3E). These 
results suggest that activating FGF signalling restores the ability of Nnat-




Fig. 5.3. FGF4 and FGF5 restore the ability of Nnat-KD ESCs to generate NSCs   
46C or Nnat-KD ESCs were differentiated for 6 days. On the first two days of 
differentiation, Nnat-KD ESCs were exposed to 5 ng/ml of FGF4 or 10 ng/ml of FGF5. 
After differentiation for 6 days, the cells were fixed and stained with the NSC marker 
Nestin (red). (A) 46C ESCs could generate Sox1/GFP+ and Nestin+ NSCs after 
differentiation for 6 days. (B) The generation of Nestin+ NSCs was reduced in Nnat-KD 
ESCs. (C) With 5 ng/ml of FGF4 treatment or (D) 10 ng/ml of FGF5 treatment, the ability 
of Nnat-KD ESCs to generate Sox1/GFP+ and Nestin+ NSCs was restored. (E) The 
percentage of both Sox1-GFP and Nestin-expressing NSCs was counted. Nnat-KD cells 
generated significantly fewer NSCs than 46C ESCs (5.6 ± 1.5% vs. 18.7 ± 2.6%, p < 0.05, 
two-tailed Student’s t test), and the generation of NSCs in Nnat-KD ESCs was 
significantly increased to 14.4 ± 1.9% and 15.6 ± 2.1% after FGF4 or FGF5 treatment 
respectively (n = 3, p < 0.05, two-tailed Student’s t test). There was no significant 
difference in the percentage of NSC generated between 46C and FGF4 or FGF5 treated 
Nnat-KD ESCs. All nuclei were stained with DAPI (blue).  Scale bar, 20 μm. 
Abbreviations: DAPI, 4',6-diamidino-2-phenylindole; ESC, embryonic stem cell; FGF, 
Fibroblast growth factor; GFP, green fluorescent protein; Nnat-KD, Nnat-knockdown; 
NSC, neural stem cell; Sox1, SRY (sex determining region Y)-box 1. 
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To determine whether FGF4- or FGF5-restored Sox1-GFP+/Nestin+ NSCs 
can give rise to neurons, the same experimental procedures were carried 
out as described above, but now the cultures were allowed to differentiate 
for 14 days to enable the generation of neurons. As shown in section 3.2.4, 
Nnat knock-down in 46C ESCs significantly reduced the formation of 
neurons (Fig. 5.4A-B). The exposure of Nnat-KD cells to 5 ng/ml of FGF4 
or 10 ng/ml of FGF5 for the first two days of differentiation restored the 
ability of these cells to generate NeuN-expressing neurons (Fig. 5.4C-D). 
Quantified data revealed that the generation of NeuN-expressing neurons 
from Nnat-KD ESCs was significantly increased after FGF4 or FGF5 
treatment from 2.4% to 12.2% or 11.8% (n = 3, p < 0.05) (Fig. 5.4E), but 
not to the levels seen in differentiated wild type 46C ESCs (23.1%, n = 3, 
p < 0.05). The difference observed between 46C and Nnat-KD ESCs may 
be due to the fact that the cells were only treated with FGF4 or FGF5 for 
the first two days of differentiation (at a time when ESCs are generating 
NSCs, see section 3.2.1) and not during the time when these cells go on to 
differentiate into NPCs and neurons. This could suggest that FGF4 or 
FGF5 only compensates for the early action of Nnat in neural induction 
(the first 2 days of differentiation), because of the time period of FGF 
treatments. However, the in vivo and in vitro expression patterns of Nnat 
reveal that this protein is still highly expressed after the neuroectoderm is 
formed (see section 1.7), suggesting that Nnat may be still required when 




Fig. 5.4. FGF4 and FGF5 restore the ability of Nnat-KD ESCs to generate neurons. 
46C or Nnat-KD ESCs were differentiated for 14 days. On the first two days of 
differentiation, Nnat-KD ESCs were exposed to 5 ng/ml of FGF4 or 10 ng/ml of FGF5. 
After differentiated for 14 days, the cells were fixed and stained with the nuclear neuronal 
marker NeuN (red). (A) 46C ESCs generated NeuN+ neurons after 14 days of 
differentiation. (B) The generation of NeuN+ neurons was significantly decreased in Nnat-
KD ESCs. (C) With 5 ng/ml of FGF4 treatment or (D) 10 ng/ml of FGF5 treatment, the 
ability of Nnat-KD ESCs to generate NeuN+ neurons was restored. (E) The percentage of 
NeuN+ neurons was counted. Nnat-KD cells generated significantly fewer neurons than 
46C ESCs (2.4 ± 1.2% vs. 23.1 ± 2.3%, p < 0.01, two-tailed Student’s t test). The 
generation of neurons in Nnat-KD ESCs was significantly increased to 12.2 ± 1.9% and 
11.8 ± 2.1% after FGF4 or FGF5 treatment respectively (n = 3, p < 0.05, two-tailed 
Student’s t test), but could not reach the level of 46C ESCs (p < 0.05, two-tailed Student’s 
t test). All nuclei were stained with DAPI (blue).  Scale bar, 20 μm. 
Abbreviations:  DAPI, 4',6-diamidino-2-phenylindole; ESC, embryonic stem cell; FGF, 




5.2.3 Blocking p-Erk signalling abolished Tg-restored the capacity of 
neural specification in Nnat-KD ESCs  
As shown in sections 5.2.1 and 5.2.2, the FGF/Erk pathway plays a crucial 
role in neural induction in wild type ESCs and also rescues the impairment 
in neural cell production of Nnat-KD ESCs. Next, I wanted to establish 
whether the FGF/Erk pathway is involved in Tg-restored neural 
specification in Nnat-KD ESCs. To do this, Nnat-KD ESCs were first 
treated with 25 nM Tg for 30 minutes on the first day of differentiation to 
restore the ability of these cells to generate NSCs (as described previously 
in section 4.2.3). Then, to test whether or not this restored ability to 
generate NSCs was reduced by the inhibition of FGF/Erk signalling, the 
Tg-treated Nnat-KD ESCs were also exposed to 100 ng/ml PD173074 or 5 
μM PD184352 for the first 2 days of differentiation. As expected (see 
section 4.2.3.2), after 6 days of differentiation, Tg restored the ability of 
Nnat-KD ESCs to generate Sox1-GFP and Nestin-expressing NSCs cells 
(Fig. 5.5A-B). However, this ability was dramatically reduced when 
FGF/Erk signalling was suppressed by addition of PD173074 or 
PD184352 (Fig. 5.5C-D). Therefore, the FGF/Erk pathway is involved in 




Fig. 5.5. The inhibition of FGF/Erk signalling restricts the ability of Tg to rescue the 
generation of NSCs from Nnat-KD ESCs.  
Nnat-KD ESCs were differentiated for 6 days. On the first day of differentiation, cells 
were treated with 25 nM Tg (an inhibitor of Apt2a/SERCA) for 30 minutes to restore 
their ability to generate NSCs. Cells were also exposed to 100 ng/ml PD173074 (an 
inhibitor of FGFR) or 5 μM PD184352 (an inhibitor of MEK) for the first two days of 
differentiation to inhibit FGF/Erk signalling. After six days of differentiation, Nnat-KD 
cells were fixed and analysed for expression of the NSC markers, Sox1-GFP and Nestin. 
(A, B) Tg rescued the ability of Nnat-KD ESCs to generate Sox1-GFP+ (green) and 
Nestin+ (red) NSCs. (C, D) Only a few Sox1-GFP+ and Nestin+ NSCs were observed 
when Tg-treated Nnat-KD cells were exposed to PD173074 or PD184352 for the first two 
days of differentiation. Thus, the activation of FGF/Erk signalling is required for the Tg 
rescue of Nnat-KD ESCs to generate NSCs. All nuclei were stained with DAPI (blue). 
Scale bar, 20 μm. 
Abbreviations: Apt2a/SERCA, sarcoendoplasmic reticulum Ca2+-ATPase; DAPI, 4',6-
diamidino-2-phenylindole; Erk, Extracellular Signal-regulated Kinase; ESC, embryonic 
stem cell; FGF, Fibroblast growth factor; FGFR, FGF receptor; GFP, green fluorescent 
protein; MEK, Mitogen-activated Protein/Extracellular Signal-regulated Kinase Kinase; 
Nnat-KD, Nnat-knockdown; NSC, neural stem cell; Sox1, SRY (sex determining region 
Y)-box 1; Tg, Thapsigargin. 
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5.2.4 Increasing [Ca2+]i activates Erk signalling    
I have shown above that Erk signalling is involved in the Tg-restored 
neural induction in Nnat-KD ESCs. The next question I would like to find 
out is whether the increase in [Ca2+]i caused by the treatment of Nnat-KD 
ESCs with Tg (pivotal for restoring NSC development, see section 4.2.3.2) 
triggers the activation of Erk signalling. To answer this question, I 
employed Western blotting to analyse whether Erk1/2 were activated by 
Tg treatment in Nnat-KD ESCs. First, I established the effect of different 
concentrations of Tg on the p-Erk1/2 levels. To this end, Nnat-KD ESCs 
were plated out onto gelatin-coated plates in non-differentiating conditions 
and the next day 25, 100, or 1000 nM Tg was added into the culture 
medium for 5 minutes before cells were immediately collected and lysates 
prepared for analysis. The cell lysates were run on a gel, transferred to a 
nitrocellulose membrane and the membrane blotted with anti-p-Erk1/2 
antibodies (for details of Western blotting see section 2.7). If treatment of 
Nnat-KD ESCs with Tg activates Erk signalling, then the active form of 
Erk1/2, p-Erk1/2, should be increased. In Figure 5.6A, p-Erk1/2 was 
increased in cultures treated with all three concentrations of Tg, with a Tg 
concentration as low as 25 nM being sufficient to activate Erk signalling in 
Nnat-KD ESCs. This may explain why 25 nM Tg can rescue the defective 
neural induction in Nnat-KD ESCs. Further, to determine when the peak of 
p-Erk activity was observed, Nnat-KD ESCs samples were collected after 
5, 10, 20, and 60 minutes of 25 nM Tg treatments. The results showed that 
the activation of Erk1/2 peaked at 10 minutes and declined thereafter (Fig. 
5.6B). Therefore, from experiments described in section 4.2.3.2 and above, 
I hypothesise that Tg causes an increase in [Ca2+]i which then activates 
Erk1/2; so it is likely that Nnat has a similar function, as we know that Tg 
imitates the action of Nnat (see section 4.2.3).  
 
Thus, my data suggests that Tg increases [Ca2+]i, which leads to the 
activation of Erk signalling that then mediates neural induction in Nnat-
KD ESCs. There is a question as to whether Tg activates Erk signalling at 
the level of FGFRs, which are upstream elements of the Erk pathway. To 
answer this question, I adopted a biochemical approach together with 
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Western blotting. Prior to treatment with Tg, Nnat-KD ESCs were treated 
with the FGFR inhibitor PD173074 (100 ng/ml for 2 hours), and then 
Nnat-KD ESCs were cultured with 25 nM Tg and PD173074 for 10 
minutes together. After treatment, Nnat-KD ESCs were collected and the 
level of p-Erk1/2 analysed using immunoblotting (Fig. 5.6C). The level of 
p-Erk1/2 observed in Lane 1, represents basal activity under 
undifferenitating conditions without Tg or PD173074 treatments. As 
expected, p-Erk1/2 was increased after Tg treatment (Fig. 5.6C, compare 
lane 1 with lane 2), and was decreased by the treatment of PD173074 (Fig. 
5.6C, compare lane 1 with lane 3). This result suggested that as well as 
FGF, other signals also activated Erk1/2 in mouse ESCs. For example, 
EGFR (epidermal growth factor receptor) is expressed by the ICM in 
mouse and is active throughout preimplantation and gastrulation 
(Adamson, 1990; Brison and Schultz, 1996), so EGFR may also be active 
in mouse ESCs. Like FGFR, EGFR is also a receptor tyrosine kinase (RTK) 
that activates the Erk1/2 pathway (Xia et al., 2002). Thus, EGF/Erk may 
be active in mouse ESCs. Similarly, PDGFR (platelet-derived growth 
factor receptor) is another RTK that has also been shown to be active in 
the ICM of vertebrates (Artus et al., 2010; Karpova et al., 1997; Osterlund 
et al., 1996), suggesting that Erk1/2 may also be phosphorylated by the 
activation of PDGFR in mouse ESCs.  
 
When FGFR were inhibited by PD173074, p-Erk1/2 was still increased by 
treatment with Tg (Fig. 5.6C, compare lane 3 with lane 4). These 
observations suggest that FGF/Erk signalling and Tg-mediated Erk 
signalling represent two different pathways that converge at the level of 
Erk1/2. It has previously been demonstrated in Hela, human mesenchymal 
stem, and Jurkat T-cells that an increase in [Ca2+]i caused by Tg 
administration activates RasGRP, which in turn activates Ras and 
Raf/MEK/Erk protein kinase cascade (for details see section 1.5.4.3) 
(Denys et al., 2004; Kupzig et al., 2005; Riddle et al., 2006). Therefore my 
results are consistent with this observation that Tg-mediated Erk signalling 




Fig. 5.6. FGFR is not involved in the activation of Tg-mediated Erk signalling.  
Nnat-KD ESCs were cultured in non differentiating culture conditions. After different 
treatments, the protein levels of p-Erk1/2 were analysed by Western blotting using an 
anti-p-Erk1/2 antibody. (A) After Nnat-KD ESCs were exposed to 25, 100, or 1000 nM 
Tg for five minutes, the levels of  p-Erk/12 were increased in all conditions. (B) Nnat-KD 
ESCs were treated with 25 nM Tg for 5, 10, 20, and 60 minutes to activate Erk1/2. The 
activation of Erk1/2 peaked at 10 minutes and declined thereafter. (C) To verify whether 
FGFR was involved in the activation of Tg-mediated Erk signalling, Nnat-KD ESCs were 
treated with the FGFR inhibitor (100 ng/ml PD173074) for 2 hours first followed by a 10 
min treatment with 25 nM Tg to activate Erk1/2 in the presence of PD173074. Lane 1 
shows the basal level of p-Erk1/2 under culture condition without Tg or PD173074. As 
expected, p-Erk1/2 was increased by treatment with Tg (compare lane 1 with lane 2), and 
p-Erk1/2 was decreased by the treatment of PD173074 (compare lane 1 with lane 3). 
When Nnat-KD ESCs were treated with PD173074 and Tg together, p-Erk1/2 was still 
increased by treatment with Tg (compare lane 3 with lane 4), suggesting that the FGFR is 
not involved in the activation of Tg-mediated Erk signalling. 
Abbreviations: Erk, Extracellular Signal-regulated Kinase; ESC, embryonic stem cell; 
FGFR, Fibroblast growth factor receptor; Nnat-KD, Nnat-knockdown; p-Erk1/2, 
phosphorylated Erk1/2; Tg, Thapsigargin.    
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As shown in Chapter 4, Nnat acts to inhibit the movement of cytosolic 
Ca2+ into the ER by antagonising Apt2a/SERCA, which then causes an 
increase in [Ca2+]i. This action of Nnat resembles that of Tg, a specific 
blocker of Apt2a/SERCA. As shown in Figure 5.6, the treatment of Nnat-
KD ESCs with Tg increases p-Erk1/2, and the Tg-mediated 
phosphorylation of Erk1/2 is not abrogated by exposure to the FGFR 
inhibitor PD173074. These results suggest that Tg is not acting at the level 
of FGFRs to cause the phosphorylation of Erk1/2. I propose that Nnat may 
act in the same manner to activate Erk signalling and initiate neural 
induction in mouse ESCs.  
 
46C and Nnatα-OE ESCs were cultured in the presence or absence of 100 
ng/ml PD173074 or 5 μM PD184352 for the first two days (Fig. 5.1). Cell 
samples were collected after 6 days of differentiation, and cells were 
analysed for Sox1-GFP and Nestin-expressing NSCs. 46C and Nnatα-OE 
ESCs generated NSCs as usual after 6 days of differentiation (Fig. 5.7A 
and D). As shown in section 5.2.1, the generation of NSCs was reduced in 
the PD173074 treated 46C ESCs (Fig. 5.7B). Interestingly, NSCs were 
still generated from the PD173074 treated Nnatα-OE ESCs (Fig. 5.7E), but 
the number of NSCs generated by these cells were fewer that were 
generated by untreated Nnatα-OE ESCs (Fig. 5.7, compare D with E). This 
result suggests that FGFs that are secreted from ESCs and act in an 
autocrine or paracrine manner also play a part in the neural induction of 
Nnatα-OE ESCs. Although PD173074 treatment reduced the generation of 
NSCs in both Nnatα-OE and wild type ESCs, the reduction was more 
severe in wild type compared with Nnatα-OE ESCs (Fig. 5.7, compare B 
with E), suggesting that the over-expression of Nnatα partially 
compensates for the loss of activation of FGFRs during neural induction. 
The treatment of Nnatα-OE ESCs with the MEK inhibitor PD184352 to 
inhibit the activation of Erk1/2 almost abolished the production of NSCs 
(Fig. 5.7F). Similarly results were observed for PD184352 treated 46C 
ESCs (Fig. 5.7C). This data suggest that Nnat-mediated neural induction 
occurs via the activation of Erk signalling.  
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Fig. 5.7. The activation of Erk signalling plays a crucial role in Nnat-mediated neural 
induction.  
46C and Nnatα-OE ESCs were differentiated for six days. Cells were exposed to 100 
ng/ml PD173074 (an inhibitor of FGFR) or 5 μM PD184352 (an inhibitor of MEK) for 
the first two days of differentiation to inhibit the FGF/Erk signalling. After six days of 
differentiation, 46C and Nnatα-OE cells were fixed and analysed for expression of the 
NSC markers, Sox1-GFP and Nestin. (A,D) Nnatα-OE ESCs generated more Sox1-GFP+ 
(green) and Nestin+ (red) NSCs than 46C ESCs. (B) The treatment of 46C ESCs with 
PD173074 significantly reduced the generation of NSCs, suggesting that the endogenous 
FGF is pivotal for neural induction in wild type ESCs. (E) However, some NSCs were 
still generated when Nnatα-OE cells were exposed to PD173074 for the first two days of 
differentiation, suggesting that the over-expression of Nnatα partially compensates the 
generation of NSCs for loss of action of endogenous FGF during neural induction, and the 
FGFR is not involved in the Nnat-mediated neural induction. (C,F) When 46C or Nnatα-
OE cells were exposed to PD184352 for the first two days of differentiation, very few 
NSCs were observed. Therefore the activation of Erk1/2 dose play a crucial role in both 
FGF and Nnat-mediated neural induction. All nuclei were stained with DAPI (blue). 
Scale bar, 20 μm. 
Abbreviations: DAPI, 4',6-diamidino-2-phenylindole; Erk, Extracellular Signal-regulated 
Kinase; ESC, embryonic stem cell; FGF, Fibroblast growth factor; FGFR, FGF receptor; 
GFP, green fluorescent protein; MEK, Mitogen-activated Protein/Extracellular Signal-
regulated Kinase Kinase; Nnatα-OE, Nnatα-overexpression; NSC, neural stem cell; Sox1, 
SRY (sex determining region Y)-box 1. 
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5.2.5 The activation of BMP signalling prevents ESCs differentiating 
along a neural pathway 
As BMP signalling suppresses neural induction in vertebrates, it is likely 
that neural induction in mouse ESCs will be inhibited by activating BMP 
signalling (see sections 1.4 and 1.6.2). I adopted an immunocytochemical 
analysis to explore the effects of BMP signalling on neural induction in 
46C, Nnat-KD, and Nnatα-OE ESCs. 46C, Nnat-KD, and Nnatα-OE ESCs 
were differentiated for six days, with the Nnat-KD ESCs being treated 
with 25 nM Tg for 30 minutes on the first day to restore their ability to 
generate NSCs (see section 4.2.3). In 46C ESCs, 10 ng/ml of BMP4 
activates BMPR causing phosphorylation of Smad1 at its C-terminus to 
activate dowstream signalling (Stavridis et al., 2007; Ying et al., 2003). 
Because the first two days of differentiation is the time during which 
neural induction occurs (see section 3.2.1), 10 ng/ml BMP4 was added into 
the culture medium over this time period to see if the generation of NSCs 
was inhibited. After 6 days of differentiation, cells were fixed and 
analysed for the expression of the NSC markers, Sox1-GFP and Nestin. 
Exposure to BMP4 reduced the generation of NSCs from 46C ESCs (Fig. 
5.8A-B). As reported previously (see section 4.2.3), Tg restored the ability 
of Nnat-KD ESCs to generate NSCs, but the number of NSCs generated 
under these ‘Tg-rescue’ conditions was reduced by BMP4 administration 
(Fig. 5.8C-E). Although BMP4 also decreased the generation of NSCs 
from Nnatα-OE ESCs, the suppressive effect in Nnatα-OE ESCs was not 
as severe as in wild type ESCs (Fig. 5.8F-G). Thus, the activation of BMP 
signalling markedly reduced the ability of wild type mouse ESCs to 
differentiate along a neural pathway, and when Nnatα was over-expressed, 
the repressive ability of BMP signalling was reduced. When BMP4 was 
administered on the third day of differentiation (avoiding the first two 
days), BMP4 no longer suppressed the ability of 46C, Tg-treated Nnat-KD, 
or Nnatα-OE ESCs to generate of NSCs. Thus the first two days of 




Fig. 5.8. Nnat may compete with BMP signalling during the neural induction of ESCs. 
46C, Nnat-KD, and Nnatα-OE ESCs were differentiated for six days. Cells were exposed 
to 10 ng/ml BMP4 for the first two days of differentiation. After six days of 
differentiation, cells were fixed and analysed for expression of the NSC markers, Sox1-
GFP and Nestin. (A) 46C ESCs generated Sox1-GFP+ (green) and Nestin+ (red) NSCs. (B) 
The administration of BMP4 restricted the generation of NSCs from 46C ESCs. (C) The 
generation of NSCs was reduced in Nnat-KD ESCs. (D) When Nnat-KD ESCs were 
exposed to 25nM Tg for 30 minutes on the first day of differentiation, the ability of Nnat-
KD ESCs to generate NSCs was regained. (E) The generation of NSCs from Tg-treated 
Nnat-KD ESCs was suppressed when cells were exposed to BMP4. (F) Nnatα-OE ESCs 
generated more NSCs than 46C ESCs. (G) BMP4 treatment only partially reduced the 
generation of NSCs from Nnatα-OE ESCs. These results suggested that activation of 
BMP signalling markedly reduced the ability of wild type mouse ESCs to differentiate 
along a neural pathway, and when Nnat is over-expressed, the repressive ability of BMP 
signalling is reduced. Thus, Nnat and BMP may compete with each other during the 
neural induction of ESCs. All nuclei were stained with DAPI (blue). Scale bar, 20 μm. 
Abbreviations: BMP, Bone morphogenetic protein; DAPI, 4',6-diamidino-2-phenylindole; 
Erk, Extracellular Signal-regulated Kinase; ESC, embryonic stem cell; GFP, green 
fluorescent protein; Nnat-KD, Nnat-knockdown; Nnatα-OE, Nnatα-overexpression; NSC, 




5.2.6 Nnat may down-regulate the transcription of BMP4 and its 
target genes, Msx1 and Msx2  
The expression of BMP4 and its target genes, Msx1 and Msx2, are up-
regulated in embryonic ectoderm as it differentiates along an epidermal 
fate, but are down-regulated in neuroectoderm (see section 1.4). In order to 
determine whether Nnat-mediated signalling down-regulates the 
expression of BMP4, Msx1 and Msx2 in mouse ESCs to promote a neural 
fate, the expression of BMP4, Msx1 and Msx2 were evaluated in 46C, 
Nnatα-OE, and Nnat-KD ESCs using quantitative real-time PCR.  
 
46C, Nnatα-OE, and Nnat-KD ESCs were grown on gelatin-coated plates 
and cultured in non-differentiating conditions until they reached 100% 
confluency. Then the ESCs were collected for analysing the expression 
levels of BMP4, Msx1, and Msx2 using real-time PCR. The expression of 
BMP4, Msx1 and Msx2 were found to be up-regulated in Nnat-KD ESCs 
as compared with 46C and Nnatα-OE ESCs (Fig. 5.9). Thus it appeared 
that Nnat may down-regulate the expression of BMP4 and its target genes, 
so the increase in expression of BMP4 in Nnat-KD ESCs may restrict their 
neural differentiation through increased expression of its target genes 
Msx1 and Msx2. However, the above results did not show that Nnat 
directly inhibits BMP signalling. To test this possibility a luciferase 
reporter gene assay could be used. Using this assay, the expression of 
target genes could be analysed by quantitative determination of firefly 
luciferase activity in transfected cells (Brasier et al., 1989). For instance, 
the vector contains a luciferase reporter gene with an upstream multiple 
cloning site for introducing the promoter region of BMP4, Msx1, or Msx2. 
Nnat is then sub-cloned into another expression vector and both vectors 
co-transfected into 3T3 cells and the luciferase activity analysed. If Nnat 
directly inhibited BMP signalling, then the luciferase activity with a 





Fig. 5.9. Nnat may down-regulate the expression of BMP4 and its target genes Msx1 and 
Msx2 in ESCs.  
The expression of BMP4 and its target genes, Msx1 and Msx2, are up-regulated when 
embryonic ectoderm differentiates along an epidermal pathway, but was down-regulated 
in neuroectoderm. In order to determine whether Nnat-mediated signalling down-
regulates the expression of BMP4, Msx1 and Msx2 in mouse ESCs to promote a neural 
fate, the expression of the message for these proteins were evaluated in 46C, Nnatα-OE, 
and Nnat-KD ESCs using quantitative real-time PCR. The expression of BMP4, Msx1, 
and Msx2 were up-regulated in Nnat-KD ESCs compared with 46C and Nnatα-OE ESCs 
(p < 0.05, one-way ANOVA test). Thus Nnat may down-regulate the expression of BMP4 
and its target genes to facilitate ESCs to differentiate along a neural pathway.  
Abbreviations: ANOVA, analysis of variance; BMP4, Bone morphogenetic protein 4; ES, 
embryonic stem; Nnat-KD, Nnat-knockdown; Nnatα-OE, Nnatα-overexpression; PCR, 
polymerase chain reaction. 
 
The above data shows that Nnat may down-regulate the expression of 
BMP4, so may influence BMP signalling by reducing the availability of 
this ligand. The binding of BMP to its receptor activates Smad1 and causes 
the phosphorylation of Smad1 at its C-terminus, and then the C-ter-p-
Smad1 is translocated to the nucleus where it activates its target genes 
Msx1 and Msx2 (see section 1.4.1). It is undetermined whether Nnat can 
down-regulate the expression of Msx1 and Msx2 by suppressing C-ter-p-
Smad1. As discussed, in Xenopus activation of FGF/Erk signalling causes 
the degradation of C-ter-p-Smad1 and inhibits BMP signalling thus 
enabling neural induction to occur (see the section 1.5.1.4; Fuentealba et 
al., 2007; Kuroda et al., 2005; Pera et al., 2003). Furthermore, I have 
shown that increasing [Ca2+]i activates Erk signalling in Nnat-KD ESCs 
(see section 5.2.4). Thus, increasing [Ca2+]i may induce the degradation of 
C-ter-p-Smad1 via Erk signalling. To examine this hypothesis, Nnat-KD 
cells were treated with BMP4 to increase C-ter-p-Smad1, and then [Ca2+]i 
(and hence activated Erk1/2) was increased by Tg treatment to determine 
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whether C-ter-p-Smad1 was reduced by the activation of Tg-mediated Erk 
signalling.  
 
In 46C ESCs, the phosphorylation of Smad1 at its C-terminus induced by 
BMP4 peaks 60 minutes after 10 ng/ml BMP4 treatment (Ying et al., 
2003). Nnat-KD ESCs are generated from 46C ESCs, so Nnat-KD ESCs 
were pretreated with 10 ng/ml BMP4 for 60 minutes to reach the peak of 
phosphorylation. Then 25 nM Tg was added into the culture medium with 
BMP4 for another 10, 30, and 60 minutes to activate Erk1/2. After BMP4 
and Tg treatment, cells were lysed to prepare whole cell lysates and the 
levels of C-ter-p-Smad1 analysed by Western blotting using an anti-C-ter-
p-Smad1 antibody (Fig. 5.10). The base level of C-ter-p-Smad1 in Nnat-
KD ESCs was shown in Lane 1 (Fig. 5.10). After BMP4 treatment for 70 
minutes, C-ter-p-Smad1 was increased (Fig. 5.10, compare lane 1 with 
lane 2), and it was not decreased when cells were exposed to Tg for 10 
minutes, which is the peak of Tg-mediated Erk1/2 phosphorylation (Fig. 
5.10, compare lane 2 with lane 3). The activation of Smad1 declined after 
90 and 120 minutes of BMP4 treatment (Fig. 5.10, compare lanes 2, 4, 
with 6), and at these same time points the C-ter-p-Smad1 was not 
decreased by Tg (Fig. 5.10, compare lanes 4 with 5, and 6 with 7). 
Therefore adding Tg after exposing cells to BMP4 did not decrease the C-
ter-p-Smad1. Therefore, Tg-treatment did not decrease BMP4 induced C-
ter-p-Smad1 expression in mouse ESCs, so Nnat may not be repressing 




Fig. 5.10. Activation of Erk signalling does not decrease C-ter-p-Smad1 in mouse ESCs. 
In Xenopus, activation of Erk signalling decreases C-ter-p-Smad1 to promote neural 
induction. To determine whether the Tg-mediated Erk signalling decreased the C-ter-p-
Smad1 in mouse ESCs Nnat-KD ESCs were treated with 10 ng/ml BMP4 for 60 minutes 
to increase the C-ter-p-Smad1, and then 25 nM Tg was added into the culture medium 
with BMP4 for another 10, 30, and 60 minutes to activate Erk1/2. After BMP4 and Tg 
treatment, the levels of C-ter-p-Smad1 were analysed by Western blotting using an anti-
C-ter-p-Smad1 antibody. Lane 1 revealed the base level of C-ter-p-Smad1 in Nnat-KD 
ESCs. After BMP4 treatment for 70 minutes, C-ter-p-Smad1 was increased (compare lane 
1 with 2), and it was not decreased when cells were exposed to Tg for 10 minutes 
(compare lane 2 with 3). The activation of Smad1 declined at 90 and 120 minutes of 
BMP4 treatment (compare lane 2, 4, with 6), and at the same time points the C-ter-p-
Smad1 was not decreased by Tg (compare lane 4 with 5, and 6 with 7). The results show 
that Tg-treatment does not decrease BMP4 induced C-ter-p-Smad1 expression in mouse 
ESCs, so the activation of Erk signalling may not inhibit C-ter-p-Smad1 in mouse ESCs.  
Abbreviations: BMP, Bone morphogenetic protein; C-ter-p-Smad1, C-terminal 
phosphorylated Smad1; Erk, Extracellular Signal-regulated Kinase; ESC, embryonic stem 
cell; Nnat-KD, Nnat-knockdown; Tg, Thapsigargin. 
 
5.2.7 BMP antagonists do not restore the generation of neuroectoderm 
from Nnat-KD ESCs 
My research indicates that Nnat increases [Ca2+]i which activates Erk 
signalling and initiates neural induction in mouse ESCs. Furthermore, 
Nnat may also down-regulate the expression of BMP4 and its target genes. 
Both activating Erk signalling and suppressing BMP signalling are pivotal 
in neural induction (details see sections 1.4 and 1.5). To test whether BMP 
inhibition is sufficient to induce the neural differentiation of Nnat-KD 
ESCs, BMP antagonists were used to suppress BMP signalling in these 
cells and the ability of these cells to generate neuroectoderm was evaluated.  
 
100 ng/ml Noggin, 150 ng/ml Chordin, or 150 ng/ml Follistatin has 
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previously been used to antagonise BMP signaling in cultured ESCs 
(Gerrard et al., 2005; Hosseinkhani et al., 2007; Naito et al., 2006; Suzuki 
et al., 2006; Yuasa et al., 2005). These ESCs are different from 46C ESCs 
used in my experiments and there is no evidence that the reported 
concentrations of Chordin or Follistatin will inhibit BMP signalling in a 
monolayer differentiation model of 46C ESCs; however, such evidence 
does exist for 100 ng/ml Noggin (Stavridis et al., 2007). Therefore 
different concentrations of BMP antagonists were applied to Nnat-KD 
ESCs to see if the generation of neuroectoderm was rescued (Noggin (100 
or 200 ng/ml), Chordin (150 or 300 ng/ml) or Follistatin (150 or 300 
ng/ml)).  Because Sox1-expressing neuroectodermal cells are generated 
after 2-3 days of differentiation (see section 3.2.1), Nnat-KD ESCs were 
grown under differentiating conditions in the presence of BMP antagonists 
for four days before being fixed, to allow the generation of sufficient 
Sox1-GFP-expressing neuroectodermal cells, which is an indication of 
neural induction having taken place. 46C cells differentiated in the absence 
of antagonists were included as a positive control for the generation of 
Sox1-GFP+ neuroectodermal cells, as were Nnat-KD cells treated with 
25nM Tg for 30 minutes on the first day of differentiation to rescue their 
ability to generate NSCs (details see section 4.2.3.2).  
 
As expected, after 4 days of differentiation 46C ESCs generated Sox1-
GFP+ neuroectodermal cells (Fig. 5.11A), as did Tg-treated Nnat-KD 
ESCs (Fig. 5.11B and C). Interestingly, when Nnat-KD ESCs were treated 
either with Noggin (100 or 200 ng/ml), Chordin (150 or 300 ng/ml) or 
Follistatin (150 or 300 ng/ml) throughout the 4-day differentiation period, 
Nnat-KD ESCs still failed to undergo neural induction (Fig. 5.11D-F). 
Even when these cells were cultured with a combination of 200 ng/ml 
Noggin, 300 ng/ml Chordin, and 300 ng/ml Follistatin for 4 days, the 
ability of Nnat-KD ESCs to generate neuroectodermal cells was still not 
restored (Fig. 5.11G). Thus simply inhibiting BMP signalling was not 
sufficient to cause neural induction in Nnat-KD ESCs. The results suggest 
that Nnat may not only down-regulate the expression of BMP4, but also 
affect other pathways, such as increasing cytosolic Ca2+ which in turn 
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Fig. 5.11. BMP antagonists do not restore the ability of Nnat-KD ESCs to generate 
neuroectoderm.  
46C and Nnat-KD ESCs were grown under differentiation conditions for four days and 
then were fixed to analyse the generation of Sox1-GFP+ neuroectodermal cells. (A) After 
4 days of differentiation, 46C ESCs generated Sox1-GFP+ cells. (B) The generation of 
neuroectodermal cells was significantly reduced in Nnat-KD ESCs. (C) 25 nM Tg was 
applied to Nnat-KD ESCs for 30 minutes on the first day of differentiation and this 
restored their ability to generate Sox1-GFP+ cells. When Nnat-KD ESCs were exposed to 
(D) 200 ng/ml Noggin, (E) 300 ng/ml Chordin, or (F) 300 ng/ml Follistatin throughout 
the 4-day differentiation period, the generation of Sox1-GFP+ cells was not regained. (G) 
Even Nnat-KD ESCs were cultured with a combination of 200 ng/ml Noggin, 300 ng/ml 
Chordin, and 300 ng/ml Follistatin; the ability of Nnat-KD ESCs to generate 
neuroectodermal cells was still not restored. Thus, simply inhibiting BMP signalling by 
BMP antagonists was not sufficient to cause neural induction in Nnat-KD ESCs. All 
nuclei were stained with DAPI (blue). Scale bar, 20 μm. 
Abbreviations: BMP, Bone morphogenetic protein; DAPI, 4',6-diamidino-2-phenylindole; 
ESC, embryonic stem cell; GFP, green fluorescent protein; Nnat-KD, Nnat-knockdown; 
Sox1, SRY (sex determining region Y)-box 1; Tg, Thapsigargin. 
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5.3 Discussion  
5.3.1 Summary of main findings 
In summary, I have shown that activation of FGF/Erk signalling is 
required for the neural induction of mouse ESCs, and my work confirms 
that of others showing that inhibition of FGF/Erk signalling dramatically 
reduces the ability of ESCs to generate NSCs (Cohen et al., 2010; Tropepe 
et al., 2001). Nnat functions by increasing [Ca2+]i (see section 4.2.3) which 
in turn causes activation of Erk signalling leading to neural induction, and 
this action of Nnat is a novel finding of my research. Furthermore, the 
treatment of mouse ESCs with BMP4 suppressed neural induction. The 
expression of BMP4 and its target genes were found to be up-regulated by 
Nnat knocked-down, suggesting that Nnat may also promote neural 
induction by down-regulation of BMP transcription. However, the 
treatment of Nnat-KD ESCs with BMP antagonists did not rescue the 
generation of neuroectoderm. This result implies that the inhibition of 
BMP signalling alone is insufficient for neural induction to occur. In line 
with this, I suggest that Nnat may act not only by down-regulation of BMP 
transcription, but also by activating the Erk pathway to initiate neural 
induction in mouse ESCs. 
 
5.3.2 The activation of Erk1/2 is crucial to FGF and Nnat induced 
neural induction of mouse ESCs  
Mouse ESCs are derived from the ICM of the blastocyst of mouse 
embryos and Fgf4 is expressed in the ICM (Blagovic et al., 2011; 
Niswander and Martin, 1992; Rappolee et al., 1994), suggesting that Fgf4 
is expressed in mouse ESCs too. Using real-time PCR, I have confirmed 
the expression of Fgf4 by 46C, Nnat-KD, and Nnatα-OE ESCs, and no 
difference was observed in the expression levels of Fgf4 in these three 
ESC types (see Appendix 6). Thus, although mouse ESCs were grown in 
differentiating conditions without the addition of exogenous FGFs, FGFs 
generated by ESCs were present in these cultures. As shown in section 
5.2.1, the treatment of 46C ESCs with the FGFR inhibitor PD173074 
significantly reduced the generation of NSCs from 46C ESCs, so FGF 
signalling is pivotal for the neural induction of wild type (Nnat intact) 
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mouse ESCs, confirming work published by Tropepe et al. (2001). 
Without the inhibition of FGF signalling, knocking down Nnat expression 
also reduces the generation of NSCs (see section 3.2.4), so both Nnat and 
FGF are required for the neural induction of mouse ESCs. Further, when 
Nnatα was over-expressed, ESCs exposed to the FGFR inhibitor still 
generated NSCs (see section 5.2.4), suggesting that the over-expression of 
Nnatα compensates for the loss of action of FGF during neural induction. 
In contrast, the activation of FGF signalling by treating Nnat-KD ESCs 
with FGF4 or FGF5 rescued the ability of Nnat-KD ESCs to generate 
NSCs (see section 5.2.2). These results suggest that Nnat and FGF act in 
parallel to promote neural induction, and Nnat and FGF can compensate 
for one another.  
 
Tg (a specific inhibitor of Apt2a/SERCA) mimics the function of Nnat to 
increase [Ca2+]i, and an increase in [Ca
2+]i leads to the activation of Erk1/2 
in Nnat-KD ESCs (see section 5.2.4), so Nnat inhibits the Apt2a/SERCA 
to cause an increase in [Ca2+]i which in turn activates Erk1/2. Further, the 
activation of Erk1/2 is required for neural induction, as the MEK inhibitor 
PD184352, which blocks the phosphorylation of Erk1/2 by MEK, 
suppresses neural induction in wild type, and Nnatα-OE ESCs (details see 
sections 5.2.1, and 5.2.4). However, the FGFR inhibitor PD173074 
significantly reduces the generation of NSCs from wild type ESCs, but 
only partially reduces the generation from Nnatα-OE ESCs (see section 
5.2.4). My data suggest that Nnat activates Erk1/2 to initiate neural 
induction in mouse ESCs, and the activation of Erk signalling is not via the 
activation of FGFR (Fig. 5.12). Thus the activation of Erk1/2 is crucial for 
FGF and Nnat induced neural induction, and Nnat may cooperate with 





Fig. 5.12. The action of Nnat and FGF are parallel to activate Erk signalling in neural 
induction of ESCs. 
In mouse ESCs, Nnat causes an increase in [Ca2+]i which in turn activates Ras through the 
exchange of bound GDP for GTP. At the same time, the binding of FGF with FGFRs also 
activates Ras, and in turn Ras-GTP activates the Raf/MEK/Erk protein kinase cascade to 
promote neural induction. Either the treatment of ESCs with PD173074 (an inhibitor of 
FGFR) or Nnat knocked-down in ESCs significantly suppressed neural induction in ESCs. 
Thus both the action of Nnat and FGF are required for neural specification in wild type 
ESCs. When Nnatα was over-expressed in ESCs, the generation of NSCs was partially 
reduced by PD173074, but almost abolished by PD184352 (an inhibitor of MEK), 
suggesting that the action of Nnat and FGF act in parallel to activate Erk signalling 
causing neural induction of ESCs.  
Abbreviations: Erk, Extracellular Signal-regulated Kinase; ESC, embryonic stem cell; 
FGF, Fibroblast growth factor; FGFR, FGF receptor; GDP, Guanosine diphosphate; GTP, 
Guanosine triphosphate; MEK, Mitogen-activated Protein/Extracellular Signal-regulated 
Kinase Kinase;  NSC, neural stem cell. 
 
The above discussion leads to the idea that in order to initiate neural 
induction, the level of p-Erk1/2 needs to reach a certain threshold. In wild 
type ESCs, both Nnat and FGF induce the phosphorylation of Erk1/2 (Fig. 
5.12), enabling levels of p-ERK1/2 to reach the threshold needed to enable 
ESCs to generate neuroectodermal cells. When Nnat was knocked-down in 
ESCs, the generation of NSCs was significantly reduced (see section 
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3.2.4.2), suggesting that the p-Erk1/2 activated by FGF does not reach the 
required threshold. In contrast, when the action of FGF was blocked by 
PD173074, the formation of NSCs was also suppressed in wild type ESCs 
(see section 5.2.1), suggesting that the levesl of p-Erk1/2 activated by Nnat 
also does not reach the required threshold. Furthermore, the over-
expression of Nnatα compensated for the loss of FGFR activation in 
PD173074 treated Nnatα-OE ESCs, resulting in neural specification of 
Nnatα-OE ESCs (see section 5.2.4). This result implies that even without 
the activation of FGFR, the levels of p-Erk1/2 generated by the over-
expression of Nnatα is sufficient to reach the required threshold. Similarly, 
the treatment of Nnat-KD ESCs with FGF4 also compensated for the Nnat 
knock-down inducing the generation of NSCs (see section 5.2.2), 
suggesting that even without the action of Nnat, the levels of p-Erk1/2 
caused by the presence of exogenous FGFs again reached the required 
threshold for neural induction. If the hypothesis that p-Erk1/2 needs to 
reach a certain threshold for neural induction to occur is correct, then an 
increase in p-Erk1/2 should also induce neural induction. The binding of 
IGF2 (insulin-like growth factor 2) to its receptor activates the 
Raf/MEK/Erk protein kinase cascade (Desbois-Mouthon et al., 2006). The 
injection of Xenopus embryos with IGF2 increased p-Erk1/2 and also 
induced the ectopic neural tissue (Pera et al., 2003). This result fits with 
my hypothesis, but further confirmation is still required. For example, 
Nnat-KD ESCs could be treated with different concentrations of FGF4 and 
the levels of p-Erk1/2 evaluated using immunoblotting. If the hypothesis is 
true, then the treatment of Nnat-KD ESCs with FGF4 will induce the 
generation of NSCs after p-Erk1/2 passes certain level. 
 
5.3.3 Nnat may down-regulate the expression of BMP and activate Erk 
signalling to facilitate the generation of neuroectoderm from mouse 
ESCs  
When mouse ESCs were exposed to BMP4, the generation of 
neuroectoderm was reduced (see section 5.2.5). Thus my work confirms 
previous reports that the activation of BMP signalling inhibits neural 
induction in ESCs (details see section 1.6; Finley et al., 1999; LaVaute et 
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al., 2009; Stavridis et al., 2007; Tropepe et al., 2001). Conversely the 
inhibition BMP signalling is required for neural induction (see sections 1.2 
and 1.3). As shown in section 5.2.5, Nnat may down-regulate the 
expression of BMP4 and its target genes, Msx1 and Msx2. However, using 
BMP antagonists, such as Noggin, Chordin, and Follistatin, to inhibit BMP 
signalling did not restore the ability of Nnat-KD ESCs to generate 
neuroectodermal cells (see section 5.2.7). Therefore, as well as down-
regulating the expression of BMP, Nnat must also affect other signals to 
initiate neural induction. I have shown that Nnat physically interacts with 
Apt2a/SERCA and inhibits Apt2a/SERCA pumping cytosolic Ca2+ into the 
ER, and thus causes an increase in [Ca2+]i (see sections 4.2.1, 4.2.2, and 
4.2.3). An increase in [Ca2+]i activates Erk signalling (see section 5.2.4) 
and the activation of Erk signalling is essential for neural induction of 
mouse ESCs (see section 5.2.1). Therefore, Nnat, via its ability to elevate 
[Ca]i, activates the instructive Erk signal to facilitate the generation of 
neuroectodermal cells from mouse ESCs.  
 
Therefore, it appears that these positive (such as FGF/Erk and Nnat) and 
negative (such as BMP) signals compete with each other to decide the 
lineage fates of mouse ESCs. When wild type ESCs were exposed to 
BMP4, to repress neural induction, the generation of NSCs was 
significantly reduced (see section 5.2.5). However, this suppressive effect 
of BMP4 on neural induction was partially reversed when the positive cue 
Nnat is augmented. For example, when Nnatα was over-expressed in ESCs, 
the treatment of Nnatα-OE ESCs with BMP4 could not completely inhibit 
the generation of NSCs from Nnatα-OE ESCs (see section 5.2.5). This 
result suggests that increasing expression of a positive cue (Nnat) can push 
ESCs towards a neural fate even in the presence of a negative signal 
(BMP). However, the popular ‘default model’ for neural induction 
proposes that ectodermal cells give rise to neural cells autonomously in the 
absence of BMP activation (details see section 1.3). My observation that 
Nnatα-OE ESCs still generate neural cells in the presence of BMP4 does 
not fit with the default model.   
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If the default model is correct, then the process of neural induction should 
not need any positive cue in the absence of BMP activation. Thus the 
treatment of Nnat-KD ESCs with BMP antagonists should let ESCs take 
up their default fate - to differentiate into neural cells.  My observation that 
such treatments did not induce the generation of neuroectoderm from 
Nnat-KD ESCs contradict this assumption (see section 5.2.7). Certainly, 
neural induction is not as simple as the default model implies. The 
insufficiency of the default model is also raised by many other studies 
(details see section 1.5), suggesting that in addition to the inhibition of the 
negative signal (BMP), positive cues are required (such as FGF/Erk and 
Nnat) to let the neural induction occur.  
 
5.3.4 The activation of Erk signalling may not inhibit C-ter-p-Smad1 
in mouse ESCs  
As discussed in section 1.5.1.4, BMP signalling is inhibited by Erk 
signalling in Xenopus neural induction. The activation of BMP signalling 
causes the phosphorylation of Smad1 at its C-terminus and the resulting C-
ter-p-Smad1 is translocated into the nucleus where it activates epidermal 
genes, such as Msx1, Cytokeratin, and Vent2 (Pera et al., 2003). The 
activation of Erk signalling phosphorylates C-ter-p-Smad1 at a linker 
region to induce degradation of C-ter-p-Smad1, which results in the 
inhibition of BMP signalling facilitating neural induction (Fuentealba et al., 
2007; Kuroda et al., 2005). Furthermore, it has been demonstrated that the 
same interaction between C-ter-p-Smad1 and p-Erk1/2 occurs in mouse 
and human cell lines (Aubin et al., 2004; Fuentealba et al., 2007; 
Kretzschmar et al., 1997; Sapkota et al., 2007). Therefore Nnat-mediated 
Erk signalling may also suppress the C-ter-p-Smad1 to inhibit BMP 
signalling in mouse ESCs.  
 
In this chapter, I have demonstrated that Tg can induce the 
phosphorylation of Erk1/2 in Nnat-KD ESCs (see section 5.2.4), but the 
results shown in section 5.2.6 revealed that the activation of Erk1/2 by the 
treatment of Nnat-KD ESCs with Tg did not reduce the C-ter-p-Smad1. 
Although C-ter-p-Smad1 is not reduced, it does not mean that the linker 
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region of C-ter-p-Smad1 is not phosphorylated by p-Erk1/2. To clarify this, 
I have tried to determine whether the activation of Erk signalling caused 
the phosphorylation of Smad1 at the linker region. If the linker region is 
phosphorylated by p-Erk1/2, then the Linker-p-Smad1 should be increased 
after Tg treatment. Linker-p-Smad1 was analysed by Western blotting 
using an anti-Linker-p-Samd1 antibody, but I failed to identify this protein 
because there was no specific band in my immunoblotting analysis. 
Because I did not have a suitable positive control for the expression of 
Linker-p-Samd1, it was possible that the anti-Linker-p-Samd1 antibody 
used in immunoblotting was not good enough to detecting Linker-p-
Samd1. Thus, at present, it is not clear whether or not the linker region of 
Smad1 is phosphorylated by p-Erk1/2 in mouse ESCs.     
 
Studies in HEK293 cells have shown that when the linker region is 
phosphorylated by p-Erk1/2, C-ter-pSmad1 is inactivated through 
polyubiquitination or interaction with Smurf1 that C-ter-pSmad1 is kept in 
the cytosol and not degraded immediately (Sapkota et al., 2007). Although 
my data did not show that the activation of Tg-mediated Erk signalling 
reduced C-ter-p-Smad1 (see section 5.2.5), the cytosolic retention of C-ter-
p-Smad1 could not be ruled out. To solve this problem, subcellular 
fractionation could be used to separate the cytosolic and nuclear fractions 
from the whole cell lysate. Because C-ter-p-Smad1 will relocate to nucleus 
to activate target genes, the C-ter-p-Smad1 in the nuclear fraction could be 
considered as the active form. In my experiments, I analysed the C-ter-p-
Smad1 using whole cell lysate, so I could not determine the proportion of 
nuclear to cytosolic C-ter-p-Smad1. If the C-ter-p-Smad1 is just retained in 
the cytosol after the phosphorylation of linker region, the amount of C-ter-
p-Smad1 in whole cell lysate will not be changed so there will be no 
observable differences between Tg-treated ESCs and no Tg treatment. 
Using the subcellular fractionation techniques, the proportion of C-ter-p-
Smad1 in the nuclear fraction will be detected. If it is the case that the 
activation of Tg-mediated Erk signalling decreases the proportion of C-ter-
p-Smad1 in the nuclear fraction and increases C-ter-p-Smad1 in the 
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cytosolic fraction, then the activation of Tg-mediated Erk signalling may 
inactivate C-ter-p-Smad1 by cytosolic retention.  
 
5.3.5 What are the downstream target genes activated by p-Erk1/2 in 
neural induction? 
The activation of Erk signalling is pivotal for the neural induction of 
mouse ESCs, but most of its downstream target genes are still unknown. 
Erk1/2 is a protein kinase and the active form (p-Erk1/2) will physically 
interact with various transcription factors, such as NF-B, Bcl2, cAMP-
responsive element-binding protein, GATA, GAB, c-Myc, Ets, AP1, and 
Sp1, and in turn these transcription factors activate different genes (Chang 
et al., 2003; Chotteau-Lelievre et al., 2001; Dajee et al., 2003; Karin, 1995; 
Liu et al., 2005; Milanini-Mongiat et al., 2002; Pages, 2007; Yeh et al., 
2004; Ying et al., 2002), but which transcription factors are responsible for 
up-regulating genes to initiate neural induction still needs to be elucidated.   
 
Recently, Yoo et al. (2011) found that the poly (ADP-ribose) polymerase 1 
(PARP-1), which modifies nuclear proteins by polymerization of ADP-
ribose units, is a substrate for p-Erk1/2 and is responsible for neural 
specification of human ESCs. It has been demonstrated that PARP-1 is 
directly phosphorylated by p-Erk1/2 (Kauppinen et al., 2006), and the 
activity of PARP-1 is increased during human ESCs neural differentiation, 
and reduced by treatments with the FGFR inhibitor SU5402, the MEK 
inhibitor U0126, or the PARP-1 specific inhibitor PJ34 (Yoo et al., 2011). 
The treatment of ESCs with PJ34 significantly reduced the generation of 
SOX2 or PAX6-expressing neural progenitors, suggesting that the 
activation of PARP-1 promotes neural induction in human ESCs. Using 
chromatin immunoprecipitation analysis, the promoter region of PAX6 
was observed in the precipitated chromatin DNA using a anti-PARP-1 
antibody (Yoo et al., 2011), suggesting that the PARP-1 is involved in the 
activation of PAX6. Thus Erk/PARP-1 signalling is involved in neural 
induction of human ESCs, but this does not rule out the possibility that 
other p-Erk1/2 substrates are also involved in the process of neural 
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induction. For example, Erm is a transcription factor of the Ets family 
(substrate of p-Erk1/2) and is expressed in the neural plate of mouse and 
chicken embryos (Chotteau-Lelievre et al., 2001; Stavridis et al., 2007). It 
has been shown that Erm is involved in the neuronal fate decision of 
neural crest stem cells (Paratore et al., 2002), but it is unknown whether 
Erm is required in neural induction. Similarly Sp1, another substrate of p-
Erk1/2, is expressed in neuroectoderm, hematopoietic cells, and giant 
trophoblast cells of mouse embryos at 8.5 dpc (Saffer et al., 1991). The 
human early neural marker SOX3 and mouse Sox2 promoters contain 
binding sites for Sp1 (Archer et al., 2010; Kovacevic Grujicic et al., 2005; 
Wiebe et al., 2000), and Sp1 is also a positive regulator of the NSC marker 
Nestin in mouse (Cheng et al., 2004). Therefore, FGF/Erk signalling may 
cause the phosphorylation of Sp1 that in turn activates Sox2 and Nestin to 















6.0 Discussion   
6.1 Summary of main findings 
This thesis focused upon elucidating the role of Nnat in the neural induction; 
using mouse ESCs as a model system in conjunction with loss- and gain-of-
function approaches. I found that Nnat was expressed in neuroectodermal 
cells, neural progenitors, and neurons during ESCs neural differentiation 
(see section 3.2.2, Fig. 3.2 and 3.3), suggesting that Nnat may play a role in 
neural development. This hypothesis was confirmed since Nnat-OE ESCs 
generated an excess of NSCs and neurons (see section 3.2.3, Fig. 3.5 and 
3.6), while Nnat-KD ESCs generated significantly fewer neuroectodermal 
cells, NSCs, and subsequently neurons (see section 3.2.4.2, Fig. 3.8). These 
results implied that Nnat was required for neural induction in mouse ESCs. 
However, these observations could not be explained by Nnat-KD ESCs 
simply failing to differentiate efficiently into any of the three primary germ 
layers (see section 3.2.6, Fig. 3.11), rather that these ESCs did not give rise 
to neuroectodermal cells efficiently. Indeed, when mouse Nnat mRNA was 
injected into Xenopus embryos, the domain of neural plate marker NCAM-
expressing cells was expanded and similarly, in animal cap assays, the 
expression of the neural plate marker Nrp1 was up-regulated (see section 
3.2.7, Fig. 3.13), suggesting that the neural inductive effect of Nnat is 
conserved in Xenopus and mouse ESCs.  
 
At the amino acid level Nnat shows 50% homology with Phospholamban (an 
inhibitor of Apt2a/SERCA) and this suggests that Nnat may act to increase 
[Ca2+]i by inhibiting the action of Apt2a/SERCA, a Ca
2+ ATPase located in 
the membrane of ER that transports cytosolic Ca2+ into the ER to decrease 
[Ca2+]i (see section 1.7.2). Further to this, I demonstrate that Nnat physically 
interacts with Apt2a2/SERCA2 (see section 4.2.1.2). Apt2a2/SERCA2 was 
the member of Apt2a/SERCA family which was most highly expressed in 
mouse ESCs and during differentiation along the neural pathway (see 
section 1.7.2, Fig. 1.15). If Nnat inhibits the pumping of cytosolic Ca2+ into 
the ER by Apt2a2/SERCA2, then the consequences of Nnat binding to 
Apt2a2/SERCA2 should increase cytosolic Ca2+. As expected the [Ca2+]i in 
Nnat-OE ESCs was higher than in wild type and Nnat-KD ESCs (see section 
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4.2.2, Fig. 4.4). This assumption was also confirmed using the specific 
inhibitors of Apt2a/SERCA (Tg and BHQ), by reasoning that if Nnat 
inhibits Apt2a2/SERCA2 to cause an increase in [Ca2+]i, then these 
inhibitors should mimic the action of Nnat - cause an increase in [Ca2+]i (see 
section 4.2.3.1, Fig. 4.5) and restore the ability of Nnat-KD cells to generate 
NSCs and subsequently neurons. Indeed, this was shown to be the case (see 
section 4.2.3.2, Fig. 4.6 and 4.7). Together these observation indicated that 
Nnat inhibits the Apt2a2/SERCA2 to cause an increase in [Ca2+]i and this in 
turn induces neural specification. Prior to my experiments, there is no data 
of the role of Ca2+ in neural induction of higher vertebrates. My data is the 
first to reveal that Nnat causes an increase in [Ca2+]i of mouse ESCs and this 
is required for neural induction in mouse ESCs. I also showed that the 
converse was true, namely that preventing the increase in [Ca2+]i of wild 
type ESCs using BAPTA-AM (a membrane permeable calcium chelator) 
suppressed the ability of these ESCs to generate neuroectodermal cells (see 
section 4.2.4, Fig. 4.8). Thus, an increase in [Ca2+]i is required for neural 
induction in mouse ESCs and this increase in [Ca2+]i is brought about by the 
action of Nnat.  
 
I have shown that the main function of Nnat in neural induction is to 
increase [Ca2+]i, the next step was to try and identify the downstream 
consequences of this increase in [Ca2+]i in relation to neural development. 
Since the treatment of Nnat-KD ESCs with the Atp2a/SERCA inhibitor Tg 
caused an increase in [Ca2+]i and also activated Erk1/2 (see sections 1.5.4.3 
and 5.2.4, Fig. 5.6), it is feasible that this kinase may act downstream of 
Nnat. In fact, the activation of Erk signalling in Nnat-KD ESCs using FGF4 
or FGF5 also rescued the generation of NSCs and neurons (see section 5.2.2, 
Fig. 5.3 and 5.4). However, when Erk signalling was inhibited by PD184352 
(a MEK inhibitor), the treatment of Nnat-KD ESCs with Tg could no longer 
rescue the generation of neural cells (see section 5.2.3, Fig. 5.5). Thus, this 
result is due to the fact that an increase in [Ca2+]i activates Erk signalling to 
induce neural specification in mouse ESCs. Furthermore, the activation of 
BMP signalling inhibited neural induction in mouse ESCs (see section 5.2.5, 
Fig. 5.8) and the expression of BMP4 and its target genes was increased in 
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Nnat-KD ESCs compared with wild type and Nnat-OE ESCs (see section 
5.2.6, Fig. 5.9), suggesting that Nnat may down-regulate BMP signalling.  
 
In summary, my thesis described a novel function for Nnat in regulating 
neural induction in mouse ESCs. To do this, Nnat may not only down-
regulate BMP signalling, but also antagonise the action of Apt2a/SERCA to 
cause an increase in [Ca2+]i which in turn activates Erk signalling to help 
mouse ESCs give rise to neuroectodermal cells and neural progenitor cells. 
Nnat plays a pivotal role in enabling ESCs to differentiate along a neural 
lineage. 
 
6.2 The regulation of Nnat expression  
Since Nnat has a crucial role in neural development, how the expression of 
Nnat is regulated will be interesting. The promoter region of Nnat contains 
the neuron-restrictive silencer element (Dou and Joseph, 1996) that could 
bind the neuron-restrictive silencer factor and inhibit the expression of pro-
neural genes in non-neural cells (Bessis et al., 1997; Chen et al., 1998). This 
may be the reason that the expression of Nnat was sustained in developing 
neural tissue and suppressed in most non-neural tissue. In addition, Nnat is a 
maternal imprinted gene and the maternal origin-specific DNA of Nnat is 
methylated throughout embryonic development (John et al., 2001; Kagitani 
et al., 1997). Thus, DNA methylation and the neuron-restrictive silencer 
factor could act to restrict the expression of Nnat. 
 
Another transcription factors that could influence Nnat expression is 
NeuroD1, a basic helix-loop-helix transcription factor (Poulin et al., 1997), 
expressed in central nervous system and pancreas of the mouse embryo (Lee 
et al., 2000a). The binding of NeuroD1 to the promoter region of Nnat has 
been demonstrated in pancreatic -cells using chromatin 
immunoprecipitation analysis, and the expression of Nnat was decreased in 
NeuroD1 null mutants (Chu and Tsai, 2005), suggesting that the 
transcription factor NeuroD1 bound to the promoter of Nnat and activated 
the transcription of Nnat. However, at present, NeuroD1 is the only known 
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transcription factor to up-regulate Nnat expression. Using bio-informatics 
analysis, Li et al. (2010) found some possible transcription factors (PPAR, 
Rreb1, Klf15, Irf1, Krox20, Gata3, Mlxipl, Srebp1c, Foxo1, and Tcf7l2) with 
binding sites in the promoter of Nnat but whether these actually influence 
Nnat expression has yet to be confirmed.  Interestingly, the involvement of 
PPAR, Klf15, Krox20, Gata3, Foxo1, and Tcf7l2 in neural development had 
been reported (Cho and Dressler, 1998; Giudicelli et al., 2001; Ohtsuka et al., 
2011; Paik et al., 2009; Pandolfi et al., 1995; Wada et al., 2006). 
 
PPAR is highly expressed in the embryonic mouse brain and NSCs (Wada 
et al., 2006). Knocking down the expression of PPAR in mouse NSCs 
decreased the generation of neurospheres and the treatment of NSCs with an 
antagonist of PPAR induced apoptosis (Wada et al., 2006). In contrast, the 
treatment of NSCs with an agonist of PPAR increased the generation of 
neurospheres (Wang et al., 2009), suggesting that PPAR activation 
increased the proliferation of NSCs. Klf15 is expressed in the ventricular 
zone of the telencephalon at 11.5-17.5 dpc, and Klf15 knockdown in NSCs 
promoted neuronal differentiation, suggesting that Klf15 was involved in the 
self-renewal of NSCs (Ohtsuka et al., 2011). Krox20 is expressed in the 
hindbrain of mouse and chick embryos, and plays a crucial role in the 
segregation of embryonic hindbrain (Giudicelli et al., 2001; Graham and 
Lumsden, 1996). Gata3 was expressed in the central nervous system, 
somites and embryonic kidney of mammalian embryo (Debacker et al., 1999; 
George et al., 1994). Although the Gata3 knockout was lethal and embryos 
died at 11 dpc, the Gata3 null mutant showed a reduced thickness of the 
neuroepithelium and a distorted neural tube (Pandolfi et al., 1995), 
suggesting the involvement of Gata3 in neurogenesis. Foxo1 was expressed 
in the developing mouse brain and the dentate gyrus of the hippocampus 
(Hoekman et al., 2006). Foxo1 was shown to be involved in the cellular 
proliferation, differentiation, and oxidative defense of NSCs (Paik et al., 
2009). Tcf7l2 is a Wnt signalling related gene that is highly expressed in the 
developing CNS and limb buds (Cho and Dressler, 1998), suggesting that 
Tcf7l2 may play a role in neural and limb development.  
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In summary, transcription factors - neuron-restrictive silencer factor, PPAR, 
Klf15, Krox20, Gata3, Foxo1, and Tcf7l2, may be involved in the regulation 
of the transcription of Nnat during neural development. In order to validate 
the interaction of the above transcription factors with the Nnat promoter a 
Luciferase assay could be used to test whether the expression of Nnat is 
activated or suppressed by these transcription factors. 
 
6.3 Nnat is a positive instructive cue for neural induction of mouse ESCs  
The data presented in sections 3.2.4 and 3.2.7 revealed that Nnat is required 
for neural induction in mouse ESCs and can enhance the neural specification 
of embryonic ectoderm in Xenopus. Thus, Nnat can be considered as a 
positive instructive cue for neural induction. Furthermore, it has been 
demonstrated that FGFs also have the ability to induce neural induction in 
Xenopus, chick, and mouse (see sections 1.5.1). For instance, the injection of 
Fgf8 mRNA into Xenopus embryos induced the generation of ectopic neural 
tissue (see section 1.5.1.1; Pera et al., 2003), and the implantation of FGF4 
soaked beads into the prospective non-neural ectoderm of the chick embryos 
induced the formation of ectopic neural tissue (section 1.5.1.1; Rodriguez-
Gallardo et al., 1997). During gastrulation, the injection of FGF8b into 
mouse embryos promoted the generation of NSCs (Dang and Tropepe, 2010). 
Therefore, both Nnat and FGF are positive instructive cues for neural 
induction. Using a microfluidic system to remove autocrine or paracrine 
FGF4 from the culture medium, the ability of mouse ESCs to generate 
neuroectodermal cells was suppressed, suggesting that FGF4 acts as the 
autocrine or paracrine signalling to help ESCs neural specification (Blagovic 
et al., 2011). Although Nnat is not a secretory protein (Dou and Joseph, 1996; 
Joe et al., 2008), my data revealed that Nnat was expressed in cells that 
belong to the neural lineage when mouse ESCs differentiate along a neural 
differentiation pathway (see section 3.2.2). These findings suggested that 
Nnat initiates neural development of mouse ESCs internally. Thus, Nnat and 




My research suggests that Nnat causes an increase in [Ca2+]i via its ability to 
inhibit the action of Apt2a2/SERCA2 (see sections 4.2.1, 4.2.2, and 4.2.3). 
The increase in [Ca2+]i is a positive instructive cue for neural induction in 
Xenopus embryos (see section 1.5.4.1; Batut et al., 2005; Leclerc et al., 2003; 
Moreau et al., 2008). Although the role of Ca2+ in neural induction of 
mammals is unknown, my data revealed that Nnat and an increase in [Ca2+]i 
were required for neural induction in mouse ESCs (see sections 3.2.4 and 
4.2.4). Therefore, an increase in [Ca2+]i may be also a positive cue for neural 
induction in mammals. In addition, my results revealed that an increase in 
[Ca2+]i, induced by Tg treatment, in mouse ESCs activated Erk signalling 
(see section 5.2.4). A similar finding has been reported in other cells where 
an increase in [Ca2+]i activates RasGRP, and in turn activates Ras and the 
Raf/MEK/Erk protein kinase cascade (details see section 1.5.4.3; Denys et 
al., 2004; Kupzig et al., 2005; Riddle et al., 2006). Therefore it seems a 
reasonable assumption that Nnat increases [Ca2+]i and activates Erk 
signalling through this pathway.  
 
Furthermore, Erk is the effector of FGF signalling and FGF/Erk signalling is 
important for neural induction in vertebrates (see section 1.5.1.3; Kuroda et 
al., 2005; Stavridis et al., 2007; Yoo et al., 2011). Thus, these positive 
instructive cues (Nnat, an increase in [Ca2+]i, and FGF) activate Erk 
signalling to promote neural induction. My work also confirmed that from 
other laboratories showing that inhibition of Erk signalling dramatically 
reduces the ability of ESCs to generate NSCs (see sections 5.2.1 and 5.2.4; 
Cohen et al., 2010; Stavridis et al., 2007; Tropepe et al., 2001). Therefore, 
the activation of Erk signalling is important for these positive instructive 
cues in neural induction.  
 
6.4 Challenge of default model of neural induction  
According to the results of experiments investigating neural induction in 
amphibians, the default model was proposed to explain the molecular 
mechanisms of neural induction (for details see section 1.2 and 1.3). This 
popular model suggests that, in the absence of BMP signalling, ectodermal 
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cells autonomously give rise to neuroectoderm (Hemmati-Brivanlou and 
Melton, 1997a). However, I have shown that the expression of Nnat is 
required for neural induction in mouse ESCs (see section 3.2.4). The 
formation of neuroectodermal cells was significantly reduced in Nnat-KD 
ESCs and this reduction was not due to the inability of Nnat-KD ESCs to 
generate ectodermal cells (see section 3.2.6). Thus, Nnat was needed during 
the differentiation of ectodermal cells into neuroectodermal cells. Further, 
when Nnat-KD ESCs were cultured with BMP antagonists, the ability of 
Nnat-KD ESCs to generate neuroectodermal cells was not restored (see 
section 5.2.7). Thus, even in absence of BMP signalling, Nnat-KD ESCs do 
not give rise to neural cells autonomously. Therefore, neural induction in 
mouse ESCs requires not only the inhibition of BMP signalling, but also 
other signals, at least one of which is the instructive cue Nnat.  
 
In addition to Nnat, I showed that inhibiting FGFR function in wild type 
ESCs suppressed the formation of neuroectodermal cells (see section 5.2.1), 
suggesting that the activation of FGF is required for the process of neural 
specification in mouse ESCs. Similar findings were also noted in vertebrate 
embryos (see section 1.5.1.2). For example, when Xenopus embryos were 
cultured with the FGFR inhibitor (SU5402), the generation of the neural 
plate marker NCAM-expressing cells was inhibited (Delaune et al., 2005). 
Further to this, I also showed that preventing an increase in [Ca2+]i in mouse 
ESCs using the membrane permeable calcium chelator (BAPTA-AM) also 
suppressed the generation of neuroectodermal cells (see section 4.2.4). 
Similarly, the treatment of Xenopus embryos with an L-type calcium channel 
blocker, R(+)BayK, to prevent the increase in [Ca2+]i suppressed neural 
induction (see section 1.5.4.2). Thus the instructive cues Nnat (via its ability 
to increase [Ca2+]i) and FGF are pivotal for neural induction in mouse ESCs, 
showing that the default model of neural induction is far too simple.  
 
However, the default model does provide an important insight into one 
important molecular mechanism required for neural induction, that being, 
the inhibition of BMP signalling. For example, electroporation of the 
prospective neural ectoderm of chick embryos with BMP4 inhibited the 
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expression of the neural plate markers Sox2 and Sox3 (Linker and Stern, 
2004), suggesting that the activation of BMP signalling repressed the neural 
specification of ectodermal cells. Similarly, within my thesis, I have shown 
that exposure of mouse ESCs to BMP4 suppressed the generation of 
neuroectodermal cells (see section 5.2.5) and treatment of Nnat-KD ESCs 
with BMP antagonists did not rescue the ability of Nnat-KD cells to generate 
neuroectodermal cells (see section 5.2.7). Thus simply inhibiting BMP 
signalling is not enough to induce the neural specification of Nnat-KD ESCs. 
BMP antagonists have also been shown to be unable to induce the 
generation of neural tissue in the prospective non-neural ectoderm of chick 
embryos (see section 1.5.1; Streit et al., 1998). However, when FGF8 and 
Chordin (a BMP antagonist) were applied to the prospective non-neural 
ectoderm of chick embryos together, the neural plate markers ERNI and 
Sox3 were induced (Stern, 2005). This leads to the idea that the inhibition of 
BMP signalling only makes ectodermal cells competent to differentiate into 
neural cells and a further instructive cue, such as FGF, Nnat, and calcium, is 
required to commit ectoderm to a neuroectodermal fate. 
 
6.5 There is competition between neural and non-neural fates 
As shown in section 3.2.3.2, over-expression of Nnat in mouse ESCs 
promoted neural specification, suggesting that Nnat is a positive cue in 
neural induction. However, the exposure of mouse ESCs to BMP4 inhibited 
the generation of NSCs (see section 5.2.5). When Nnatα was over-expressed 
in mouse ESCs, the treatment of BMP4 could not completely inhibit the 
generation of Sox1-expressing neuroectodermal cells (see section 5.2.5). 
This result suggests that the over-expression of the positive cue, Nnat, 
overcomes the negative cue BMP4 to allow mouse ESCs to differentiate into 
neural cells. Thus the positive and negative signals compete with each other 
to determine the lineage differentiation of mouse ESCs. Similarly, animal 
caps of Xenopus embryos consist of ectodermal cells that express BMP4 
causing the animal caps to take up an epidermal fate rather than a neural fate 
(Hemmati-Brivanlou and Melton, 1997b; Wilson et al., 1997). However, the 
injection of mouse Nnat into Xenopus embryos increased the expression of 
the neural plate marker Nrp1 in animal caps (see section 3.2.7), again 
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suggesting that the positive cue, Nnat, overrides the negative cue, BMP4, in 
Xenopus ectoderm. The above findings lead to the idea that neural induction 
in mouse ESCs is like a seesaw: when positive signals are greater than 
negative signals, then ectodermal cells differentiate along a neural fate. In 
contrast, if negative signals are greater than positive signals, then cells 
differentiate along a non-neural fate.  
 
In addition to the BMP signalling, the activation of Wnt or Activin/Nodal 
signalling in the ectoderm of vertebrates represses the generation of 
neuroectodermal cells (see sections 1.4, 1.5.2, and 1.5.3). For example, when 
Smad2 mRNA was injected into Xenopus embryos to activate Activin/Nodal 
signalling, the expression of the neural markers Sox2 and Sox3 in the neural 
plate was inhibited (Chang and Harland, 2007). Similarly, during ESCs 
differentiation, the activation of BMP, Wnt, or Activin/Nodal signalling also 
suppressed the generation of neural progenitors (see section 1.6.2; Aubert et 
al., 2002; Chambers et al., 2009; Gerrard et al., 2005; LaVaute et al., 2009). 
These findings show that Wnt, or Activin/Nodal signalling as well as BMP 
signalling can act as negative cues to repress the neural induction. 
Conversely, as mentioned above, Nnat, an increase in [Ca2+]i, and FGF act 
as positive cues to promote neural specification of vertebrate ectodermal 
cells. In considering how these positive and negative signallings interact, 
some research provides evidence in that field (Fuentealba et al., 2007; 
Kuroda et al., 2005; Pera et al., 2003). For instance, the prospective non-
neural ectoderm in Xenopus expresses BMP4 which activates the 
intracellular mediator Smad1, and target genes Msx1 and Msx2, resulting in 
the ectodermal cells giving rise to epidermal cells (Hemmati-Brivanlou and 
Melton, 1997a; Khadka et al., 2006; Kretzschmar et al., 1997b; Suzuki et al., 
1997). When Fgf8 mRNA was injected into Xenopus embryos, ectopic 
neural tissue was generated from the prospective non-neural ectoderm 
(details see section 1.5.1.4; Kuroda et al., 2005; Pera et al., 2003). The result 
suggests that the negative cue (endogenous BMP4) is overwhelmed by the 
positive cue (exogenous Fgf8) in ectodermal cells so the cells go on to adopt 
a neural fate.  
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Within Chapter 5, I showed that Nnat may down-regulate the expression of 
BMP4 and its target genes Msx1 and Msx2 in mouse ESCs (see section 
5.2.5). Nnat also antagonised the action of Apt2a2/SERCA2 to cause an 
increase in [Ca2+]i of ESCs (see sections 4.2.1 and 4.2.2). The increase in 
[Ca2+]i of ESCs is a positive neural inductive cue and activates Erk 
signalling (see section 5.2.4) to promote neural specification in mouse ESCs. 
Thus, Nnat may not only down-regulate the BMP signalling a negative cue, 
but also enhance the positive cues (Calcium and Erk signalling) to initiate 
neural induction in mouse ESCs. Thus positive and negative cues must 
interact during neural induction. For example, during Xenopus gastrulation, 
ectodermal cells generate BMP4 which causes the phosphorylation of 
Smad1 at the C-terminus, and the C-ter-p-Smad1 goes on to activate target 
genes, such as Msx1, Msx2, and Vent2 which inhibit neural induction (Fig. 
6.1; for details see section 1.5.1.4; Pera et al., 2003; Phippard et al., 1996; 
Suzuki et al., 1997). FGF/Erk signalling is active in the prospective neural 
ectoderm (Christen and Slack, 1999), and activated Erk1/2 phosphorylates 
the linker region of Smad1 to suppress the action of Smad1 and promote 
neural induction in Xenopus (Pera et al., 2003). Therefore, the positive cue 
FGF/Erk signalling suppresses the negative cue BMP signalling to induce 
the neural specification of ectodermal cells in Xenopus embryos (Fig. 6.1). 
Similarly, the linker region of Smad1 contains the phosphorylation site of 
GSK3 (Glycogen synthase kinase 3) and the phosphorylation of Smad1 by 
GSK3 induces polyubiquitinylation and a decrease in Smad1 activity in 
Xenopus embryos (Fuentealba et al., 2007). Because the activity of GSK3 is 
reduced by Wnt3a, the BMP-mediated Smad1 activation can be prolonged 
by activation of Wnt signalling (Fuentealba et al., 2007; McManus et al., 
2005). Thus the negative cues, Wnt and BMP signalling, work together to 
suppress neural induction in Xenopus (Fig. 6.1). In my study, I found that 
both Nnat and FGF are positive cues for neural induction in mouse ESCs 
because loss of the action of either Nnat or FGF significantly reduced the 
generation of NSCs from ESCs (see sections 3.2.4 and 5.2.1). As shown in 
sections 4.2.2, and 5.2.4, Nnat caused an increase in [Ca2+]i in ESCs, 
resulting in activation of Erk1/2 and inhibition of BMP signalling to promote 
neural induction. Furthermore, my results (see section 5.2.1) and a previous 
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report (Stavridis et al., 2007) showed that the activation of FGF/Erk 
signalling is required for neural induction in mouse ESCs. Thus the positive 
cues Nnat and FGF activate Erk signalling and allow neural induction to 
occur (Fig. 6.1).  
 
 
Fig. 6.1. Schematic representation of the positive and negative cues in neural induction. 
The negative cue BMP induces the phosphorylation of Smad1 at C-terminus and in turn 
activates the target gene Msx1 to promote an epidermal fate and inhibit neural induction. 
The positive cue FGF activates Erk1/2 and induces neural induction. Both active Erk1/2 and 
GSK3 phosphorylate Smad1 at linker region to cause the polyubiquitinylation of Smad1 and 
inhibits the epidermal development. The activation of Wnt signalling inhibits GSK3 and 
prolongs the action of Smad1 to promote epidermal development, suggesting that Wnt is a 
negative cue for neural induction. Nnat not only suppresses the expression of BMP4 and 
Msx1, but also cause an increase in [Ca2+]i to activate Erk1/2. Thus Nnat is a positive cue 
for neural induction.  
Abbreviations: BMP, Bone morphogenetic protein; [Ca2+]i, concentration of cytosolic Ca
2+; 
Erk1/2, Extracellular Signal-regulated Kinase 1/2; FGF, Fibroblast growth factor; GSK3, 
Glycogen synthase kinase 3. 
 
The exposure of human ESCs to FGF2 and SB431542 (an inhibitor of 
Activin/Nodal signalling) induced the generation of neuroectodermal cells, 
and conversely exposure of human ESCs to FGF2 and Activin significantly 
reduced (over 80%) the expression of the neural plate marker NCAM 
(Vallier et al., 2009), suggesting that the negative cue Activin represses 
neural induction in human ESCs. However, at present, it is not known 
whether there are any interactions or crosstalk between Activin/Nodal and 
FGF pathways during neural induction. To test whether Activin directly 
suppresses the FGF/Erk pathway, mouse ESCs could be treated with Activin 
and FGF at the same time and then the levels of p-Erk1/2 analysed to see if 
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FGF-mediated Erk signalling is suppressed by Activin.  
 
6.6 Nnat plays roles in neural induction and neurogenesis  
The expression of Nnat has been shown to be increased from the beginning 
of differentiation until the formation of neurons during mouse ESCs neural 
differentiation (see sections 1.7 and 3.2.2). In vivo data also showed that 
Nnat is not only expressed during early neural development but also in the 
adult NSCs where neurogenesis occurs (see section 1.7.1). These results 
suggest that Nnat plays roles in both neural induction (the first step of neural 
development) and neurogenesis (the process by which neurons are 
generated). This assumption can help to explain the observation that 
treatment of Nnat-KD ESCs with Tg (to mimic Nnat and increase [Ca2+]i 
and hence activate Erk1/2) or FGF4 at the beginning of differentiation 
rescued their ability to NSCs, with the same numbers being generated as 
from wild type ESCs, but only partially restored their ability to generate 
neurons (see sections 4.2.3.2 and 5.2.2). Here, many fewer neurons were 
generated compared with wild type ESCs. If Nnat was only required for 
neural induction, then similar numbers of neurons would be expected to be 
seen. These observations suggest that the effects of Tg or FGF4 are not 
sustained through the whole course of neurogenesis, and in addition to the 
early role played by Nnat in neural induction, this protein also plays another 
role during the neurogenesis of NSCs.     
 
6.7 Neural induction is conserved in vertebrates 
Within my thesis, I have demonstrated that Nnat is required for neural 
induction in mouse ESCs (see section 3.2.4), and that the injection of mouse 
Nnat mRNA into Xenopus embryos induced neural specification (see section 
3.2.7). These results suggested that the role of Nnat in neural induction is 
conserved in mouse ESCs and Xenopus. This finding leads to an assumption 
that the key molecular mechanisms underlying neural induction are 
conserved cross species in vertebrates. Some published data in which the 
organiser induces neural tissue in different species support this assumption. 
For example, Hensen's node is the chick equivalent of the Xenopus organiser 
(Yuan and Schoenwolf, 1998), and when Hensen's node was isolated and 
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sandwiched between two Xenopus animal cap explants, it induced the 
generation of neural tissue in these animal caps (Kintner and Dodd, 1991). 
Thus, the organiser of chick embryos can direct Xenopus ectodermal cells 
along a neural fate. Similarly ‘the node’ which is the organiser in mouse 
embryos, is located at the anterior end of the primitive streak (Beddington, 
1994; Kinder et al., 2001), and when the anterior portion of primitive streak 
is isolated and transplanted into the ventral side of the blastocoel 
(prospective non-neural ectoderm) of a host Xenopus embryos, it can induce 
ectopic neural tissue, too (Blum et al., 1992). Thus, the organiser of mouse 
embryos can also induce neural tissue in Xenopus embryos. Finally, the 
transplantation of the organiser - equivalent of rabbit embryo into chick 
embryos induced ectopic Sox3-expressing neural tissue (Knoetgen et al., 
1999). This cross-species neural inductive ability of the organiser suggests 
that the molecular mechanisms of neural induction are conserved in the 
vertebrates.  
 
Both my experiments and previously published studies (see section 1.6.2 and 
5.2.5) showed that the activation of BMP signalling suppresses neural 
induction in ESCs. These results are consistent with the findings in Xenopus, 
chick, and mouse embryos where BMP signalling inhibits neural 
specification during gastrulation (see section 1.4). From this point of view, 
the role of BMP signalling is conserved in ESCs and vertebrates. Similarly 
the activation of FGF/Erk signalling is required for neural induction in ESCs, 
Xenopus, chick, and mouse embryos (see sections1.5.1 and 1.6.2). Thus, the 
role of FGF/Erk signalling is also conserved in ESCs and vertebrates. In 
addition to BMP and FGF/Erk signals, the activation of Wnt or 
Activin/Nodal signalling represses neural induction not only in ESCs, but 
also in vertebrate embryos during gastrulation (see sections 1.5.2, 1.5.3, and 
1.6.2). Therefore, the roles of these key signals are similar in neural 
induction of ESCs and vertebrate embryos, suggesting that the molecular 
mechanisms of neural induction are conserved. This means that since ESCs 
are easier to manipulate than mammalian embryos, studies on the molecular 
mechanisms underlying neural induction can be carried out using ESCs first, 
and then these in vitro finding could be tested in vivo. For example, my in 
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vitro findings revealed that Nnat is needed for neural specification of mouse 
ESCs (see section 3.2.4). If the role of Nnat is conserved in ESCs and mouse 
embryo, then it would be worth creating Nnat inducible knockout mouse in 
the future to study its role in neural induction of mouse embryos in vivo. 
 
6.8 Nnat/Erk may interact with Sp1 to activate the transcription of Sox2 
in neural induction 
Within Chapter 4 and 5, I showed that Nnat caused an increase in [Ca2+]i and 
in turn this increase in [Ca2+]i activated Erk1/2. The activation of Erk 
signalling is pivotal for the neural induction of mouse ESCs (see section 
5.2.1). Erk1/2 is a protein kinase and the active form (p-Erk1/2) physically 
interacts with various transcription factors (Chang et al., 2003; Dajee et al., 
2003; Karin, 1995; Pages, 2007; Yeh et al., 2004). Sp1 is one of these 
transcription factors (Milanini-Mongiat et al., 2002). It is a zinc-finger 
protein that is expressed in neuroectoderm, hematopoietic cells, and giant 
trophoblast cells of mouse embryos at 8.5 dpc (Saffer et al., 1991). The 
human early neural marker SOX3 and mouse Sox2 promoters contain 
binding sites for Sp1 (Archer et al., 2010; Kovacevic Grujicic et al., 2005; 
Wiebe et al., 2000), and Sp1 is also a positive regulator of the NSC marker 
Nestin in mouse (Cheng et al., 2004). Therefore, Nnat-mediated Erk 
signalling may cause the phosphorylation of Sp1 that in turn activates Sox2 
and Nestin to promote neural induction, but more experiments are needed to 
verify this.  
 
6.9 A better understanding of neural induction facilitates the future 
usage of ESCs in cell replacement therapy for neurodegenerative 
disorders 
Neurodegenerative disorders are diseases where neurons are progressively 
lost; examples include Parkinson’s, Alzheimer’s and Huntington’s diseases, 
and amyotrophic lateral sclerosis (Mattson, 2000). Parkinson’s disease is a 
well-known condition caused by the death of dopaminergic neurons in the 
substantia nigra of the midbrain (Lotharius and Brundin, 2002). The 
transplantation of human embryonic dopaminergic neurons into the brains of 
patients with Parkinson’s disease has been used to improve the symptoms 
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and signs of this disease (Freed et al., 2001). However, the dopaminergic 
neurons used for transplantation are isolated from human embryos. Thus the 
source of transplanted cells is an important issue because a limited number 
of dopaminergic neurons were isolated from each embryo (Kim et al., 2002). 
As discussed in section 1.6.1, ESCs are pluripotent and able to differentiate 
into all the cell types of the adult body. Therefore ESCs could be used as a 
source of different tissue-specific cells (Dang and Tropepe, 2006; Kim et al., 
2002; Williams et al., 1988; Wu et al., 2007). This implies that ESCs have a 
great therapeutic promise for cell replacement therapies and regenerative 
medicine. Further, the transplantation of ESC-derived dopaminergic neurons 
into an animal model of Parkinson’s disease improved the symptoms of this 
disease (Kim et al., 2002; Kriks et al., 2011). Similarly behavioural 
improvements in Parkinsonian rats were noted after human ESC-derived 
neural progenitors were transplanted into the striatum (Ben-Hur et al., 2004). 
In addition to Parkinson’s disease, ESCs-derived neural cells has been 
transplanted into the cortex of a mouse model of Alzheimer's disease to 
improve memory disruption of diseased mice (Wang et al., 2006). These 
results suggested that transplantation of ESC-derived neural cells is a 
possible strategy in the treatment of Neurodegenerative disorders. However, 
the long-term safety of transplanted cells is a crucial issue. For instance, 
tumour formation is a common theme of ESCs based cell replacement 
therapy (Brederlau et al., 2006; Kim et al., 2002). Although the studies cited 
above did not show that the transplantation of ESC-derived neural cells 
induced the tumour formation in animals (Ben-Hur et al., 2004; Brederlau et 
al., 2006; Kim et al., 2002; Kriks et al., 2011), these animals were sacrificed 
for analysis at 12-20 weeks after transplantation. Therefore, it is uncertain 
whether or not teratomas will be found in a long-term follow-up.  
 
In addition to tumour formation, it is hard to generate pure tissue-specific 
cells form ESCs and this has become another obstacle to their therapeutic 
uses (Dang and Tropepe, 2006). Cell replacement therapy is based on the 
fact that stem cells have the potential to be precisely directed to differentiate 
along different cell lineages, producing different tissue-specific progenitor 
cells that can be used for transplantation (Brederlau et al., 2006; Brustle et 
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al., 1999; Keller, 2005). A better understanding of the molecular 
mechanisms of neural development will help develop protocols that will 
enable the routine generation of neural progenitor cells or neurons from 
ESCs for therapeutic purposes in vitro (Suter and Krause, 2008). My study 
focused on the mechanisms by which Nnat promotes neural induction, which 
is the fist step of neural development. The data I have presented within this 
thesis demonstrate that Nnat modulates cytosolic Ca2+ levels to activate Erk 
signalling and suppress BMP signalling, resulting in promotion of neural 
induction. Although my study is basic research, it may help us to understand 
the mechanisms regulating ESCs differentiation into therapeutically relevant 
cells and facilitate the future usage of ESCs in cell replacement therapy for 






Appendix 1. Schematic vector map of pNEBR-X1-Hygro. 
(A) The vector pNEBR-X1-Hygro (New England Biolabs) contains AmpR, HygR, ori, and 
MCS downstream of 5 copies of GAL4 RE (5XRE) and a minimal promoter. (B) The 
MCS contains a sequence that can be recognised by HindIII and BamHI. Nnat was cloned 
into the HindIII and BamHI sites and the vector was transfected into ESCs to generate 
Nnat-OE ESCs. Hygromycin was used to select the transfected cells.  
Abbreviations: AmpR, Ampicillin-resistance gene; ESCs, embryonic stem cells; HygR, 
Hygromycin-resistance gene; MCS, multiple cloning site; ori, origin of replication; RE, 







Appendix 2. Negative controls for immunocytochemical analysis.  
46C ESCs were grown on gelatine-coated coverslips in non-differentiation condition for 
two days. After fixation and permeabilization, (A) Cy3-conjugated mouse, (B) Cy3-
conjugated rabbit, (C) Cy3-conjugated rat, (D) FITC-conjugated rabbit secondary 
antibodies were applied at room temperature for one hour. Cells were then washed four 
times in PBS and submerged in double distilled water prior to mounting of coverslips 
onto slides using mounting medium with DAPI to stain the nuclei. Fluorescent 
microscopy images were acquired and no Cy3 or FITC fluorescence was observed in the 
absence of primary antibody. Scale bar, 20 μm. 
Abbreviations: Cy3, Cyanine 3; DAPI, 4',6-diamidino-2-phenylindole; ESC, embryonic 






Appendix 3. Nnat expression in Nnatα-OE, Nnatβ-OE, and 46C ESCs. 
The selected Nnat-OE clones and 46C ESCs were grown on gelatine-coated coverslips 
and cultured in non-differentiating condition for two days. After fixation, the expression 
of Nnat was detected by immunocytochemical analysis using the primary antibody 
against both Nnatα and Nnatβ. (A) The basal expression of Nnat (red) in 46C ESCs was 
revealed. (B-I) The expression of Nnat was increased in clones 4, 7, and 8 of Nnatα-OE 
ESCs. (J-Q) The expression of Nnat was increased in clones 2 and 4 of Nnatβ-OE ESCs. 
All nuclei were stained with DAPI (blue). Scale bar, 20 μm. 







Appendix 4. Anti-Keratin 18 antibody did not bind non-specifically. 
The 46C and Nnatα-OE ESCs were grown on gelatine-coated coverslips and cultured in 
differentiating conditions with/without BMP4 (10 ng/ml) treatment for 4 days. After 
fixation, the expression of the epidermal marker Keratin 18 was detected by 
immunocytochemical analysis. If the anti-Keratin 18 antibody cross reacted with actin 
and/or collagen, then the Sox1-GFP+ cells should be stained with the antibody.  (A,C) 
46C and Nnatα-OE ESCs generated Sox1-GFP+ neuroectodermal cells after 4 days of 
differentiation. (B) BMP4 is an epidermal inducer and neural inhibitor, so the treatment of 
46C ESCs with BMP4 suppressed the generation of Sox1-GFP+ neural progenitors and 
induced the generation of Keratin 18+ epidermal cells (red), which could be a positive 
control for anti-keratin antibody. (D) After treatment with BMP4, Nnatα-OE ESCs still 
generated Sox1-GFP+ cells and the expression of Keratin 18 was reduced. In Figure A, C, 
and D, Keratin 18 was not expressed in these Sox1-GFP+ cells, suggesting that the anti-
Keratin 18 antibody did not cross react with actin and/or collagen. All nuclei were stained 
with DAPI (blue). Scale bar, 20 μm. 
Abbreviations: BMP, Bone morphogenetic protein; DAPI, 4',6-diamidino-2-phenylindole; 
ESC, embryonic stem cell; GFP, green fluorescent protein; Nnat, Neuronatin; Sox1, SRY 





Appendix 5. 5 μM PD184352 suppresses FGF4-induced phosphorylation of Erk1/2. 
46C ESCs were treated with 5 ng/ml of FGF4 and/or 5 μM PD184352 for one hour and 
then the protein levels of p-Erk1/2 were analysed by Western blotting using an anti-p-
Erk1/2 antibody. The exposure of FGF4 increased p-Erk1/2, and the activation of Erk1/2 
was inhibited by the MEK inhibitor PD184352.   
Abbreviations: Erk, Extracellular Signal-regulated Kinase; ESC, embryonic stem cell; 
FGF4, Fibroblast growth factor 4; MEK, Mitogen-activated Protein/Extracellular Signal-








Appendix 6. Mouse ESCs express Fgf4 in non-differentiating conditions. 
The ability of wild type mouse ESCs to generate NSCs in the monolayer culture system 
was suppressed by PD173074 (a FGFR inhibitor) treatment, suggesting that FGF plays a 
role in neural induction of mouse ESCs. Fgf4 is the first expressed gene of FGF family 
during mouse embryogenesis. Fgf4 is expressed in ICM and mouse ESCs are generated 
from ICM, so Fgf4 should be also expressed in ESCs. 46C, Nnatα-OE, and Nnat-KD 
ESCs were grown in non-differentiating conditions, and cultures were collected to 
examine the expression of genes using real-time PCR. 46C, Nnatα-OE, and Nnat-KD 
ESCs all expressed Fgf4 and there was no significantly difference between these ESCs (p 
> 0.05, one-way ANOVA test). Fgf5 is the marker of primitive ectoderm and it is not 
expressed in ESCs. As expected, these mouse ESCs did not express Fgf5.   
Abbreviations: ANOVA, analysis of variance; ESC, embryonic stem cell; Fgf, fibroblast 
growth factor; Nnat-KD, Nnat-knockdown; Nnatα-OE, Nnatα-overexpression; PCR, 
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